{
  "type": "FeatureCollection",
  "features": [
    {
      "type": "Feature",
      "id": "12",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.298987,
            -3.485903
          ],
          [
            2.386938,
            -3.361085
          ],
          [
            5.945711,
            1.696129
          ],
          [
            6.034319,
            1.82204
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "1",
        "dest": "2",
        "label": "Progesterone Receptor Signaling Mechanisms. -- The biology of progesterone receptor in the normal mammary gland and in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "13",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.299442,
            -3.490666
          ],
          [
            2.407154,
            -3.613482
          ],
          [
            6.596918,
            -8.372417
          ],
          [
            6.703281,
            -8.492616
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "1",
        "dest": "3",
        "label": "Progesterone Receptor Signaling Mechanisms. -- Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "24",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.027933,
            1.826785
          ],
          [
            5.774979,
            1.900629
          ],
          [
            -0.343019,
            3.685396
          ],
          [
            -0.595339,
            3.758941
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "4",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "25",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.036005,
            1.82208
          ],
          [
            6.036128,
            1.679947
          ],
          [
            6.041859,
            -4.8616
          ],
          [
            6.041984,
            -5.004922
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "5",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Interplay between progesterone and prolactin in mammary development and implications for breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "27",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.028526,
            1.822096
          ],
          [
            5.730872,
            1.729172
          ],
          [
            -3.358163,
            -1.10938
          ],
          [
            -3.657649,
            -1.202902
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "7",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- From the ranks of mammary progesterone mediators, RANKL takes the spotlight.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "210",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.036202,
            1.822024
          ],
          [
            6.040604,
            1.769096
          ],
          [
            6.116231,
            0.859812
          ],
          [
            6.120586,
            0.807457
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "10",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Progesterone/RANKL is a major regulatory axis in the human breast.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "214",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.043895,
            1.826769
          ],
          [
            6.232189,
            1.882563
          ],
          [
            9.727684,
            2.917939
          ],
          [
            9.916148,
            2.973738
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "14",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "231",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.037391,
            1.82681
          ],
          [
            6.087929,
            1.913293
          ],
          [
            7.500437,
            4.32791
          ],
          [
            7.551459,
            4.415009
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "31",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Progesterone signalling in breast cancer: a neglected hormone coming into the limelight.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "48",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.604872,
            3.758873
          ],
          [
            -0.710637,
            3.589598
          ],
          [
            -6.359002,
            -5.458369
          ],
          [
            -6.463797,
            -5.625649
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "4",
        "dest": "8",
        "label": "Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. -- Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "419",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.60172,
            3.763719
          ],
          [
            -0.491805,
            3.926455
          ],
          [
            5.081882,
            12.109211
          ],
          [
            5.190734,
            12.267094
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "4",
        "dest": "19",
        "label": "Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. -- Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "420",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.601904,
            3.763666
          ],
          [
            -0.558792,
            3.833954
          ],
          [
            0.423466,
            5.433626
          ],
          [
            0.46661,
            5.503801
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "4",
        "dest": "20",
        "label": "Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. -- Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "422",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.60649,
            3.758938
          ],
          [
            -0.710994,
            3.680591
          ],
          [
            -3.403352,
            1.660146
          ],
          [
            -3.508483,
            1.581196
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "4",
        "dest": "22",
        "label": "Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. -- A role for site-specific phosphorylation of mouse progesterone receptor at serine 191 in vivo.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "56",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.04517,
            -5.009654
          ],
          [
            6.208936,
            -5.129923
          ],
          [
            12.640119,
            -9.829751
          ],
          [
            12.804954,
            -9.949474
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "5",
        "dest": "6",
        "label": "Interplay between progesterone and prolactin in mammary development and implications for breast cancer. -- Progesterone regulation of stem and progenitor cells in normal and malignant breast.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "527",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.138284,
            -5.006924
          ],
          [
            7.342572,
            -5.00199
          ],
          [
            19.455034,
            -4.952372
          ],
          [
            20.496669,
            -4.948104
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "5",
        "dest": "27",
        "label": "Interplay between progesterone and prolactin in mammary development and implications for breast cancer. -- The pivotal role of insulin-like growth factor I in normal mammary development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "533",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.071451,
            -5.004993
          ],
          [
            6.886307,
            -4.940703
          ],
          [
            24.336536,
            -3.562556
          ],
          [
            25.15194,
            -3.498102
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "5",
        "dest": "33",
        "label": "Interplay between progesterone and prolactin in mammary development and implications for breast cancer. -- Hormonal regulation of the immune microenvironment in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1059",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.123099,
            0.802704
          ],
          [
            6.241254,
            0.68034
          ],
          [
            10.837123,
            -4.076197
          ],
          [
            10.953797,
            -4.19672
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "10",
        "dest": "59",
        "label": "Progesterone/RANKL is a major regulatory axis in the human breast. -- Comment on \"Progesterone/RANKL is a major regulatory axis in the human breast\".",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1060",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.123149,
            0.802745
          ],
          [
            6.211795,
            0.714348
          ],
          [
            8.761928,
            -1.828554
          ],
          [
            8.850311,
            -1.916651
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "10",
        "dest": "60",
        "label": "Progesterone/RANKL is a major regulatory axis in the human breast. -- RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1478",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.929306,
            2.973719
          ],
          [
            10.126012,
            2.885352
          ],
          [
            15.784756,
            0.341146
          ],
          [
            15.980874,
            0.252929
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "14",
        "dest": "78",
        "label": "Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland. -- Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1479",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.942648,
            2.973741
          ],
          [
            10.376478,
            2.919234
          ],
          [
            18.261093,
            1.928188
          ],
          [
            18.694841,
            1.873649
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "14",
        "dest": "79",
        "label": "Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland. -- BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "1482",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.981542,
            2.978413
          ],
          [
            11.008012,
            3.020084
          ],
          [
            25.448857,
            3.606164
          ],
          [
            26.475271,
            3.647808
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "14",
        "dest": "82",
        "label": "Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland. -- Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1484",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.930874,
            2.978441
          ],
          [
            10.202437,
            3.072569
          ],
          [
            18.49573,
            5.941975
          ],
          [
            18.766971,
            6.035611
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "14",
        "dest": "84",
        "label": "Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland. -- Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "31196",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.549843,
            4.419795
          ],
          [
            7.429105,
            4.514004
          ],
          [
            3.74185,
            7.384015
          ],
          [
            3.621255,
            7.477609
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "31",
        "dest": "196",
        "label": "Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. -- Harmful effect of ER\u03b2 on BCRP-mediated drug resistance and cell proliferation in ER\u03b1/PR-negative breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "89",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.463787,
            -5.625602
          ],
          [
            -6.385029,
            -5.498079
          ],
          [
            -3.197451,
            -0.320899
          ],
          [
            -3.11964,
            -0.194317
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "9",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "811",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.466751,
            -5.630441
          ],
          [
            -6.52954,
            -5.733886
          ],
          [
            -8.573175,
            -9.088601
          ],
          [
            -8.635028,
            -9.189708
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "11",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- Paracrine-rescued lobulogenesis in chimeric outgrowths comprising progesterone-receptor-null mammary epithelium and redirected wild-type testicular cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "812",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.463712,
            -5.630404
          ],
          [
            -6.34079,
            -5.819261
          ],
          [
            1.002974,
            -16.917446
          ],
          [
            1.124883,
            -17.097456
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "12",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "813",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.463651,
            -5.630416
          ],
          [
            -6.349705,
            -5.799825
          ],
          [
            -0.26444,
            -14.73692
          ],
          [
            -0.151539,
            -14.900001
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "13",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "815",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.463053,
            -5.630348
          ],
          [
            -6.311079,
            -5.790661
          ],
          [
            1.593069,
            -14.037393
          ],
          [
            1.747432,
            -14.196096
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "15",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "821",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.467383,
            -5.630339
          ],
          [
            -6.548855,
            -5.720471
          ],
          [
            -8.962657,
            -8.383367
          ],
          [
            -9.043958,
            -8.472774
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "21",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- Research resource: progesterone receptor targetome underlying mammary gland branching morphogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "849",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.4548,
            -5.630342
          ],
          [
            -6.171517,
            -5.693507
          ],
          [
            -0.234404,
            -7.015643
          ],
          [
            0.048088,
            -7.078465
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "49",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1923",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.229389,
            12.267155
          ],
          [
            5.919295,
            12.224631
          ],
          [
            16.023256,
            11.601109
          ],
          [
            16.713151,
            11.558485
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "23",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1926",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.21897,
            12.271724
          ],
          [
            5.740271,
            12.316519
          ],
          [
            13.748643,
            13.003681
          ],
          [
            14.269142,
            13.048279
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "26",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- Progesterone receptor A-regulated gene expression in mammary organoid cultures.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "19104",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.192583,
            12.271727
          ],
          [
            5.203641,
            12.379747
          ],
          [
            5.602575,
            16.24407
          ],
          [
            5.613676,
            16.350609
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "104",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "19105",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.191638,
            12.271809
          ],
          [
            5.165797,
            12.358064
          ],
          [
            4.44323,
            14.757744
          ],
          [
            4.417835,
            14.841625
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "105",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- Collaborative interaction of Oct-2 with Oct-1 in transactivation of lactogenic hormones-induced \u03b2-casein gene expression in mammary epithelial cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "19107",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.191624,
            12.271809
          ],
          [
            5.139213,
            12.443045
          ],
          [
            2.263899,
            21.626315
          ],
          [
            2.211957,
            21.787722
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "107",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "19111",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.191604,
            12.271745
          ],
          [
            5.17109,
            12.335169
          ],
          [
            4.734151,
            13.682394
          ],
          [
            4.71368,
            13.745329
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "111",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "19114",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.178844,
            12.27173
          ],
          [
            4.92954,
            12.31403
          ],
          [
            1.309243,
            12.927531
          ],
          [
            1.060289,
            12.969665
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "114",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "2048",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.466905,
            5.508597
          ],
          [
            0.388942,
            5.669551
          ],
          [
            -3.564605,
            13.745999
          ],
          [
            -3.641814,
            13.901518
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "20",
        "dest": "48",
        "label": "Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse. -- Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "635",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.822091,
            -9.949505
          ],
          [
            13.079953,
            -9.906637
          ],
          [
            16.838707,
            -9.281176
          ],
          [
            17.09627,
            -9.238276
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "6",
        "dest": "35",
        "label": "Progesterone regulation of stem and progenitor cells in normal and malignant breast. -- Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "640",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.806088,
            -9.949508
          ],
          [
            12.734206,
            -9.870175
          ],
          [
            10.832706,
            -7.765071
          ],
          [
            10.76031,
            -7.6847
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "6",
        "dest": "40",
        "label": "Progesterone regulation of stem and progenitor cells in normal and malignant breast. -- Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "27158",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            20.56436,
            -4.95015
          ],
          [
            20.470787,
            -5.009772
          ],
          [
            18.619182,
            -6.188305
          ],
          [
            18.525216,
            -6.248048
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "27",
        "dest": "158",
        "label": "The pivotal role of insulin-like growth factor I in normal mammary development. -- Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "27159",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            20.562988,
            -4.950162
          ],
          [
            20.401837,
            -5.025319
          ],
          [
            16.431082,
            -6.874085
          ],
          [
            16.270224,
            -6.94884
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "27",
        "dest": "159",
        "label": "The pivotal role of insulin-like growth factor I in normal mammary development. -- On the possible role of mammary-derived growth hormone in human breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "27161",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            20.609063,
            -4.945485
          ],
          [
            21.366476,
            -4.902545
          ],
          [
            32.364677,
            -4.278709
          ],
          [
            33.122318,
            -4.235716
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "27",
        "dest": "161",
        "label": "The pivotal role of insulin-like growth factor I in normal mammary development. -- Critical questions in mammary gland development, lactational biology and breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "33202",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.171676,
            -3.493432
          ],
          [
            24.835853,
            -3.413075
          ],
          [
            15.951224,
            -1.285153
          ],
          [
            15.615135,
            -1.204606
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "33",
        "dest": "202",
        "label": "Hormonal regulation of the immune microenvironment in the mammary gland. -- Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "33203",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.21245,
            -3.493438
          ],
          [
            25.817066,
            -3.447949
          ],
          [
            35.068009,
            -2.751673
          ],
          [
            35.672648,
            -2.706149
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "33",
        "dest": "203",
        "label": "Hormonal regulation of the immune microenvironment in the mammary gland. -- Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "33204",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.251187,
            -3.495696
          ],
          [
            26.170177,
            -3.494702
          ],
          [
            35.876936,
            -3.484223
          ],
          [
            36.799082,
            -3.483229
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "33",
        "dest": "204",
        "label": "Hormonal regulation of the immune microenvironment in the mammary gland. -- Hormonal regulation of the cytokine microenvironment in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "33205",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.194656,
            -3.493442
          ],
          [
            25.564249,
            -3.428303
          ],
          [
            33.566449,
            -2.016979
          ],
          [
            33.936469,
            -1.951683
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "33",
        "dest": "205",
        "label": "Hormonal regulation of the immune microenvironment in the mammary gland. -- Stromal fibroblasts and the immune microenvironment: partners in mammary gland biology and pathology?",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "60337",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.854744,
            -1.921373
          ],
          [
            8.89397,
            -1.966198
          ],
          [
            9.474607,
            -2.629539
          ],
          [
            9.513688,
            -2.674175
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "60",
        "dest": "337",
        "label": "RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase. -- The expression of syndecan-1, syndecan-4 and decorin in healthy human breast tissue during the menstrual cycle.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "60338",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.966698,
            -1.919443
          ],
          [
            9.980996,
            -1.923435
          ],
          [
            17.446064,
            -1.952814
          ],
          [
            18.585551,
            -1.957301
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "60",
        "dest": "338",
        "label": "RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase. -- Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "60339",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.860896,
            -1.921342
          ],
          [
            9.084828,
            -1.985175
          ],
          [
            13.803281,
            -3.329503
          ],
          [
            14.026638,
            -3.393099
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "60",
        "dest": "339",
        "label": "RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase. -- Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78459",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.005076,
            0.248245
          ],
          [
            16.518478,
            0.185053
          ],
          [
            27.277896,
            -1.139225
          ],
          [
            27.791146,
            -1.202386
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "459",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Prepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78460",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.02494,
            0.248248
          ],
          [
            17.069713,
            0.185457
          ],
          [
            38.848009,
            -1.123317
          ],
          [
            39.893521,
            -1.186135
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "460",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Prepubertal exposure to cow's milk reduces susceptibility to carcinogen-induced mammary tumorigenesis in rats.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78461",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.049431,
            0.248248
          ],
          [
            17.212838,
            0.20536
          ],
          [
            34.027097,
            -0.414444
          ],
          [
            35.190507,
            -0.457328
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "461",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Prepubertal octylphenol exposure up-regulate BRCA1 expression, down-regulate ERalpha expression and reduce rat mammary tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78462",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.091913,
            0.250767
          ],
          [
            17.319838,
            0.252939
          ],
          [
            28.841564,
            0.273302
          ],
          [
            29.964505,
            0.275286
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "462",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78463",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.003026,
            0.248248
          ],
          [
            16.318095,
            0.204797
          ],
          [
            20.927881,
            -0.430897
          ],
          [
            21.243197,
            -0.474381
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "463",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Lack of ABCG2 shortens latency of BRCA1-deficient mammary tumors and this is not affected by genistein or resveratrol.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78464",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.006253,
            0.252917
          ],
          [
            16.414597,
            0.300225
          ],
          [
            22.893725,
            1.050808
          ],
          [
            23.302219,
            1.098124
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "464",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Segregated responses of mammary gland development and vaginal opening to prepubertal genistein exposure in Bscl2(-/-) female mice with lipodystrophy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79466",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.767648,
            1.873646
          ],
          [
            19.73114,
            1.915149
          ],
          [
            33.22424,
            2.496242
          ],
          [
            34.187389,
            2.537712
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "466",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79467",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.77415,
            1.868979
          ],
          [
            20.028299,
            1.82079
          ],
          [
            40.302705,
            1.041636
          ],
          [
            41.5569,
            0.99343
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "467",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "79468",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.746746,
            1.868973
          ],
          [
            19.904154,
            1.787739
          ],
          [
            50.836494,
            -0.384087
          ],
          [
            51.993409,
            -0.465326
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "468",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79469",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.730036,
            1.868976
          ],
          [
            19.491292,
            1.761892
          ],
          [
            46.170879,
            -1.992242
          ],
          [
            46.93281,
            -2.099405
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "469",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- BRCA1, hormone, and tissue-specific tumor suppression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79470",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.73848,
            1.868973
          ],
          [
            19.772707,
            1.77246
          ],
          [
            52.488854,
            -1.281717
          ],
          [
            53.522955,
            -1.378239
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "470",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79471",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.75085,
            1.868979
          ],
          [
            19.817348,
            1.802517
          ],
          [
            43.330935,
            0.336748
          ],
          [
            44.39814,
            0.27021
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "471",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "82488",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.61142,
            3.648175
          ],
          [
            27.743101,
            3.619927
          ],
          [
            40.72245,
            3.29586
          ],
          [
            41.939935,
            3.265458
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "488",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- HIF-1\u03b1 overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "82489",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.556895,
            3.647808
          ],
          [
            27.311429,
            3.574965
          ],
          [
            45.503898,
            1.817171
          ],
          [
            46.258632,
            1.744197
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "489",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "82490",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.611395,
            3.651652
          ],
          [
            27.833156,
            3.675161
          ],
          [
            42.898895,
            3.964996
          ],
          [
            44.265109,
            3.991275
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "490",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "82491",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.529057,
            3.65249
          ],
          [
            26.4566,
            3.69859
          ],
          [
            25.341547,
            4.407696
          ],
          [
            25.268665,
            4.454022
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "491",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- Expression microarray identifies the unliganded glucocorticoid receptor as a regulator of gene expression in mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "82492",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.588465,
            3.647812
          ],
          [
            27.91336,
            3.592414
          ],
          [
            52.436295,
            2.56649
          ],
          [
            53.761456,
            2.511026
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "492",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "82493",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.523094,
            3.652484
          ],
          [
            26.258977,
            3.716604
          ],
          [
            20.663703,
            5.073757
          ],
          [
            20.400207,
            5.137603
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "493",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- The unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP beta.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "82494",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.545149,
            3.652481
          ],
          [
            26.920757,
            3.723349
          ],
          [
            35.707915,
            5.379439
          ],
          [
            36.083171,
            5.450072
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "494",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- Glucocorticoid receptor repression mediated by BRCA1 inactivation in ovarian cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "84502",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.786644,
            6.040286
          ],
          [
            19.26345,
            6.126532
          ],
          [
            32.83127,
            8.574123
          ],
          [
            33.308116,
            8.659885
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "502",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "84503",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.772252,
            6.040341
          ],
          [
            18.722702,
            6.117998
          ],
          [
            17.478636,
            8.06366
          ],
          [
            17.428843,
            8.141352
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "503",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "84504",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.776422,
            6.040335
          ],
          [
            18.824754,
            6.083717
          ],
          [
            19.51883,
            6.706315
          ],
          [
            19.566896,
            6.749402
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "504",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Myc is required for \u03b2-catenin-mediated mammary stem cell amplification and tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "84505",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.781281,
            6.040283
          ],
          [
            19.097626,
            6.138282
          ],
          [
            29.307852,
            9.289944
          ],
          [
            29.624353,
            9.387239
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "505",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "84506",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.783476,
            6.040283
          ],
          [
            19.047333,
            6.103498
          ],
          [
            24.606402,
            7.433455
          ],
          [
            24.870904,
            7.496642
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "506",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "947",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.118863,
            -0.189595
          ],
          [
            -3.170201,
            -0.008717
          ],
          [
            -6.148278,
            10.425705
          ],
          [
            -6.200623,
            10.607032
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "47",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "950",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.122928,
            -0.189601
          ],
          [
            -3.329368,
            -0.086775
          ],
          [
            -10.21579,
            3.341375
          ],
          [
            -10.422539,
            3.444173
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "50",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Epimorphin is a novel regulator of the progesterone receptor isoform-a.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "951",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.123817,
            -0.18961
          ],
          [
            -3.332945,
            -0.102229
          ],
          [
            -9.305673,
            2.392639
          ],
          [
            -9.514131,
            2.479659
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "51",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "952",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.12751,
            -0.194305
          ],
          [
            -3.407181,
            -0.26466
          ],
          [
            -9.891761,
            -1.895609
          ],
          [
            -10.171846,
            -1.966031
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "52",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "953",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.120735,
            -0.194295
          ],
          [
            -3.271071,
            -0.332368
          ],
          [
            -10.037843,
            -6.533032
          ],
          [
            -10.189811,
            -6.671681
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "53",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1241",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.124681,
            -17.102002
          ],
          [
            1.063295,
            -17.182677
          ],
          [
            -0.605199,
            -19.361578
          ],
          [
            -0.667096,
            -19.44187
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "41",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- High hopes for RANKL: will the mouse model live up to its promise?",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "1242",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.121649,
            -17.101966
          ],
          [
            0.904474,
            -17.204264
          ],
          [
            -6.656704,
            -20.728553
          ],
          [
            -6.874486,
            -20.828926
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "42",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- A local basis for progesterone action during mammary tumorigenesis - no longer RANK and file.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "1244",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.094881,
            -17.097488
          ],
          [
            0.434134,
            -17.050716
          ],
          [
            -10.39446,
            -16.28257
          ],
          [
            -11.05543,
            -16.235583
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "44",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1245",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.119724,
            -17.101957
          ],
          [
            0.969743,
            -17.152052
          ],
          [
            -1.651359,
            -18.025338
          ],
          [
            -1.802254,
            -18.075482
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "45",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- RANKL inhibition: a promising novel strategy for breast cancer treatment.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1246",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.120599,
            -17.101963
          ],
          [
            0.749086,
            -17.245193
          ],
          [
            -17.290947,
            -24.051925
          ],
          [
            -17.663071,
            -24.188974
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "46",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1269",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.125094,
            -17.10196
          ],
          [
            1.045043,
            -17.237528
          ],
          [
            -2.640971,
            -23.361382
          ],
          [
            -2.721952,
            -23.493087
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "69",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1270",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.128562,
            -17.102011
          ],
          [
            1.249844,
            -17.231461
          ],
          [
            6.475343,
            -22.715278
          ],
          [
            6.595248,
            -22.838782
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "70",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1376",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.148146,
            -14.904585
          ],
          [
            -0.050455,
            -15.028494
          ],
          [
            3.983987,
            -20.076683
          ],
          [
            4.082469,
            -20.198076
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "13",
        "dest": "76",
        "label": "Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. -- Hormone action in the mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1585",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.747295,
            -14.196154
          ],
          [
            1.603704,
            -14.060256
          ],
          [
            -4.859516,
            -7.870892
          ],
          [
            -5.004667,
            -7.730542
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "15",
        "dest": "85",
        "label": "The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. -- Wnt4 is not sufficient to induce lobuloalveolar mammary development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "49235",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.059987,
            -7.078363
          ],
          [
            0.145938,
            -6.938653
          ],
          [
            3.930592,
            -0.757441
          ],
          [
            4.015586,
            -0.61825
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "235",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "49278",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.064941,
            -7.083111
          ],
          [
            0.48377,
            -7.234693
          ],
          [
            21.197104,
            -14.647217
          ],
          [
            21.616789,
            -14.795276
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "278",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "49279",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.068718,
            -7.083099
          ],
          [
            0.515858,
            -7.18467
          ],
          [
            15.494344,
            -10.571987
          ],
          [
            15.942209,
            -10.672758
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "279",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "49280",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.058862,
            -7.083176
          ],
          [
            0.079703,
            -7.221729
          ],
          [
            0.997408,
            -13.269378
          ],
          [
            1.018018,
            -13.403741
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "280",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Conditional deletion of \u03b2-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "49281",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.063064,
            -7.083111
          ],
          [
            0.300278,
            -7.204369
          ],
          [
            9.709281,
            -11.982388
          ],
          [
            9.945845,
            -12.101577
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "281",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "49282",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.066491,
            -7.083096
          ],
          [
            0.56151,
            -7.22662
          ],
          [
            23.893089,
            -13.924409
          ],
          [
            24.388602,
            -14.064906
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "282",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "49283",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.063643,
            -7.083118
          ],
          [
            0.233441,
            -7.160324
          ],
          [
            4.55212,
            -9.119182
          ],
          [
            4.721807,
            -9.195945
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "283",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Corneal morphogenesis during development and diseases.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "49284",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.066804,
            -7.083105
          ],
          [
            0.528734,
            -7.212535
          ],
          [
            20.112975,
            -12.657725
          ],
          [
            20.574307,
            -12.784799
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "284",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "49285",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.061005,
            -7.083105
          ],
          [
            0.181407,
            -7.194861
          ],
          [
            4.60509,
            -11.278401
          ],
          [
            4.726027,
            -11.389324
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "285",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- A bioluminescence reporter mouse that monitors expression of constitutively active \u03b2-catenin.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "49286",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.060039,
            -7.083158
          ],
          [
            0.126462,
            -7.185929
          ],
          [
            2.323848,
            -10.570596
          ],
          [
            2.390356,
            -10.67252
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "286",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- In vivo and in vitro models for the therapeutic targeting of Wnt signaling using a Tet-O\u0394N89\u03b2-catenin system.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "23125",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.734019,
            11.553901
          ],
          [
            16.400728,
            11.506608
          ],
          [
            11.023926,
            10.742586
          ],
          [
            10.690823,
            10.695189
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "23",
        "dest": "125",
        "label": "A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells. -- ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "26156",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.295508,
            13.052909
          ],
          [
            14.285898,
            13.183372
          ],
          [
            13.880594,
            18.614977
          ],
          [
            13.871095,
            18.74041
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "26",
        "dest": "156",
        "label": "Progesterone receptor A-regulated gene expression in mammary organoid cultures. -- Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "26157",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.294285,
            13.052897
          ],
          [
            14.211729,
            13.191556
          ],
          [
            10.494958,
            19.341611
          ],
          [
            10.413302,
            19.474439
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "26",
        "dest": "157",
        "label": "Progesterone receptor A-regulated gene expression in mammary organoid cultures. -- A potential role of progestin-induced laminin-5/\u03b16-integrin signaling in the formation of side branches in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "104631",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.61733,
            16.355152
          ],
          [
            5.814907,
            16.48683
          ],
          [
            14.513785,
            22.186961
          ],
          [
            14.711269,
            22.313953
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "104",
        "dest": "631",
        "label": "Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. -- The chromatin landscape of the casein gene locus.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "104632",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.615751,
            16.355155
          ],
          [
            5.735387,
            16.503417
          ],
          [
            11.651257,
            23.676062
          ],
          [
            11.772566,
            23.81953
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "104",
        "dest": "632",
        "label": "Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. -- Lactogenic hormone stimulation and epigenetic control of L-amino acid oxidase expression in lactating mammary glands.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "104633",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.616951,
            16.355134
          ],
          [
            5.805135,
            16.495093
          ],
          [
            14.674814,
            22.964431
          ],
          [
            14.863187,
            23.098848
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "104",
        "dest": "633",
        "label": "Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. -- A functional study of proximal goat \u03b2-casein promoter and intron 1 in immortalized goat mammary epithelial cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "105106",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.418849,
            14.846192
          ],
          [
            4.51698,
            14.97928
          ],
          [
            8.836935,
            20.747012
          ],
          [
            8.936062,
            20.877054
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "105",
        "dest": "106",
        "label": "Collaborative interaction of Oct-2 with Oct-1 in transactivation of lactogenic hormones-induced \u03b2-casein gene expression in mammary epithelial cells. -- Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "105110",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.41664,
            14.846186
          ],
          [
            4.380761,
            15.00745
          ],
          [
            2.465085,
            23.412696
          ],
          [
            2.428607,
            23.568305
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "105",
        "dest": "110",
        "label": "Collaborative interaction of Oct-2 with Oct-1 in transactivation of lactogenic hormones-induced \u03b2-casein gene expression in mammary epithelial cells. -- Oct-1 functions as a transactivator in the hormonal induction of beta-casein gene expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "105634",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.418801,
            14.846237
          ],
          [
            4.518703,
            14.98818
          ],
          [
            9.119786,
            21.411037
          ],
          [
            9.218624,
            21.54628
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "105",
        "dest": "634",
        "label": "Collaborative interaction of Oct-2 with Oct-1 in transactivation of lactogenic hormones-induced \u03b2-casein gene expression in mammary epithelial cells. -- Gap junctions mediate STAT5-independent \u03b2-casein expression in CID-9 mammary epithelial cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "107639",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.211507,
            21.792208
          ],
          [
            2.229966,
            21.952067
          ],
          [
            3.215733,
            30.204154
          ],
          [
            3.234023,
            30.351545
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "639",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107640",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.208307,
            21.792139
          ],
          [
            2.017191,
            21.935508
          ],
          [
            -7.434481,
            28.8318
          ],
          [
            -7.625988,
            28.967318
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "640",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107641",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.211486,
            21.792176
          ],
          [
            2.226473,
            21.931015
          ],
          [
            2.932948,
            28.311069
          ],
          [
            2.947781,
            28.441326
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "641",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Mutational analysis of progesterone receptor functional domains in stable cell lines delineates sets of genes regulated by different mechanisms.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107642",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.211488,
            21.792211
          ],
          [
            2.227721,
            21.944003
          ],
          [
            3.050847,
            29.411386
          ],
          [
            3.066922,
            29.552392
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "642",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107643",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.20915,
            21.792159
          ],
          [
            2.061802,
            21.948527
          ],
          [
            -5.807042,
            30.027023
          ],
          [
            -5.953033,
            30.171454
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "643",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- The PRB-dependent FOXO1/IGFBP-1 axis is essential for progestin to inhibit endometrial epithelial growth.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107644",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.209839,
            21.792179
          ],
          [
            2.131969,
            21.916445
          ],
          [
            -1.152407,
            27.053286
          ],
          [
            -1.229375,
            27.171079
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "644",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107646",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.209454,
            21.792159
          ],
          [
            2.116322,
            21.907795
          ],
          [
            -1.578122,
            26.415403
          ],
          [
            -1.670107,
            26.525555
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "646",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Influence of AKT on progesterone action in endometrial diseases.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107647",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.208125,
            21.792127
          ],
          [
            2.021524,
            21.92318
          ],
          [
            -6.473975,
            27.753655
          ],
          [
            -6.660621,
            27.878576
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "647",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "111656",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.712214,
            13.74994
          ],
          [
            4.669371,
            13.88764
          ],
          [
            2.740478,
            19.991512
          ],
          [
            2.6981,
            20.123269
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "111",
        "dest": "656",
        "label": "A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2. -- Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "111658",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.711049,
            13.749964
          ],
          [
            4.593919,
            13.895684
          ],
          [
            -0.927387,
            20.646002
          ],
          [
            -1.043299,
            20.784909
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "111",
        "dest": "658",
        "label": "A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2. -- Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "114662",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.046206,
            12.974288
          ],
          [
            1.000433,
            13.148408
          ],
          [
            -1.581172,
            22.725806
          ],
          [
            -1.626549,
            22.889141
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "114",
        "dest": "662",
        "label": "Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression. -- Peroxisome proliferator-activated receptor gamma activation inhibits progesterone-stimulated human MUC1 expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "114663",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.046458,
            12.974306
          ],
          [
            1.024888,
            13.114037
          ],
          [
            0.053705,
            19.311282
          ],
          [
            0.032366,
            19.445117
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "114",
        "dest": "663",
        "label": "Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression. -- Expression of human MUC1 during early pregnancy in the human MUC1 transgenic mouse model.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "114664",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.044552,
            12.974264
          ],
          [
            0.880446,
            13.141768
          ],
          [
            -8.122408,
            22.120862
          ],
          [
            -8.285043,
            22.278644
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "114",
        "dest": "664",
        "label": "Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression. -- MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-\u03baB p65 and binding to cytokine promoters: importance of extracellular domain.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "48123",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.641823,
            13.901473
          ],
          [
            -3.600431,
            13.815886
          ],
          [
            -2.443055,
            11.410566
          ],
          [
            -2.402379,
            11.325634
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "48",
        "dest": "123",
        "label": "Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development. -- Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "48277",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.6441,
            13.906178
          ],
          [
            -3.716482,
            14.055439
          ],
          [
            -7.210445,
            21.127933
          ],
          [
            -7.282093,
            21.269887
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "48",
        "dest": "277",
        "label": "Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development. -- Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57BL/6 mice.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "35216",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.18668,
            -9.233661
          ],
          [
            18.821704,
            -9.184451
          ],
          [
            46.123374,
            -8.361753
          ],
          [
            47.758272,
            -8.312429
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "216",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- In vivo expansion of the mammary stem/ progenitor cell population by xanthosine infusion.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "35217",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.200462,
            -9.235067
          ],
          [
            18.21912,
            -9.224932
          ],
          [
            27.535143,
            -9.132217
          ],
          [
            28.776686,
            -9.119858
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "217",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- Immortalized, pre-malignant epithelial cell populations contain long-lived, label-retaining cells that asymmetrically divide and retain their template DNA.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "35218",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.146149,
            -9.238273
          ],
          [
            17.820064,
            -9.28145
          ],
          [
            27.737253,
            -9.916225
          ],
          [
            28.410775,
            -9.959291
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "218",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- Putative rabbit conjunctival epithelial stem/progenitor cells preferentially reside in palpebral conjunctiva.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "35220",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.200392,
            -9.235467
          ],
          [
            19.127883,
            -9.224797
          ],
          [
            51.310457,
            -9.04659
          ],
          [
            53.728691,
            -9.033196
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "220",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- Xanthosine administration does not affect the proportion of epithelial stem cells in bovine mammary tissue, but has a latent negative effect on cell proliferation.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "35221",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.138207,
            -9.23827
          ],
          [
            17.89914,
            -9.300741
          ],
          [
            33.888873,
            -10.610796
          ],
          [
            34.649673,
            -10.672993
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "221",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- In vitro expansion of the mammary stem/progenitor cell population by xanthosine treatment.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "40247",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.793852,
            -7.684656
          ],
          [
            11.408625,
            -7.724537
          ],
          [
            19.773229,
            -8.26677
          ],
          [
            20.388102,
            -8.3066
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "40",
        "dest": "247",
        "label": "Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells. -- Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "158910",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.591478,
            -6.252724
          ],
          [
            19.799311,
            -6.292792
          ],
          [
            36.255228,
            -6.838375
          ],
          [
            37.462881,
            -6.87839
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "158",
        "dest": "910",
        "label": "Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. -- Parity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "158911",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.582956,
            -6.248079
          ],
          [
            19.591042,
            -6.209972
          ],
          [
            32.678248,
            -5.714974
          ],
          [
            33.685608,
            -5.676854
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "158",
        "dest": "911",
        "label": "Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. -- Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "158912",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.543533,
            -6.252727
          ],
          [
            19.124585,
            -6.314089
          ],
          [
            31.014675,
            -7.568023
          ],
          [
            31.596351,
            -7.629279
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "158",
        "dest": "912",
        "label": "Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. -- Growth hormone potentiates 17\u03b2-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "158913",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.540265,
            -6.252727
          ],
          [
            19.158382,
            -6.329329
          ],
          [
            34.85439,
            -8.270304
          ],
          [
            35.472067,
            -8.346506
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "158",
        "dest": "913",
        "label": "Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. -- Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "159914",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.232509,
            -6.948856
          ],
          [
            15.682751,
            -6.909813
          ],
          [
            8.377455,
            -6.390741
          ],
          [
            7.905397,
            -6.357179
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "159",
        "dest": "914",
        "label": "On the possible role of mammary-derived growth hormone in human breast cancer. -- Androgens and the breast.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "161919",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.185596,
            -4.235716
          ],
          [
            33.7941,
            -4.299543
          ],
          [
            46.701907,
            -5.652021
          ],
          [
            47.310562,
            -5.715726
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "919",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- Key signalling nodes in mammary gland development and cancer: Myc.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "161920",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.206046,
            -4.231056
          ],
          [
            34.050399,
            -4.18493
          ],
          [
            47.151504,
            -3.468921
          ],
          [
            47.995832,
            -3.422757
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "920",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- The role of activin in mammary gland development and oncogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "161921",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.17636,
            -4.235713
          ],
          [
            33.721271,
            -4.333379
          ],
          [
            51.237459,
            -7.464569
          ],
          [
            51.78257,
            -7.561702
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "921",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- TGF\u03b2 biology in breast: 15 years on.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "161922",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.186057,
            -4.235713
          ],
          [
            33.953967,
            -4.314528
          ],
          [
            53.968568,
            -6.365437
          ],
          [
            54.73667,
            -6.444001
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "922",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- On mammary gland growth factors: roles in normal development and in cancer.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "161923",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.196192,
            -4.235716
          ],
          [
            33.817366,
            -4.279801
          ],
          [
            43.055444,
            -4.935143
          ],
          [
            43.676666,
            -4.979191
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "923",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "161924",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.242804,
            -4.233396
          ],
          [
            34.36699,
            -4.233513
          ],
          [
            47.062514,
            -4.234866
          ],
          [
            48.109001,
            -4.234978
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "924",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- Lactation and neonatal nutrition: defining and refining the critical questions.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "4780",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.24074,
            10.611747
          ],
          [
            -6.976399,
            10.654614
          ],
          [
            -17.771313,
            11.282925
          ],
          [
            -18.506415,
            11.325661
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "80",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "47271",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.20191,
            10.611845
          ],
          [
            -6.241101,
            10.771662
          ],
          [
            -8.228564,
            18.739703
          ],
          [
            -8.267376,
            18.892162
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "271",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "47274",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.203487,
            10.611747
          ],
          [
            -6.357836,
            10.775478
          ],
          [
            -14.71054,
            19.470668
          ],
          [
            -14.865507,
            19.628317
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "274",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1G protein-coupled receptor via repression of ER\u03b1, Akt1, and Stat5.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "47275",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.201894,
            10.611753
          ],
          [
            -6.239045,
            10.761549
          ],
          [
            -8.076194,
            18.056933
          ],
          [
            -8.113866,
            18.203833
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "275",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- ER\u03b1 phosphorylation at Y537 by Src triggers E6-AP-ER\u03b1 binding, ER\u03b1 ubiquitylation, promoter occupancy, and target gene expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "47276",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.204364,
            10.611744
          ],
          [
            -6.412576,
            10.768774
          ],
          [
            -17.24301,
            18.798416
          ],
          [
            -17.451877,
            18.950101
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "276",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- Canid progesterone receptors lack activation function 3 domain-dependent activity.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "50287",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.428407,
            3.448896
          ],
          [
            -10.497584,
            3.595276
          ],
          [
            -13.757719,
            10.450675
          ],
          [
            -13.827754,
            10.596648
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "50",
        "dest": "287",
        "label": "Epimorphin is a novel regulator of the progesterone receptor isoform-a. -- MiR-126-3p regulates progesterone receptors and involves development and lactation of mouse mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "50288",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.426409,
            3.448862
          ],
          [
            -10.374298,
            3.586568
          ],
          [
            -8.028792,
            9.751444
          ],
          [
            -7.976115,
            9.888862
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "50",
        "dest": "288",
        "label": "Epimorphin is a novel regulator of the progesterone receptor isoform-a. -- Uterine progesterone receptor expression, conceptus development, and ovarian function in pigs treated with RU 486 during early pregnancy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "5156",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -9.541105,
            2.479656
          ],
          [
            -10.069542,
            2.42197
          ],
          [
            -20.218299,
            1.313693
          ],
          [
            -20.746934,
            1.255947
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "51",
        "dest": "56",
        "label": "Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice. -- Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "52289",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.194338,
            -1.966046
          ],
          [
            -10.58773,
            -1.896162
          ],
          [
            -19.682263,
            -0.280027
          ],
          [
            -20.076187,
            -0.210011
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "289",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "52290",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.185575,
            -1.97075
          ],
          [
            -10.463706,
            -2.121109
          ],
          [
            -23.888107,
            -9.341838
          ],
          [
            -24.166661,
            -9.490491
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "290",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "52291",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.189522,
            -1.966027
          ],
          [
            -10.618341,
            -1.844899
          ],
          [
            -27.460113,
            2.913425
          ],
          [
            -27.887666,
            3.0341
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "291",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "52292",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.195158,
            -1.966043
          ],
          [
            -10.520246,
            -1.911685
          ],
          [
            -16.414772,
            -0.925793
          ],
          [
            -16.73976,
            -0.871427
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "292",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "52293",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.275646,
            -1.966133
          ],
          [
            -11.508558,
            -1.936816
          ],
          [
            -24.417376,
            -1.629835
          ],
          [
            -25.673102,
            -1.599968
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "293",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "52294",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.1785,
            -1.966006
          ],
          [
            -10.081964,
            -1.880868
          ],
          [
            -7.420873,
            0.466965
          ],
          [
            -7.324753,
            0.551779
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "294",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "52295",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.185491,
            -1.970725
          ],
          [
            -10.354043,
            -2.062678
          ],
          [
            -15.423491,
            -4.824758
          ],
          [
            -15.591767,
            -4.916284
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "295",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Comparison of increased aromatase versus ER\u03b1 in the generation of mammary hyperplasia and cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53296",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.199635,
            -6.67638
          ],
          [
            -10.545557,
            -6.787855
          ],
          [
            -23.197519,
            -10.843951
          ],
          [
            -23.543407,
            -10.954166
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "296",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "53297",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.194079,
            -6.676454
          ],
          [
            -10.28849,
            -6.812229
          ],
          [
            -14.356291,
            -12.616015
          ],
          [
            -14.449632,
            -12.747889
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "297",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Cyclin D1 determines estrogen signaling in the mammary gland in vivo.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "53298",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.190988,
            -6.676408
          ],
          [
            -10.132559,
            -6.773297
          ],
          [
            -8.292031,
            -9.813963
          ],
          [
            -8.232732,
            -9.911512
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "298",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53299",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.196451,
            -6.676377
          ],
          [
            -10.406547,
            -6.797211
          ],
          [
            -18.738944,
            -11.559539
          ],
          [
            -18.950474,
            -11.679534
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "299",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "53300",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.19371,
            -6.676411
          ],
          [
            -10.276271,
            -6.826169
          ],
          [
            -14.260684,
            -13.979404
          ],
          [
            -14.344333,
            -14.127622
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "300",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Estrogen regulation of thrombospondin-1 in human breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53301",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.193349,
            -6.676442
          ],
          [
            -10.243235,
            -6.80321
          ],
          [
            -12.262245,
            -11.899086
          ],
          [
            -12.311529,
            -12.022459
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "301",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "53303",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.19481,
            -6.676402
          ],
          [
            -10.354891,
            -6.833125
          ],
          [
            -18.471596,
            -14.687772
          ],
          [
            -18.63209,
            -14.840774
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "303",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53304",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.196715,
            -6.676374
          ],
          [
            -10.457109,
            -6.816894
          ],
          [
            -22.448514,
            -13.229999
          ],
          [
            -22.709038,
            -13.367771
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "304",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- A model of spontaneous mouse mammary tumor for human estrogen receptor- and progesterone receptor-negative breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53305",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.191117,
            -6.67638
          ],
          [
            -10.126569,
            -6.792665
          ],
          [
            -7.664294,
            -11.203121
          ],
          [
            -7.599382,
            -11.318603
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "305",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Cyclin D1 regulates hepatic estrogen and androgen metabolism.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53306",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.195406,
            -6.676426
          ],
          [
            -10.331745,
            -6.784556
          ],
          [
            -15.078603,
            -10.531405
          ],
          [
            -15.215324,
            -10.638732
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "306",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "53307",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.190967,
            -6.67642
          ],
          [
            -10.109368,
            -6.810222
          ],
          [
            -6.594482,
            -12.528992
          ],
          [
            -6.512112,
            -12.661725
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "307",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Examining the role of cyclin D1 in breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "44249",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -11.091324,
            -16.23561
          ],
          [
            -11.341965,
            -16.36673
          ],
          [
            -22.377057,
            -22.043797
          ],
          [
            -22.627577,
            -22.170302
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "44",
        "dest": "249",
        "label": "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. -- Progestin effects on cell proliferation pathways in the postmenopausal mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "44251",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -11.087625,
            -16.235624
          ],
          [
            -11.122088,
            -16.359268
          ],
          [
            -12.545287,
            -21.391282
          ],
          [
            -12.580027,
            -21.512151
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "44",
        "dest": "251",
        "label": "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. -- Cell adhesion signaling regulates RANK expression in osteoclast precursors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "44252",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -11.094131,
            -16.235601
          ],
          [
            -11.390119,
            -16.329316
          ],
          [
            -20.790725,
            -19.281103
          ],
          [
            -21.086716,
            -19.373232
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "44",
        "dest": "252",
        "label": "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. -- Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "44253",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -11.087638,
            -16.23561
          ],
          [
            -11.117765,
            -16.340761
          ],
          [
            -12.185243,
            -20.027973
          ],
          [
            -12.21547,
            -20.131205
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "44",
        "dest": "253",
        "label": "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. -- Receptor activator of NF-\u03baB ligand promotes proliferation of a putative mammary stem cell unique to the lactating epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "45257",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.838277,
            -18.075515
          ],
          [
            -2.390153,
            -18.033626
          ],
          [
            -10.573952,
            -17.411279
          ],
          [
            -11.125771,
            -17.369238
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "45",
        "dest": "257",
        "label": "RANKL inhibition: a promising novel strategy for breast cancer treatment. -- Central control of fever and female body temperature by RANKL/RANK.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "45258",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.839614,
            -18.079954
          ],
          [
            -2.405234,
            -18.120977
          ],
          [
            -10.633969,
            -18.716686
          ],
          [
            -11.199828,
            -18.757575
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "45",
        "dest": "258",
        "label": "RANKL inhibition: a promising novel strategy for breast cancer treatment. -- RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "4661",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.673393,
            -24.193251
          ],
          [
            -17.881219,
            -24.291919
          ],
          [
            -25.245619,
            -27.737161
          ],
          [
            -25.454141,
            -27.833215
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "61",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Role of the RANK/RANKL pathway in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "46259",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.66843,
            -24.193319
          ],
          [
            -17.648761,
            -24.283626
          ],
          [
            -17.028862,
            -27.095909
          ],
          [
            -17.009496,
            -27.182686
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "259",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- [The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications].",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "46260",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.668434,
            -24.193251
          ],
          [
            -17.634144,
            -24.346953
          ],
          [
            -15.753497,
            -32.469946
          ],
          [
            -15.718605,
            -32.614577
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "260",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Receptor activator of nuclear factor-kappa B ligand (RANKL) stimulates bone-associated tumors through functional RANK expressed on bone-associated cancer cells?",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "46261",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.665219,
            -24.188977
          ],
          [
            -17.56488,
            -24.130622
          ],
          [
            -15.450655,
            -22.894921
          ],
          [
            -15.350575,
            -22.836142
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "261",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- RANK signalling in bone lesions with osteoclast-like giant cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46262",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.668398,
            -24.19329
          ],
          [
            -17.642907,
            -24.301607
          ],
          [
            -16.67053,
            -28.361646
          ],
          [
            -16.644896,
            -28.466718
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "262",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46264",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.670071,
            -24.193327
          ],
          [
            -17.734358,
            -24.315328
          ],
          [
            -20.445917,
            -29.349206
          ],
          [
            -20.509461,
            -29.464428
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "264",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "46265",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.664283,
            -24.193251
          ],
          [
            -17.449868,
            -24.291939
          ],
          [
            -9.852065,
            -27.737808
          ],
          [
            -9.636935,
            -27.833881
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "265",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "46266",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.664982,
            -24.193296
          ],
          [
            -17.432811,
            -24.321766
          ],
          [
            -6.981253,
            -29.963151
          ],
          [
            -6.749081,
            -30.085156
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "266",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- The RANKL/RANK system as a therapeutic target for bone invasion by oral             squamous cell carcinoma (Review).",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46267",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.679104,
            -24.193259
          ],
          [
            -17.993743,
            -24.259223
          ],
          [
            -25.488183,
            -25.82014
          ],
          [
            -25.802752,
            -25.885222
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "267",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Targeting RANKL in breast cancer: bone metastasis and beyond.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46268",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.665821,
            -24.193256
          ],
          [
            -17.498596,
            -24.308763
          ],
          [
            -10.592512,
            -28.983026
          ],
          [
            -10.423932,
            -29.094684
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "268",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46269",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.666719,
            -24.193327
          ],
          [
            -17.531068,
            -24.329916
          ],
          [
            -11.136686,
            -30.591633
          ],
          [
            -11.002444,
            -30.719178
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "269",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46270",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.65816,
            -24.193253
          ],
          [
            -17.267167,
            -24.270788
          ],
          [
            -6.337515,
            -26.41864
          ],
          [
            -5.946722,
            -26.494723
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "270",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "69336",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.721995,
            -23.49746
          ],
          [
            -2.649384,
            -23.617655
          ],
          [
            0.41249,
            -28.580724
          ],
          [
            0.485736,
            -28.696812
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "336",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- Activation of NF-\u03baB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "69395",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.724995,
            -23.493087
          ],
          [
            -2.767605,
            -23.437535
          ],
          [
            -3.602509,
            -22.344392
          ],
          [
            -3.644877,
            -22.288684
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "395",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "69396",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.725363,
            -23.497469
          ],
          [
            -2.774199,
            -23.549212
          ],
          [
            -3.676729,
            -24.501751
          ],
          [
            -3.725168,
            -24.552675
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "396",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "69397",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.732858,
            -23.497441
          ],
          [
            -3.026678,
            -23.563626
          ],
          [
            -10.00376,
            -25.125328
          ],
          [
            -10.298314,
            -25.190832
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "397",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "69398",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.728508,
            -23.497441
          ],
          [
            -2.919109,
            -23.576292
          ],
          [
            -8.284613,
            -25.776119
          ],
          [
            -8.475805,
            -25.85378
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "398",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "69399",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.720241,
            -23.49748
          ],
          [
            -2.578134,
            -23.599016
          ],
          [
            2.457468,
            -27.144423
          ],
          [
            2.600048,
            -27.243268
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "399",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- RANKL Signaling and ErbB Receptors in Breast Carcinogenesis.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "69400",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.721957,
            -23.497506
          ],
          [
            -2.634187,
            -23.641768
          ],
          [
            1.707035,
            -30.565208
          ],
          [
            1.793936,
            -30.699296
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "400",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4\u207a T cells to T-regulatory cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "7077",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.596012,
            -22.8432
          ],
          [
            6.502184,
            -23.001922
          ],
          [
            1.491501,
            -31.184607
          ],
          [
            1.398537,
            -31.330569
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "77",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "70358",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.599536,
            -22.843143
          ],
          [
            6.742028,
            -22.986395
          ],
          [
            13.789828,
            -29.868775
          ],
          [
            13.930908,
            -30.002215
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "358",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- RAR\u03b11 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70401",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.596332,
            -22.84316
          ],
          [
            6.533572,
            -22.980602
          ],
          [
            3.575123,
            -29.290412
          ],
          [
            3.513015,
            -29.419117
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "401",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70402",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.61736,
            -22.843094
          ],
          [
            7.183641,
            -22.903997
          ],
          [
            19.581284,
            -24.230414
          ],
          [
            20.148506,
            -24.290779
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "402",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "70403",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.59638,
            -22.843206
          ],
          [
            6.561269,
            -22.925581
          ],
          [
            5.579488,
            -25.208179
          ],
          [
            5.544982,
            -25.287652
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "403",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Transcriptomic profiling of progesterone in the male fathead minnow (Pimephales promelas) testis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70404",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.698386,
            -22.841466
          ],
          [
            7.990425,
            -22.848168
          ],
          [
            21.259198,
            -22.916974
          ],
          [
            22.465238,
            -22.923229
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "404",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70405",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.608426,
            -22.838776
          ],
          [
            7.143954,
            -22.734178
          ],
          [
            26.911889,
            -18.819641
          ],
          [
            27.447494,
            -18.712205
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "405",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "70406",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.601757,
            -22.8431
          ],
          [
            6.692871,
            -22.887654
          ],
          [
            8.165752,
            -23.60586
          ],
          [
            8.257,
            -23.650228
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "406",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Regulation of the MIR155 host gene in physiological and pathological processes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "70407",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.601738,
            -22.838771
          ],
          [
            6.794839,
            -22.743388
          ],
          [
            13.290736,
            -19.497267
          ],
          [
            13.484174,
            -19.399539
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "407",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Hypoxia-inducible factor 1\u03b1 promotes primary tumor growth and tumor-initiating cell activity in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "70408",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.637937,
            -22.843094
          ],
          [
            7.461052,
            -22.88674
          ],
          [
            20.535115,
            -23.578088
          ],
          [
            21.357811,
            -23.621471
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "408",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "70409",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.607986,
            -22.838782
          ],
          [
            6.967607,
            -22.765769
          ],
          [
            16.325246,
            -20.852501
          ],
          [
            16.684935,
            -20.778455
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "409",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Dietary suppression of the mammary CD29(hi)CD24(+) epithelial subpopulation and its cytokine/chemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70410",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.649232,
            -22.838788
          ],
          [
            7.634331,
            -22.797917
          ],
          [
            22.327226,
            -22.186851
          ],
          [
            23.312577,
            -22.145776
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "410",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70411",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.596491,
            -22.838768
          ],
          [
            6.573548,
            -22.780302
          ],
          [
            6.095231,
            -21.555833
          ],
          [
            6.072356,
            -21.497009
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "411",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70412",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.600632,
            -22.843125
          ],
          [
            6.703647,
            -22.911625
          ],
          [
            9.19492,
            -24.557414
          ],
          [
            9.298274,
            -24.625239
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "412",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "76446",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.09552,
            -20.19814
          ],
          [
            4.48382,
            -20.122116
          ],
          [
            14.826093,
            -18.084052
          ],
          [
            15.214802,
            -18.00697
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "76",
        "dest": "446",
        "label": "Hormone action in the mammary gland. -- Remodeling of the lymphatic vasculature during mouse mammary gland morphogenesis is mediated via epithelial-derived lymphangiogenic stimuli.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "27963",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.990011,
            -10.677359
          ],
          [
            16.68461,
            -10.719807
          ],
          [
            26.790053,
            -11.336694
          ],
          [
            27.48435,
            -11.379029
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "279",
        "dest": "63",
        "label": "Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution. -- Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "125113",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.666394,
            10.690594
          ],
          [
            10.383832,
            10.612172
          ],
          [
            2.957928,
            8.544435
          ],
          [
            2.675209,
            8.465476
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "125",
        "dest": "113",
        "label": "ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells. -- The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "125126",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.809803,
            10.691236
          ],
          [
            12.534002,
            10.670147
          ],
          [
            30.203819,
            10.453927
          ],
          [
            31.742762,
            10.435088
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "125",
        "dest": "126",
        "label": "ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells. -- Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "125727",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.763387,
            10.695186
          ],
          [
            12.156673,
            10.731207
          ],
          [
            29.512168,
            11.179556
          ],
          [
            30.905538,
            11.215522
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "125",
        "dest": "727",
        "label": "ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells. -- Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "156898",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.871466,
            18.744891
          ],
          [
            13.902011,
            18.87172
          ],
          [
            15.217708,
            24.236947
          ],
          [
            15.248542,
            24.360215
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "898",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156899",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.871466,
            18.744938
          ],
          [
            13.907542,
            18.897675
          ],
          [
            15.736874,
            26.440914
          ],
          [
            15.7726,
            26.583915
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "899",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Distinct gene-expression profiles characterize mammary tumors developed in transgenic mice expressing constitutively active and C-terminally truncated variants of STAT5.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156900",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.871472,
            18.744938
          ],
          [
            13.906112,
            18.890261
          ],
          [
            15.578338,
            25.740812
          ],
          [
            15.612628,
            25.877623
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "900",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156901",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.871445,
            18.744864
          ],
          [
            13.902858,
            18.878914
          ],
          [
            15.349298,
            24.925166
          ],
          [
            15.381077,
            25.055012
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "901",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Evaluation of molecular markers in canine mammary tumors: correlation with histological grading.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156902",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.890118,
            18.744858
          ],
          [
            14.246508,
            18.78592
          ],
          [
            19.451014,
            19.384407
          ],
          [
            19.807642,
            19.425337
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "902",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Comparison of cellular and tissue transcriptional profiles in canine mammary tumor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156903",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.877976,
            18.740425
          ],
          [
            14.177551,
            18.645884
          ],
          [
            23.925565,
            15.542204
          ],
          [
            24.22536,
            15.445953
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "903",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Transcriptomic \"portraits\" of canine mammary cancer cell lines with various phenotypes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156904",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.864482,
            18.740425
          ],
          [
            13.741119,
            18.697876
          ],
          [
            11.886592,
            18.056939
          ],
          [
            11.763573,
            18.014339
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "904",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "156905",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.868952,
            18.740404
          ],
          [
            13.812101,
            18.675748
          ],
          [
            12.546201,
            17.229812
          ],
          [
            12.489363,
            17.164616
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "905",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156906",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.875483,
            18.744894
          ],
          [
            14.002242,
            18.807336
          ],
          [
            16.731886,
            20.146208
          ],
          [
            16.858437,
            20.20801
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "906",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Gene expression pattern in canine mammary osteosarcoma.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "157907",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.413908,
            19.474422
          ],
          [
            10.508813,
            19.366773
          ],
          [
            13.995688,
            15.365145
          ],
          [
            14.091016,
            15.25456
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "157",
        "dest": "907",
        "label": "A potential role of progestin-induced laminin-5/\u03b16-integrin signaling in the formation of side branches in the mammary gland. -- Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "157908",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.409188,
            19.474419
          ],
          [
            10.281882,
            19.370491
          ],
          [
            5.77075,
            15.647321
          ],
          [
            5.643019,
            15.540825
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "157",
        "dest": "908",
        "label": "A potential role of progestin-induced laminin-5/\u03b16-integrin signaling in the formation of side branches in the mammary gland. -- Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "157909",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.413936,
            19.474427
          ],
          [
            10.498932,
            19.379579
          ],
          [
            13.264663,
            16.264477
          ],
          [
            13.349721,
            16.167835
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "157",
        "dest": "909",
        "label": "A potential role of progestin-induced laminin-5/\u03b16-integrin signaling in the formation of side branches in the mammary gland. -- Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "106635",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.939946,
            20.881594
          ],
          [
            9.070088,
            21.018782
          ],
          [
            15.064009,
            27.190237
          ],
          [
            15.19277,
            27.31944
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "106",
        "dest": "635",
        "label": "Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells. -- Bovine prolactin elevates hTF expression directed by a tissue-specific goat \u03b2-casein promoter through prolactin receptor-mediated STAT5a activation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "106636",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.938762,
            20.881611
          ],
          [
            8.998629,
            21.023048
          ],
          [
            11.820664,
            27.526175
          ],
          [
            11.879908,
            27.659008
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "106",
        "dest": "636",
        "label": "Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells. -- Regulatory roles of Oct proteins in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "106637",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.939937,
            20.881579
          ],
          [
            9.086602,
            21.035629
          ],
          [
            16.716446,
            28.809833
          ],
          [
            16.861728,
            28.952919
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "106",
        "dest": "637",
        "label": "Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells. -- Dynamic trafficking of STAT5 depends on an unconventional nuclear localization signal.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "106638",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.939959,
            20.8816
          ],
          [
            9.080828,
            21.029326
          ],
          [
            16.048306,
            28.137899
          ],
          [
            16.187777,
            28.275924
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "106",
        "dest": "638",
        "label": "Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells. -- Buffalo alpha S1-casein gene 5'-flanking region and its interspecies comparison.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "634108",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.221194,
            21.550738
          ],
          [
            9.286447,
            21.704647
          ],
          [
            12.681038,
            29.464571
          ],
          [
            12.745675,
            29.607264
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "634",
        "dest": "108",
        "label": "Gap junctions mediate STAT5-independent \u03b2-casein expression in CID-9 mammary epithelial cells. -- Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "634109",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.217247,
            21.550672
          ],
          [
            9.067706,
            21.65976
          ],
          [
            3.36337,
            25.75641
          ],
          [
            3.212988,
            25.862629
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "634",
        "dest": "109",
        "label": "Gap junctions mediate STAT5-independent \u03b2-casein expression in CID-9 mammary epithelial cells. -- Analysis of mammary specific gene locus regulation in differentiated cells derived by somatic cell fusion.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "123715",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.403529,
            11.325631
          ],
          [
            -2.525382,
            11.449695
          ],
          [
            -7.557576,
            16.519377
          ],
          [
            -7.680415,
            16.641651
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "123",
        "dest": "715",
        "label": "Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland. -- Amphiregulin mediates progesterone-induced mammary ductal development during puberty.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "123716",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.402427,
            11.325719
          ],
          [
            -2.467214,
            11.460311
          ],
          [
            -5.258645,
            17.189206
          ],
          [
            -5.322696,
            17.318836
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "123",
        "dest": "716",
        "label": "Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland. -- Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "80199",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.575239,
            11.330236
          ],
          [
            -19.198094,
            11.378605
          ],
          [
            -29.49311,
            12.176865
          ],
          [
            -30.11587,
            12.225075
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "199",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80272",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.549055,
            11.330249
          ],
          [
            -18.63736,
            11.392071
          ],
          [
            -20.477777,
            12.677449
          ],
          [
            -20.566692,
            12.739391
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "272",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80273",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.54306,
            11.330273
          ],
          [
            -18.453507,
            11.407023
          ],
          [
            -16.175539,
            13.351969
          ],
          [
            -16.086591,
            13.427615
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "273",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- E3 ubiquitin protein ligase, E6-associated protein (E6-AP) regulates PI3K-Akt signaling and prostate cell growth.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80472",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.548896,
            11.325628
          ],
          [
            -18.65207,
            11.24903
          ],
          [
            -21.276512,
            9.294076
          ],
          [
            -21.378989,
            9.217504
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "472",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: involvement of the RB-microRNA axis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80473",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.56489,
            11.325655
          ],
          [
            -19.089175,
            11.262729
          ],
          [
            -30.225553,
            9.922984
          ],
          [
            -30.75,
            9.859751
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "473",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "80474",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.543966,
            11.325612
          ],
          [
            -18.474253,
            11.235462
          ],
          [
            -16.409309,
            8.55335
          ],
          [
            -16.338749,
            8.461334
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "474",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "80475",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.526293,
            11.33024
          ],
          [
            -18.154232,
            11.373969
          ],
          [
            -12.572484,
            12.029219
          ],
          [
            -12.200192,
            12.072865
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "475",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80476",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.589058,
            11.325661
          ],
          [
            -19.373296,
            11.284203
          ],
          [
            -30.560158,
            10.692199
          ],
          [
            -31.344401,
            10.650652
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "476",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "80477",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.543626,
            11.325597
          ],
          [
            -18.45088,
            11.223999
          ],
          [
            -15.38275,
            7.844791
          ],
          [
            -15.289888,
            7.742024
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "477",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80478",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.542896,
            11.325631
          ],
          [
            -18.40198,
            11.212022
          ],
          [
            -13.127439,
            6.931291
          ],
          [
            -12.985814,
            6.815704
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "478",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "56315",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -20.770727,
            1.25599
          ],
          [
            -20.861605,
            1.346475
          ],
          [
            -23.514437,
            3.985462
          ],
          [
            -23.605086,
            4.075517
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "56",
        "dest": "315",
        "label": "Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia. -- Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "56316",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -20.761951,
            1.255944
          ],
          [
            -20.485938,
            1.356769
          ],
          [
            -11.355266,
            4.68793
          ],
          [
            -11.078914,
            4.788564
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "56",
        "dest": "316",
        "label": "Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia. -- Analysis of PTEN, estrogen receptor \u03b1 and progesterone receptor expression in endometrial hyperplasia using tissue microarray.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "56317",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -20.764307,
            1.25595
          ],
          [
            -20.572305,
            1.367439
          ],
          [
            -13.582336,
            5.419371
          ],
          [
            -13.389533,
            5.530845
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "56",
        "dest": "317",
        "label": "Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia. -- Endometrial progesterone resistance and PCOS.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "290146",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.170213,
            -9.495194
          ],
          [
            -24.112466,
            -9.656623
          ],
          [
            -21.108305,
            -17.919842
          ],
          [
            -21.051101,
            -18.074078
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "290",
        "dest": "146",
        "label": "Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer. -- Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "290150",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.17246,
            -9.495145
          ],
          [
            -24.228357,
            -9.587064
          ],
          [
            -25.934994,
            -12.380431
          ],
          [
            -25.991643,
            -12.47268
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "290",
        "dest": "150",
        "label": "Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer. -- Epithelial-stromal interaction and progesterone receptors in the mouse uterus.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "295117",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -15.599695,
            -4.92097
          ],
          [
            -15.793059,
            -5.045997
          ],
          [
            -23.618019,
            -10.078755
          ],
          [
            -23.810937,
            -10.20201
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "295",
        "dest": "117",
        "label": "Comparison of increased aromatase versus ER\u03b1 in the generation of mammary hyperplasia and cancer. -- Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "6173",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.461813,
            -27.837377
          ],
          [
            -25.714362,
            -28.003869
          ],
          [
            -41.027697,
            -37.587454
          ],
          [
            -41.281905,
            -37.737596
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "73",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "61340",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.457293,
            -27.837413
          ],
          [
            -25.401334,
            -27.924468
          ],
          [
            -23.638626,
            -30.630205
          ],
          [
            -23.581833,
            -30.716175
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "340",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "61341",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.462386,
            -27.837358
          ],
          [
            -25.666703,
            -27.950372
          ],
          [
            -34.192556,
            -32.557403
          ],
          [
            -34.398596,
            -32.666021
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "341",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- Denosumab for the treatment of bone metastases in advanced breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "61342",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.457441,
            -27.83741
          ],
          [
            -25.402184,
            -27.933782
          ],
          [
            -23.478389,
            -31.234171
          ],
          [
            -23.422978,
            -31.327612
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "342",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- The RANK Pathway in Advanced Breast Cancer: Does Src Play a Role?",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "61343",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.459858,
            -27.837424
          ],
          [
            -25.520048,
            -27.94381
          ],
          [
            -27.81655,
            -31.922472
          ],
          [
            -27.87597,
            -32.023277
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "343",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- Progestogens and risk of breast cancer: a link between bone and breast?",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "61344",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.458704,
            -27.837394
          ],
          [
            -25.461765,
            -27.967447
          ],
          [
            -25.606111,
            -33.911318
          ],
          [
            -25.60921,
            -34.034868
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "344",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "25957",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.009259,
            -27.186881
          ],
          [
            -17.023322,
            -27.318005
          ],
          [
            -17.686058,
            -33.31398
          ],
          [
            -17.700293,
            -33.438676
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "259",
        "dest": "57",
        "label": "[The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications]. -- RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "26058",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -15.718348,
            -32.618599
          ],
          [
            -15.735744,
            -32.765946
          ],
          [
            -16.716564,
            -40.66614
          ],
          [
            -16.734283,
            -40.801275
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "260",
        "dest": "58",
        "label": "Receptor activator of nuclear factor-kappa B ligand (RANKL) stimulates bone-associated tumors through functional RANK expressed on bone-associated cancer cells? -- Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "33671",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.483602,
            -28.700981
          ],
          [
            0.326982,
            -28.793548
          ],
          [
            -5.078626,
            -31.937048
          ],
          [
            -5.23564,
            -32.026832
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "336",
        "dest": "71",
        "label": "Activation of NF-\u03baB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. -- Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "33672",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.486147,
            -28.701003
          ],
          [
            0.432627,
            -28.820814
          ],
          [
            -1.923383,
            -33.953987
          ],
          [
            -1.977444,
            -34.068428
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "336",
        "dest": "72",
        "label": "Activation of NF-\u03baB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. -- Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "33674",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.486154,
            -28.701011
          ],
          [
            0.423289,
            -28.843457
          ],
          [
            -2.846284,
            -35.970927
          ],
          [
            -2.910137,
            -36.104403
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "336",
        "dest": "74",
        "label": "Activation of NF-\u03baB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. -- RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "77308",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.397423,
            -31.334621
          ],
          [
            1.411579,
            -31.478828
          ],
          [
            2.187977,
            -39.034944
          ],
          [
            2.202382,
            -39.168368
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "308",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "77447",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.396337,
            -31.334635
          ],
          [
            1.338449,
            -31.465178
          ],
          [
            -1.524093,
            -37.68632
          ],
          [
            -1.582792,
            -37.808945
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "447",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77448",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.403677,
            -31.334629
          ],
          [
            1.6947,
            -31.425069
          ],
          [
            11.739214,
            -34.492211
          ],
          [
            12.030974,
            -34.579697
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "448",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77449",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.398594,
            -31.334674
          ],
          [
            1.487522,
            -31.467974
          ],
          [
            5.885985,
            -37.816642
          ],
          [
            5.974031,
            -37.938691
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "449",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "77450",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.400191,
            -31.334645
          ],
          [
            1.593007,
            -31.465939
          ],
          [
            11.128769,
            -37.722118
          ],
          [
            11.321978,
            -37.843937
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "450",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77451",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.400518,
            -31.33464
          ],
          [
            1.604447,
            -31.459369
          ],
          [
            11.216106,
            -37.144283
          ],
          [
            11.420237,
            -37.260786
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "451",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "77452",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.400975,
            -31.33464
          ],
          [
            1.620084,
            -31.452409
          ],
          [
            11.374162,
            -36.54116
          ],
          [
            11.593219,
            -36.651899
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "452",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77453",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.401616,
            -31.334645
          ],
          [
            1.625345,
            -31.437589
          ],
          [
            10.326675,
            -35.35181
          ],
          [
            10.549696,
            -35.449792
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "453",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "77454",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.39841,
            -31.334666
          ],
          [
            1.462495,
            -31.445275
          ],
          [
            4.109732,
            -35.897591
          ],
          [
            4.17306,
            -36.001246
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "454",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "77455",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.396862,
            -31.334658
          ],
          [
            1.371842,
            -31.473893
          ],
          [
            0.070277,
            -38.421563
          ],
          [
            0.045495,
            -38.548053
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "455",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "77456",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.399205,
            -31.334643
          ],
          [
            1.521762,
            -31.459621
          ],
          [
            7.297458,
            -37.154801
          ],
          [
            7.42153,
            -37.272847
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "456",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- New insights into lineage restriction of mammary gland epithelium using parity-identified mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "77457",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.395889,
            -31.334635
          ],
          [
            1.316833,
            -31.453308
          ],
          [
            -2.241583,
            -36.635221
          ],
          [
            -2.321498,
            -36.747913
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "457",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77458",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.39828,
            -31.334698
          ],
          [
            1.459152,
            -31.454487
          ],
          [
            4.139552,
            -36.573249
          ],
          [
            4.199749,
            -36.684618
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "458",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63355",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.51914,
            -11.383686
          ],
          [
            27.382645,
            -11.502063
          ],
          [
            22.174772,
            -15.977159
          ],
          [
            22.040021,
            -16.091756
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "355",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Mammary adipocytes bioactivate 25-hydroxyvitamin D\u2083 and signal via vitamin D\u2083 receptor, modulating mammary epithelial cell growth.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63356",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.534952,
            -11.383615
          ],
          [
            28.10021,
            -11.482968
          ],
          [
            46.799432,
            -14.748193
          ],
          [
            47.365393,
            -14.846316
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "356",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Age-related changes in the epithelial and stromal compartments of the mammary gland in normocalcemic mice lacking the vitamin D3 receptor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63357",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.523787,
            -11.383649
          ],
          [
            27.627664,
            -11.509907
          ],
          [
            31.917541,
            -16.667973
          ],
          [
            32.022259,
            -16.792341
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "357",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Adipose-specific Vdr deletion alters body fat and enhances mammary epithelial density.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63359",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.536097,
            -11.383618
          ],
          [
            28.07714,
            -11.471128
          ],
          [
            43.870668,
            -14.012851
          ],
          [
            44.410329,
            -14.099233
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "359",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63360",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.529514,
            -11.383606
          ],
          [
            27.893691,
            -11.492638
          ],
          [
            41.152644,
            -15.430541
          ],
          [
            41.516745,
            -15.537721
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "360",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Adipocyte derived paracrine mediators of mammary ductal morphogenesis controlled by retinoic acid receptors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63361",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.550137,
            -11.383606
          ],
          [
            28.474173,
            -11.458436
          ],
          [
            51.750593,
            -13.336578
          ],
          [
            52.675091,
            -13.410885
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "361",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Transgenic Expression of Vitamin D Receptor in Gut Epithelial Cells Ameliorates Spontaneous Colitis Caused by Interleukin-10 Deficiency.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63362",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.57942,
            -11.379029
          ],
          [
            28.806186,
            -11.330225
          ],
          [
            49.246749,
            -10.515862
          ],
          [
            50.473276,
            -10.466925
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "362",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63364",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.545451,
            -11.379023
          ],
          [
            28.226378,
            -11.312814
          ],
          [
            43.431625,
            -9.830496
          ],
          [
            44.112475,
            -9.763959
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "364",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Morphogenesis of the developing mammary gland: stage-dependent impact of adipocytes.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63365",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.607956,
            -11.383606
          ],
          [
            29.091963,
            -11.423047
          ],
          [
            49.283398,
            -11.959142
          ],
          [
            50.767649,
            -11.99851
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "365",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Active plasma kallikrein localizes to mast cells and regulates epithelial cell apoptosis, adipocyte differentiation, and stromal remodeling during mammary gland involution.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63366",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.53607,
            -11.383609
          ],
          [
            27.906749,
            -11.443469
          ],
          [
            35.413477,
            -12.652896
          ],
          [
            35.78437,
            -12.712506
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "366",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Mammary ductal growth is impaired in mice lacking leptin-dependent signal transducer and activator of transcription 3 signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63367",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.632813,
            -11.380496
          ],
          [
            29.128317,
            -11.36941
          ],
          [
            45.256414,
            -11.249845
          ],
          [
            46.252162,
            -11.242462
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "367",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Physiological functions of Vitamin D in adipose tissue.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "117677",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.81111,
            -10.201995
          ],
          [
            -23.647966,
            -10.091915
          ],
          [
            -17.761619,
            -6.098026
          ],
          [
            -17.599259,
            -5.987351
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "117",
        "dest": "677",
        "label": "Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis. -- 7,8-Dihydroxycoumarin exerts antitumor potential on DMBA-induced mammary carcinogenesis by inhibiting ER\u03b1, PR, EGFR, and IGF1R: involvement of MAPK1/2-JNK1/2-Akt pathway.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "117678",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.808237,
            -10.202019
          ],
          [
            -23.448516,
            -10.070868
          ],
          [
            -7.867677,
            -4.348212
          ],
          [
            -7.508254,
            -4.215464
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "117",
        "dest": "678",
        "label": "Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis. -- Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73426",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.282268,
            -37.741348
          ],
          [
            -41.112627,
            -37.852728
          ],
          [
            -33.389215,
            -42.743619
          ],
          [
            -33.219533,
            -42.847077
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "426",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Out-RANKing BRCA1 in Mutation Carriers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73427",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.284952,
            -37.74137
          ],
          [
            -41.275235,
            -37.860949
          ],
          [
            -40.806215,
            -43.399884
          ],
          [
            -40.796598,
            -43.508629
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "427",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "73428",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.278741,
            -37.741335
          ],
          [
            -40.867432,
            -37.860915
          ],
          [
            -20.650472,
            -43.496625
          ],
          [
            -20.238377,
            -43.606518
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "428",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-\u03baB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73429",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.284789,
            -37.74135
          ],
          [
            -41.263147,
            -37.869058
          ],
          [
            -40.137643,
            -44.201961
          ],
          [
            -40.115663,
            -44.319538
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "429",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Can we prevent BRCA1-associated breast cancer by RANKL inhibition?",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73430",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.282762,
            -37.741353
          ],
          [
            -41.115852,
            -37.874438
          ],
          [
            -32.083319,
            -44.712989
          ],
          [
            -31.915737,
            -44.83305
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "430",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Persistent Activation of NF-\u03baB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73431",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.280762,
            -37.741333
          ],
          [
            -40.987266,
            -37.866244
          ],
          [
            -25.915821,
            -43.992434
          ],
          [
            -25.621484,
            -44.106388
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "431",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73432",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.27926,
            -37.741348
          ],
          [
            -40.868282,
            -37.872305
          ],
          [
            -18.921818,
            -44.522828
          ],
          [
            -18.511965,
            -44.640561
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "432",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- RANKL/RANK control Brca1 mutation- .",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "73433",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.282139,
            -37.741338
          ],
          [
            -41.061794,
            -37.879025
          ],
          [
            -28.636367,
            -45.220782
          ],
          [
            -28.414935,
            -45.344008
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "433",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- NF-\u03baB at the Crossroads of Normal Mammary Gland Biology and the Pathogenesis and Prevention of <i>BRCA1</i>-Mutated Breast Cancer.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "57255",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.711996,
            -33.442661
          ],
          [
            -18.250942,
            -33.53412
          ],
          [
            -37.606622,
            -36.753815
          ],
          [
            -38.147588,
            -36.841958
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "255",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- RANK as a therapeutic target in cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "57256",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.704095,
            -33.442673
          ],
          [
            -17.922474,
            -33.56262
          ],
          [
            -28.095852,
            -38.961636
          ],
          [
            -28.314395,
            -39.073479
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "256",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- RANKL/RANK-beyond bones.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "57263",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.707638,
            -33.442676
          ],
          [
            -18.02296,
            -33.529631
          ],
          [
            -28.721446,
            -36.427469
          ],
          [
            -29.036116,
            -36.511138
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "263",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- RANKL/RANK - from bone physiology to breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "57318",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.705949,
            -33.442673
          ],
          [
            -18.019365,
            -33.555992
          ],
          [
            -31.818423,
            -38.394835
          ],
          [
            -32.131691,
            -38.501209
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "318",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- The effect of sex hormones on bone metabolism of the otic capsule--an overview.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "57319",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.707835,
            -33.442663
          ],
          [
            -17.994365,
            -33.519066
          ],
          [
            -26.61109,
            -35.784905
          ],
          [
            -26.899215,
            -35.859594
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "319",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- Physiology and pathophysiology of the RANKL/RANK system.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "57320",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.712912,
            -33.442661
          ],
          [
            -18.127276,
            -33.507813
          ],
          [
            -28.80389,
            -35.169513
          ],
          [
            -29.218183,
            -35.233328
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "320",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "57321",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.703511,
            -33.442673
          ],
          [
            -17.905176,
            -33.574997
          ],
          [
            -28.261007,
            -40.09031
          ],
          [
            -28.463251,
            -40.21196
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "321",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- The RANKL-RANK Story.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58322",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.735324,
            -40.80497
          ],
          [
            -16.788557,
            -40.927901
          ],
          [
            -19.488029,
            -46.860485
          ],
          [
            -19.540749,
            -46.970449
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "322",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "58323",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.735319,
            -40.804956
          ],
          [
            -16.785692,
            -40.92096
          ],
          [
            -19.217256,
            -46.27755
          ],
          [
            -19.267117,
            -46.382389
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "323",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "58324",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.733624,
            -40.804942
          ],
          [
            -16.676313,
            -40.920039
          ],
          [
            -13.909889,
            -46.236647
          ],
          [
            -13.853163,
            -46.340744
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "324",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Expression of receptor activator of nuclear factor kappa-B as a poor prognostic marker in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58325",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.734019,
            -40.804932
          ],
          [
            -16.698388,
            -40.931807
          ],
          [
            -14.79552,
            -47.351897
          ],
          [
            -14.760217,
            -47.464401
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "325",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Examination of the mechanisms of osteolysis in patients with metastatic breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58326",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.731265,
            -40.804928
          ],
          [
            -16.5488,
            -40.905631
          ],
          [
            -8.77175,
            -45.054711
          ],
          [
            -8.589498,
            -45.148577
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "326",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- RANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "58327",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.729506,
            -40.804923
          ],
          [
            -16.485776,
            -40.892012
          ],
          [
            -7.44658,
            -44.040744
          ],
          [
            -7.203873,
            -44.123102
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "327",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "58328",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.737762,
            -40.804897
          ],
          [
            -16.8646,
            -40.87422
          ],
          [
            -20.678493,
            -42.92476
          ],
          [
            -20.806951,
            -42.992678
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "328",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58329",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.735317,
            -40.804932
          ],
          [
            -16.78314,
            -40.914101
          ],
          [
            -18.985712,
            -45.745874
          ],
          [
            -19.033025,
            -45.845444
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "329",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58330",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.73533,
            -40.804949
          ],
          [
            -16.793384,
            -40.936439
          ],
          [
            -19.978324,
            -47.747147
          ],
          [
            -20.035859,
            -47.862891
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "330",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Effects of icariin on the regulation of the OPG-RANKL-RANK system are mediated through the MAPK pathways in IL-1\u03b2-stimulated human SW1353 chondrosarcoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58331",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.735312,
            -40.804895
          ],
          [
            -16.795377,
            -40.939985
          ],
          [
            -20.279673,
            -48.301312
          ],
          [
            -20.340917,
            -48.422339
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "331",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58332",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.734117,
            -40.804942
          ],
          [
            -16.706826,
            -40.925976
          ],
          [
            -15.322885,
            -46.771588
          ],
          [
            -15.295858,
            -46.880032
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "332",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58333",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.732367,
            -40.804951
          ],
          [
            -16.580527,
            -40.933071
          ],
          [
            -8.471687,
            -47.412658
          ],
          [
            -8.321242,
            -47.526133
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "333",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Osteoprotegerin in bone metastases: mathematical solution to the puzzle.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58334",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.731944,
            -40.80493
          ],
          [
            -16.557406,
            -40.926674
          ],
          [
            -7.593555,
            -46.876332
          ],
          [
            -7.420682,
            -46.985216
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "334",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "58335",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.73154,
            -40.804904
          ],
          [
            -16.537228,
            -40.920389
          ],
          [
            -6.92751,
            -46.378881
          ],
          [
            -6.732801,
            -46.48434
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "335",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71250",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -5.232648,
            -32.030817
          ],
          [
            -5.065704,
            -32.082106
          ],
          [
            -1.728072,
            -33.101453
          ],
          [
            -1.561131,
            -33.152133
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "250",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71254",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -5.259043,
            -32.026842
          ],
          [
            -5.618807,
            -31.991015
          ],
          [
            -10.736612,
            -31.479857
          ],
          [
            -11.096013,
            -31.443855
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "254",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "71413",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -5.243097,
            -32.030822
          ],
          [
            -5.477754,
            -32.148916
          ],
          [
            -16.041213,
            -37.302722
          ],
          [
            -16.275871,
            -37.413515
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "413",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-\u03baB ligand\u2013induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+\u2013nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "71414",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -5.242597,
            -32.030827
          ],
          [
            -5.462731,
            -32.157757
          ],
          [
            -16.087791,
            -38.068131
          ],
          [
            -16.308259,
            -38.18617
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "414",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71415",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -5.242144,
            -32.030809
          ],
          [
            -5.448652,
            -32.166508
          ],
          [
            -16.190361,
            -38.937572
          ],
          [
            -16.397519,
            -39.062451
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "415",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71416",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -5.241951,
            -32.030817
          ],
          [
            -5.443128,
            -32.172614
          ],
          [
            -16.329948,
            -39.505839
          ],
          [
            -16.531933,
            -39.635391
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "416",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71417",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -5.244603,
            -32.030814
          ],
          [
            -5.515549,
            -32.129221
          ],
          [
            -15.753036,
            -35.768309
          ],
          [
            -16.025422,
            -35.86299
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "417",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Impact of RANK signalling on survival and chemotherapy response in osteosarcoma.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72418",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.98106,
            -34.072383
          ],
          [
            -2.161563,
            -34.204529
          ],
          [
            -11.430731,
            -40.705222
          ],
          [
            -11.611753,
            -40.826488
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "418",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-\u03baB in hormone-independent MDA-MB-231 cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72419",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.981771,
            -34.072388
          ],
          [
            -2.219537,
            -34.210204
          ],
          [
            -14.915666,
            -41.233556
          ],
          [
            -15.154316,
            -41.359123
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "419",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Receptor activator of nuclear factor-\u03baB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72420",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.980701,
            -34.072412
          ],
          [
            -2.127466,
            -34.198251
          ],
          [
            -9.212184,
            -40.044626
          ],
          [
            -9.357461,
            -40.159735
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "420",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Suppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72421",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.001583,
            -34.072363
          ],
          [
            -2.424691,
            -34.10768
          ],
          [
            -8.499789,
            -34.613124
          ],
          [
            -8.922722,
            -34.648199
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "421",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-\u03baB-mediated epithelial-mesenchymal transition.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72422",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.982855,
            -34.072383
          ],
          [
            -2.269833,
            -34.19793
          ],
          [
            -16.289745,
            -40.098675
          ],
          [
            -16.577232,
            -40.214806
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "422",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17\u03b2-estradiol.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72423",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.985439,
            -34.072376
          ],
          [
            -2.282468,
            -34.154392
          ],
          [
            -11.869257,
            -36.758339
          ],
          [
            -12.166431,
            -36.837703
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "423",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Butein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72424",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.987914,
            -34.072363
          ],
          [
            -2.248392,
            -34.125303
          ],
          [
            -7.765905,
            -35.238854
          ],
          [
            -8.027087,
            -35.291194
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "424",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Knockdown of receptor for advanced glycation end products attenuate 17\u03b1-ethinyl-estradiol dependent proliferation and survival of MCF-7 breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72425",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.980887,
            -34.07237
          ],
          [
            -2.116231,
            -34.177514
          ],
          [
            -7.705626,
            -38.403514
          ],
          [
            -7.842066,
            -38.503787
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "425",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Benzoquinone from Fusarium pigment inhibits the proliferation of estrogen receptor-positive MCF-7 cells through the NF-\u03baB pathway via estrogen receptor signaling.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "7481",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.910753,
            -36.108353
          ],
          [
            -2.888139,
            -36.243139
          ],
          [
            -1.711644,
            -42.928584
          ],
          [
            -1.689241,
            -43.049573
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "81",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74434",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.914,
            -36.10828
          ],
          [
            -3.099051,
            -36.228606
          ],
          [
            -12.030801,
            -41.81268
          ],
          [
            -12.216133,
            -41.923841
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "434",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74435",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.913643,
            -36.10827
          ],
          [
            -3.08445,
            -36.234184
          ],
          [
            -11.744925,
            -42.348095
          ],
          [
            -11.916173,
            -42.463565
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "435",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "74436",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.911377,
            -36.108338
          ],
          [
            -2.927621,
            -36.216485
          ],
          [
            -3.612742,
            -40.640038
          ],
          [
            -3.628797,
            -40.74043
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "436",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74437",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.911584,
            -36.10828
          ],
          [
            -2.942581,
            -36.225793
          ],
          [
            -4.403348,
            -41.560505
          ],
          [
            -4.434729,
            -41.670677
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "437",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74438",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.911393,
            -36.108318
          ],
          [
            -2.926231,
            -36.201319
          ],
          [
            -3.471409,
            -39.540901
          ],
          [
            -3.486315,
            -39.630063
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "438",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "74439",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.909614,
            -36.108313
          ],
          [
            -2.826494,
            -36.217396
          ],
          [
            0.754763,
            -40.770965
          ],
          [
            0.836939,
            -40.872051
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "439",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74440",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.909625,
            -36.108326
          ],
          [
            -2.833757,
            -36.209241
          ],
          [
            0.175819,
            -40.106384
          ],
          [
            0.250753,
            -40.200742
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "440",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Cigarette smoke induces epithelial to mesenchymal transition and increases the metastatic ability of breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "74441",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.909914,
            -36.10828
          ],
          [
            -2.833778,
            -36.231645
          ],
          [
            0.931076,
            -42.08518
          ],
          [
            1.008275,
            -42.200075
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "441",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74442",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.90963,
            -36.108286
          ],
          [
            -2.821622,
            -36.223256
          ],
          [
            1.230691,
            -41.331363
          ],
          [
            1.319719,
            -41.439452
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "442",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30883",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.201896,
            -39.17209
          ],
          [
            2.154764,
            -39.298225
          ],
          [
            -0.297123,
            -45.543932
          ],
          [
            -0.34381,
            -45.656795
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "308",
        "dest": "83",
        "label": "c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer. -- BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "44992",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.975738,
            -37.942442
          ],
          [
            5.99689,
            -38.051956
          ],
          [
            6.928301,
            -42.710205
          ],
          [
            6.949217,
            -42.811104
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "449",
        "dest": "92",
        "label": "Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors. -- Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1687",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.005385,
            -30.631564
          ],
          [
            15.09424,
            -30.567316
          ],
          [
            17.243576,
            -29.00035
          ],
          [
            17.331693,
            -28.935587
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "16",
        "dest": "87",
        "label": "Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. -- Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "87100",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.334498,
            -28.931408
          ],
          [
            17.335232,
            -28.843804
          ],
          [
            17.358302,
            -26.045854
          ],
          [
            17.359023,
            -25.95731
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "100",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "8786",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.341392,
            -28.935601
          ],
          [
            17.600291,
            -29.012857
          ],
          [
            25.048099,
            -31.210176
          ],
          [
            25.306223,
            -31.285448
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "86",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- Lineage specific methylation of the Elf5 promoter in mammary epithelial cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "8788",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.350646,
            -28.931493
          ],
          [
            17.767044,
            -28.878834
          ],
          [
            26.091886,
            -27.820445
          ],
          [
            26.508275,
            -27.767232
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "88",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "87352",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.333554,
            -28.935634
          ],
          [
            17.290599,
            -29.03267
          ],
          [
            15.768466,
            -32.411089
          ],
          [
            15.725368,
            -32.505005
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "352",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "87514",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.335238,
            -28.935658
          ],
          [
            17.377175,
            -29.052945
          ],
          [
            19.146029,
            -33.874656
          ],
          [
            19.187479,
            -33.984626
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "514",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- Polycomb group gene Ezh2 regulates mammary gland morphogenesis and maintains the luminal progenitor pool.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100402",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.362618,
            -25.953087
          ],
          [
            17.472062,
            -25.888759
          ],
          [
            20.055303,
            -24.360374
          ],
          [
            20.164993,
            -24.295058
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "402",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "100234",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.368576,
            -25.953084
          ],
          [
            17.893552,
            -25.837212
          ],
          [
            39.916166,
            -20.878778
          ],
          [
            40.442999,
            -20.757955
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "234",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Small molecule antagonists of the Wnt/\u03b2-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "10062",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.357343,
            -25.957366
          ],
          [
            17.261432,
            -26.080496
          ],
          [
            13.129014,
            -31.257352
          ],
          [
            13.034191,
            -31.37308
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "62",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "100101",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.435377,
            -25.957288
          ],
          [
            18.742176,
            -25.993206
          ],
          [
            36.404737,
            -26.477583
          ],
          [
            37.711681,
            -26.513344
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "101",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "100219",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.353521,
            -25.957305
          ],
          [
            17.162527,
            -26.030506
          ],
          [
            12.075469,
            -27.963169
          ],
          [
            11.884276,
            -28.035153
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "219",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Differential gene expression in nuclear label-retaining cells in the developing mouse mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100389",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.362727,
            -25.953081
          ],
          [
            17.578345,
            -25.829756
          ],
          [
            27.176924,
            -20.216327
          ],
          [
            27.39249,
            -20.087666
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "389",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "100513",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.379014,
            -25.953087
          ],
          [
            17.758238,
            -25.913146
          ],
          [
            23.41442,
            -25.31584
          ],
          [
            23.793739,
            -25.275677
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "513",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Chromatin effector Pygo2 mediates Wnt-notch crosstalk to suppress luminal/alveolar potential of mammary stem and basal cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "100608",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.335438,
            -25.957291
          ],
          [
            16.909083,
            -25.995267
          ],
          [
            10.843984,
            -26.534164
          ],
          [
            10.418058,
            -26.571913
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "608",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Wnt and Notch pathways have interrelated opposing roles on prostate progenitor cell proliferation and differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100609",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.386629,
            -25.95309
          ],
          [
            18.1606,
            -25.894188
          ],
          [
            34.96508,
            -24.608118
          ],
          [
            35.739044,
            -24.548558
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "609",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "100610",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.509868,
            -25.954603
          ],
          [
            19.404075,
            -25.947246
          ],
          [
            38.525714,
            -25.872957
          ],
          [
            39.878913,
            -25.867698
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "610",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Nitric oxide production upregulates Wnt/\u03b2-catenin signaling by inhibiting Dickkopf-1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100611",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.385227,
            -25.953084
          ],
          [
            18.28867,
            -25.880453
          ],
          [
            42.271515,
            -23.936346
          ],
          [
            43.174358,
            -23.862568
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "611",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "100612",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.362761,
            -25.953064
          ],
          [
            17.552443,
            -25.844701
          ],
          [
            24.929679,
            -21.556218
          ],
          [
            25.118763,
            -21.444495
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "612",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Tissue-dependent consequences of Apc inactivation on proliferation and differentiation of ciliated cell progenitors via Wnt and notch signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100613",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.373249,
            -25.953078
          ],
          [
            17.936941,
            -25.869268
          ],
          [
            35.085641,
            -23.291875
          ],
          [
            35.6486,
            -23.206379
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "613",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- How pregnancy at early age protects against breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100614",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.369203,
            -25.957296
          ],
          [
            17.633806,
            -26.012143
          ],
          [
            22.978515,
            -27.11447
          ],
          [
            23.243238,
            -27.168791
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "614",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Wnt signaling in triple negative breast cancer is associated with metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "86363",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.319133,
            -31.289459
          ],
          [
            25.653422,
            -31.400559
          ],
          [
            39.751554,
            -35.96356
          ],
          [
            40.085376,
            -36.068635
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "363",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- Molecular aspects of adipoepithelial transdifferentiation in mouse mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "86507",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.331834,
            -31.289446
          ],
          [
            25.837314,
            -31.343309
          ],
          [
            36.402496,
            -32.46198
          ],
          [
            36.907767,
            -32.515139
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "507",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "86509",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.31564,
            -31.289465
          ],
          [
            25.414045,
            -31.367226
          ],
          [
            28.329491,
            -33.641551
          ],
          [
            28.427689,
            -33.717147
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "509",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- DNA methylation restricts spontaneous multi-lineage differentiation of mesenchymal progenitor cells, but is stable during growth factor-induced terminal differentiation.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "86510",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.326401,
            -31.289451
          ],
          [
            25.812303,
            -31.362535
          ],
          [
            39.443124,
            -33.389291
          ],
          [
            39.928836,
            -33.460668
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "510",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- Transcription factor regulatory networks in mammary epithelial development and tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "86511",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.316686,
            -31.28947
          ],
          [
            25.473353,
            -31.377544
          ],
          [
            30.700086,
            -34.267815
          ],
          [
            30.855731,
            -34.352428
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "511",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- Elf5 regulation in the trophectoderm.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "86512",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.306084,
            -31.289462
          ],
          [
            25.073181,
            -31.356337
          ],
          [
            19.11105,
            -33.051934
          ],
          [
            18.878242,
            -33.117498
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "512",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "8889",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.528991,
            -27.767234
          ],
          [
            26.710249,
            -27.849626
          ],
          [
            32.245731,
            -30.335107
          ],
          [
            32.426773,
            -30.415376
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "89",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "88516",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.528984,
            -27.767248
          ],
          [
            26.735888,
            -27.862093
          ],
          [
            33.93951,
            -31.111277
          ],
          [
            34.146993,
            -31.203301
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "516",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Insulin, a key regulator of hormone responsive milk protein synthesis during lactogenesis in murine mammary explants.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "88517",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.52865,
            -27.767265
          ],
          [
            26.739087,
            -27.872183
          ],
          [
            34.767246,
            -31.796771
          ],
          [
            34.976931,
            -31.89718
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "517",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- The STAT5-regulated miR-193b locus restrains mammary stem and progenitor cell activity and alveolar differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "88518",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.535459,
            -27.767234
          ],
          [
            26.915616,
            -27.838648
          ],
          [
            37.007006,
            -29.716871
          ],
          [
            37.387516,
            -29.787025
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "518",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Protein tyrosine phosphatase 1B restrains mammary alveologenesis and secretory differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "88519",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.535768,
            -27.767237
          ],
          [
            27.056237,
            -27.862379
          ],
          [
            45.337766,
            -31.150058
          ],
          [
            45.857631,
            -31.241967
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "519",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Stat5 assumes distinct functions in mammary gland development and mammary tumor formation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "88521",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.523316,
            -27.767265
          ],
          [
            26.485743,
            -27.837528
          ],
          [
            25.517728,
            -29.631792
          ],
          [
            25.47993,
            -29.701224
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "521",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Elf5, hormones and cell fate.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "62228",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.032869,
            -31.377095
          ],
          [
            13.05578,
            -31.513631
          ],
          [
            14.247351,
            -38.330402
          ],
          [
            14.270622,
            -38.457804
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "228",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Deregulated ephrin-B2 signaling in mammary epithelial cells alters the             stem cell compartment and interferes with the epithelial differentiation pathway.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "62345",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.03441,
            -31.377151
          ],
          [
            13.16287,
            -31.517463
          ],
          [
            19.845598,
            -38.516151
          ],
          [
            19.972845,
            -38.643512
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "345",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "62346",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.037127,
            -31.377095
          ],
          [
            13.288538,
            -31.486216
          ],
          [
            23.779552,
            -35.92362
          ],
          [
            24.033083,
            -36.027988
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "346",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "62347",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.036246,
            -31.377114
          ],
          [
            13.280757,
            -31.509597
          ],
          [
            25.52378,
            -37.895472
          ],
          [
            25.768855,
            -38.018196
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "347",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "62351",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.036837,
            -31.377127
          ],
          [
            13.285595,
            -31.494187
          ],
          [
            24.237875,
            -36.499193
          ],
          [
            24.486515,
            -36.60935
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "351",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Genotoxic exposure during juvenile growth of mammary gland depletes stem cell activity and inhibits Wnt signaling.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "62353",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.035246,
            -31.377116
          ],
          [
            13.193765,
            -31.494885
          ],
          [
            20.250578,
            -36.583469
          ],
          [
            20.409061,
            -36.694199
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "353",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Slug controls stem/progenitor cell growth dynamics during mammary gland morphogenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "62354",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.036489,
            -31.377106
          ],
          [
            13.281439,
            -31.501304
          ],
          [
            24.826615,
            -37.162588
          ],
          [
            25.071811,
            -37.278622
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "354",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Lgr4 regulates mammary gland development and stem cell activity through the pluripotency transcription factor Sox2.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "101348",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.846571,
            -26.513344
          ],
          [
            38.939005,
            -26.474334
          ],
          [
            54.968662,
            -25.90039
          ],
          [
            56.06121,
            -25.861168
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "348",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101350",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.808429,
            -26.513342
          ],
          [
            38.3615,
            -26.456592
          ],
          [
            49.983356,
            -25.257653
          ],
          [
            50.536327,
            -25.200306
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "350",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- The proto-oncogene Myc is essential for mammary stem cell function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101444",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.783983,
            -26.517531
          ],
          [
            37.634393,
            -26.594839
          ],
          [
            33.393731,
            -28.76439
          ],
          [
            33.242622,
            -28.840896
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "444",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "101615",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.793928,
            -26.517539
          ],
          [
            38.130774,
            -26.637763
          ],
          [
            52.800143,
            -31.745724
          ],
          [
            53.136748,
            -31.859889
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "615",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Repression of mammary stem/progenitor cells by p53 is mediated by Notch and separable from apoptotic activity.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "101616",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.798995,
            -26.517528
          ],
          [
            38.258887,
            -26.605378
          ],
          [
            53.04213,
            -29.392602
          ],
          [
            53.502189,
            -29.478172
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "616",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Intraepithelial paracrine Hedgehog signaling induces the expansion of ciliated cells that express diverse progenitor cell markers in the basal epithelium of the mouse mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101617",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.795146,
            -26.517528
          ],
          [
            38.148677,
            -26.621681
          ],
          [
            51.570931,
            -30.503636
          ],
          [
            51.924777,
            -30.604006
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "617",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Stem/progenitor cells in non-lactating versus lactating equine mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101618",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.804254,
            -26.517525
          ],
          [
            38.398476,
            -26.594135
          ],
          [
            55.127254,
            -28.729458
          ],
          [
            55.721314,
            -28.804512
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "618",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Irradiation of juvenile, but not adult, mammary gland increases stem cell self-renewal and estrogen receptor negative tumors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101619",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.791351,
            -26.517548
          ],
          [
            37.893971,
            -26.582972
          ],
          [
            40.345576,
            -28.134709
          ],
          [
            40.44848,
            -28.199364
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "619",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Notch3 marks clonogenic mammary luminal progenitor cells in vivo.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "101620",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.811594,
            -26.517525
          ],
          [
            38.44434,
            -26.573641
          ],
          [
            51.616374,
            -27.735564
          ],
          [
            52.249526,
            -27.791107
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "620",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Stem cell research: a novel boulevard towards improved bovine mastitis management.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101621",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.817776,
            -26.517525
          ],
          [
            38.36459,
            -26.555981
          ],
          [
            46.274901,
            -27.110818
          ],
          [
            46.82175,
            -27.149076
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "621",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Epithelial vimentin plays a functional role in mammary gland development.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "89508",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            32.452475,
            -30.4194
          ],
          [
            33.207157,
            -30.491153
          ],
          [
            53.900784,
            -32.437817
          ],
          [
            54.655829,
            -32.508074
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "89",
        "dest": "508",
        "label": "Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. -- Transcript profiling of Elf5+/- mammary glands during pregnancy identifies novel targets of Elf5.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "89515",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            32.436313,
            -30.419419
          ],
          [
            32.719021,
            -30.534215
          ],
          [
            44.898261,
            -35.347395
          ],
          [
            45.180701,
            -35.455866
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "89",
        "dest": "515",
        "label": "Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. -- Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "89522",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            32.440229,
            -30.419416
          ],
          [
            32.910846,
            -30.526431
          ],
          [
            51.859651,
            -34.734994
          ],
          [
            52.329135,
            -34.836725
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "89",
        "dest": "522",
        "label": "Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. -- Elf5-centered transcription factor hub controls trophoblast stem cell self-renewal and differentiation through stoichiometry-sensitive shifts in target gene networks.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "89523",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            32.438861,
            -30.419408
          ],
          [
            32.808738,
            -30.518322
          ],
          [
            46.654136,
            -34.147055
          ],
          [
            47.024204,
            -34.242031
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "89",
        "dest": "523",
        "label": "Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. -- ELF5 isoform expression is tissue-specific and significantly altered in cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1793",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.933694,
            31.614068
          ],
          [
            -3.935266,
            31.779904
          ],
          [
            -4.03208,
            41.391974
          ],
          [
            -4.033639,
            41.536866
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "93",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- RUNX2 in mammary gland development and breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1795",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.934955,
            31.614036
          ],
          [
            -4.051494,
            31.797114
          ],
          [
            -12.083582,
            43.495959
          ],
          [
            -12.201235,
            43.653352
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "95",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1796",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.934982,
            31.614042
          ],
          [
            -4.022124,
            31.748626
          ],
          [
            -8.44006,
            38.307135
          ],
          [
            -8.528495,
            38.432968
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "96",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "1798",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.936605,
            31.610015
          ],
          [
            -4.157373,
            31.458589
          ],
          [
            -16.783519,
            22.414362
          ],
          [
            -17.005446,
            22.249161
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "98",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1799",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.938798,
            31.614023
          ],
          [
            -4.138136,
            31.691848
          ],
          [
            -10.088372,
            33.984494
          ],
          [
            -10.287338,
            34.060127
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "99",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- ER and PR signaling nodes during mammary gland development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "9355",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.034016,
            41.540421
          ],
          [
            -4.05733,
            41.656712
          ],
          [
            -5.210466,
            47.145842
          ],
          [
            -5.233548,
            47.250455
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "55",
        "label": "RUNX2 in mammary gland development and breast cancer. -- RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "93223",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.032709,
            41.540438
          ],
          [
            -3.965893,
            41.667168
          ],
          [
            -0.397659,
            48.071808
          ],
          [
            -0.331459,
            48.183894
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "223",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Cellular quiescence in mammary stem cells and breast tumor stem cells: got testable hypotheses?",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "93236",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.034007,
            41.540454
          ],
          [
            -4.060695,
            41.679534
          ],
          [
            -5.609233,
            49.233581
          ],
          [
            -5.635696,
            49.35387
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "236",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Mammary development and breast cancer: the role of stem cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "93237",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.032846,
            41.540403
          ],
          [
            -3.972535,
            41.671711
          ],
          [
            -0.571964,
            48.641027
          ],
          [
            -0.510533,
            48.759083
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "237",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Cancer stem cells in the human mammary gland and regulation of their differentiation by estrogen.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "93314",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.034016,
            41.540417
          ],
          [
            -4.058414,
            41.662462
          ],
          [
            -5.327734,
            47.69163
          ],
          [
            -5.351905,
            47.80034
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "314",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Runx2 contributes to the regenerative potential of the mammary epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "93540",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.034255,
            41.540384
          ],
          [
            -4.077382,
            41.666794
          ],
          [
            -6.442746,
            48.218925
          ],
          [
            -6.486633,
            48.333415
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "540",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "93541",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.035286,
            41.540391
          ],
          [
            -4.152891,
            41.667212
          ],
          [
            -10.603129,
            48.239389
          ],
          [
            -10.7228,
            48.354205
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "541",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBF\u03b2-dependent expression of the Wnt antagonist, sclerostin.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "93542",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.036011,
            41.540384
          ],
          [
            -4.18897,
            41.654244
          ],
          [
            -11.752656,
            47.032733
          ],
          [
            -11.907755,
            47.137852
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "542",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Noncanonical TGF-\u03b2 signaling during mammary tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "93543",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.034375,
            41.540433
          ],
          [
            -4.087604,
            41.674034
          ],
          [
            -7.089663,
            48.758956
          ],
          [
            -7.142431,
            48.875585
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "543",
        "label": "RUNX2 in mammary gland development and breast cancer. -- A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "93544",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.035789,
            41.540445
          ],
          [
            -4.181664,
            41.664428
          ],
          [
            -11.770441,
            47.784213
          ],
          [
            -11.914939,
            47.894452
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "544",
        "label": "RUNX2 in mammary gland development and breast cancer. -- A prognosis classifier for breast cancer based on conserved gene regulation between mammary gland development and tumorigenesis: a multiscale statistical model.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "9594",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.205087,
            43.656791
          ],
          [
            -12.40877,
            43.792077
          ],
          [
            -24.759128,
            51.42558
          ],
          [
            -24.964148,
            51.542922
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "94",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "95559",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.202435,
            43.656854
          ],
          [
            -12.195408,
            43.774043
          ],
          [
            -11.839089,
            49.416299
          ],
          [
            -11.83213,
            49.520648
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "559",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "95560",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.202435,
            43.656831
          ],
          [
            -12.194399,
            43.789367
          ],
          [
            -11.728217,
            50.978297
          ],
          [
            -11.72025,
            51.092645
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "560",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95561",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.205255,
            43.656811
          ],
          [
            -12.409897,
            43.785915
          ],
          [
            -24.113743,
            50.707374
          ],
          [
            -24.319458,
            50.82096
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "561",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "95562",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.204112,
            43.656788
          ],
          [
            -12.314631,
            43.775611
          ],
          [
            -18.215322,
            49.777787
          ],
          [
            -18.32768,
            49.885593
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "562",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Clinicopathological significance of CADM4 expression in invasive ductal carcinoma of the breast.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95563",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.205193,
            43.656791
          ],
          [
            -12.363963,
            43.757996
          ],
          [
            -19.59241,
            48.184609
          ],
          [
            -19.75122,
            48.277892
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "563",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95564",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.202428,
            43.656836
          ],
          [
            -12.194524,
            43.779049
          ],
          [
            -11.772518,
            49.943857
          ],
          [
            -11.764689,
            50.051555
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "564",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95565",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.205268,
            43.656822
          ],
          [
            -12.376407,
            43.764895
          ],
          [
            -20.53949,
            48.693506
          ],
          [
            -20.708872,
            48.79109
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "565",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95566",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.20375,
            43.656854
          ],
          [
            -12.278755,
            43.765686
          ],
          [
            -15.8144,
            48.671626
          ],
          [
            -15.888628,
            48.769926
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "566",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95567",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.204244,
            43.656842
          ],
          [
            -12.315115,
            43.770377
          ],
          [
            -17.798927,
            49.117534
          ],
          [
            -17.908701,
            49.219216
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "567",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "95568",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.205264,
            43.656813
          ],
          [
            -12.38702,
            43.77121
          ],
          [
            -21.602722,
            49.285402
          ],
          [
            -21.784949,
            49.388797
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "568",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95569",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.205275,
            43.656827
          ],
          [
            -12.402925,
            43.781747
          ],
          [
            -23.246081,
            50.236223
          ],
          [
            -23.44196,
            50.345663
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "569",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "95570",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.205266,
            43.656824
          ],
          [
            -12.394453,
            43.776592
          ],
          [
            -22.365367,
            49.750255
          ],
          [
            -22.552791,
            49.856207
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "570",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Testin is a tumor suppressor and prognostic marker in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96571",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.531524,
            38.436779
          ],
          [
            -8.649931,
            38.570123
          ],
          [
            -14.973354,
            45.327565
          ],
          [
            -15.090672,
            45.446134
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "571",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "96572",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.531431,
            38.436789
          ],
          [
            -8.637437,
            38.563933
          ],
          [
            -14.013075,
            44.713358
          ],
          [
            -14.118058,
            44.827581
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "572",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Hypoxic conditions induce a cancer-like phenotype in human breast epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96573",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.531283,
            38.436779
          ],
          [
            -8.622818,
            38.557149
          ],
          [
            -13.041368,
            44.125592
          ],
          [
            -13.131973,
            44.234772
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "573",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "96574",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.533988,
            38.436713
          ],
          [
            -8.82944,
            38.567163
          ],
          [
            -24.818093,
            45.269391
          ],
          [
            -25.114732,
            45.387054
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "574",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "96575",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.534276,
            38.436737
          ],
          [
            -8.834044,
            38.562048
          ],
          [
            -24.227544,
            44.70013
          ],
          [
            -24.528168,
            44.814156
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "575",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96576",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.53114,
            38.436789
          ],
          [
            -8.604624,
            38.544576
          ],
          [
            -11.770713,
            43.033995
          ],
          [
            -11.843363,
            43.133432
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "576",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "96577",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.534558,
            38.436723
          ],
          [
            -8.839423,
            38.555643
          ],
          [
            -23.82344,
            44.155669
          ],
          [
            -24.130696,
            44.265437
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "577",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96578",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.534956,
            38.436708
          ],
          [
            -8.846186,
            38.54786
          ],
          [
            -23.261302,
            43.506057
          ],
          [
            -23.572725,
            43.609034
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "578",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Role of deregulated microRNAs in breast cancer progression using FFPE tissue.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "96579",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.531136,
            38.436769
          ],
          [
            -8.599825,
            38.536941
          ],
          [
            -11.379798,
            42.473099
          ],
          [
            -11.447657,
            42.566282
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "579",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96580",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.535481,
            38.436723
          ],
          [
            -8.856128,
            38.54135
          ],
          [
            -22.74453,
            42.925853
          ],
          [
            -23.064909,
            43.023571
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "580",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96581",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.53644,
            38.436735
          ],
          [
            -8.829063,
            38.518862
          ],
          [
            -18.757958,
            41.249716
          ],
          [
            -19.048781,
            41.328059
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "581",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Morphogenesis of the papillary lesions of the breast: phenotypic observation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96582",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.534476,
            38.436713
          ],
          [
            -8.761669,
            38.526414
          ],
          [
            -17.265483,
            41.803055
          ],
          [
            -17.493817,
            41.888845
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "582",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Aberrant activation of NF-\u03baB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96583",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.536119,
            38.436715
          ],
          [
            -8.867479,
            38.533544
          ],
          [
            -22.20845,
            42.322869
          ],
          [
            -22.540619,
            42.414482
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "583",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "9880",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.008723,
            22.244782
          ],
          [
            -17.033609,
            22.073492
          ],
          [
            -18.520041,
            11.515387
          ],
          [
            -18.545444,
            11.330349
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "80",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "98185",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.007546,
            22.249216
          ],
          [
            -16.95149,
            22.396163
          ],
          [
            -14.178862,
            29.455798
          ],
          [
            -14.12336,
            29.592653
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "185",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "98213",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.00786,
            22.249233
          ],
          [
            -16.969404,
            22.409128
          ],
          [
            -14.915677,
            30.657345
          ],
          [
            -14.877574,
            30.804562
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "213",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "9839",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.006578,
            22.249121
          ],
          [
            -16.907533,
            22.366239
          ],
          [
            -12.817141,
            27.112485
          ],
          [
            -12.717293,
            27.22602
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "39",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98597",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.008171,
            22.249153
          ],
          [
            -16.996367,
            22.35878
          ],
          [
            -16.546109,
            26.473259
          ],
          [
            -16.534238,
            26.579873
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "597",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ER\u03b1(+) tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98598",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.001156,
            22.249144
          ],
          [
            -16.702963,
            22.338994
          ],
          [
            -7.307534,
            25.139473
          ],
          [
            -7.009414,
            25.227332
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "598",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "98599",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.008175,
            22.249219
          ],
          [
            -16.999985,
            22.329168
          ],
          [
            -16.777281,
            24.485286
          ],
          [
            -16.769236,
            24.562501
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "599",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "98600",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.009519,
            22.244794
          ],
          [
            -17.075151,
            22.116756
          ],
          [
            -20.02938,
            16.241669
          ],
          [
            -20.095726,
            16.107426
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "600",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "98601",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.016372,
            22.244788
          ],
          [
            -17.318108,
            22.162602
          ],
          [
            -26.093224,
            19.752019
          ],
          [
            -26.395208,
            19.668383
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "601",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98602",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.013148,
            22.244782
          ],
          [
            -17.257205,
            22.132703
          ],
          [
            -26.842439,
            17.664086
          ],
          [
            -27.085773,
            17.549054
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "602",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98603",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.011139,
            22.244745
          ],
          [
            -17.140052,
            22.140316
          ],
          [
            -21.790771,
            18.323322
          ],
          [
            -21.920184,
            18.215803
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "603",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- AKT3 regulates ErbB2, ErbB3 and estrogen receptor \u03b1 expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98604",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.007853,
            22.244699
          ],
          [
            -16.990266,
            22.172918
          ],
          [
            -16.559456,
            20.403429
          ],
          [
            -16.542212,
            20.332173
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "604",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- ER\u03b136, a new variant of the ER\u03b1 is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98605",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.009398,
            22.244725
          ],
          [
            -17.060925,
            22.128576
          ],
          [
            -19.104973,
            17.448111
          ],
          [
            -19.155866,
            17.32988
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "605",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "99606",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.284802,
            34.064006
          ],
          [
            -10.13862,
            34.101117
          ],
          [
            -7.941527,
            34.656937
          ],
          [
            -7.794718,
            34.693945
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "99",
        "dest": "606",
        "label": "ER and PR signaling nodes during mammary gland development. -- Diet and expression of estrogen alpha and progesterone receptors in the normal mammary gland.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "99607",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.27683,
            34.06013
          ],
          [
            -9.976149,
            34.022838
          ],
          [
            -5.429636,
            33.456964
          ],
          [
            -5.12916,
            33.419436
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "99",
        "dest": "607",
        "label": "ER and PR signaling nodes during mammary gland development. -- Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "55313",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -5.23574,
            47.253659
          ],
          [
            -5.372471,
            47.373415
          ],
          [
            -13.0838,
            53.692752
          ],
          [
            -13.21934,
            53.796301
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "55",
        "dest": "313",
        "label": "RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland. -- Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94545",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.960135,
            51.545849
          ],
          [
            -24.499523,
            51.647134
          ],
          [
            -0.066165,
            56.701525
          ],
          [
            0.396094,
            56.791249
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "545",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94546",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.971259,
            51.545863
          ],
          [
            -25.287609,
            51.648037
          ],
          [
            -42.069525,
            56.744382
          ],
          [
            -42.384977,
            56.834215
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "546",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in\u00a0situ ductal carcinoma (IDC\u00a0+\u00a0DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94547",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.962332,
            51.545859
          ],
          [
            -24.642416,
            51.652036
          ],
          [
            -6.972349,
            57.13831
          ],
          [
            -6.65314,
            57.230739
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "547",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94548",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.969402,
            51.545849
          ],
          [
            -25.165184,
            51.652098
          ],
          [
            -36.052912,
            57.17694
          ],
          [
            -36.249599,
            57.269967
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "548",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94549",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.96205,
            51.545859
          ],
          [
            -24.649929,
            51.643175
          ],
          [
            -8.82427,
            56.308429
          ],
          [
            -8.511342,
            56.395454
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "549",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94550",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.966261,
            51.545859
          ],
          [
            -24.93506,
            51.643258
          ],
          [
            -23.353148,
            56.31164
          ],
          [
            -23.321483,
            56.399792
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "550",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Expression of androgen receptors in primary breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "94551",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.965305,
            51.545851
          ],
          [
            -24.87484,
            51.638001
          ],
          [
            -20.509006,
            55.866008
          ],
          [
            -20.417351,
            55.950242
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "551",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "94552",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.970886,
            51.54587
          ],
          [
            -25.244713,
            51.642792
          ],
          [
            -38.955669,
            56.235445
          ],
          [
            -39.23013,
            56.322259
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "552",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- HOXB9 expression promoting tumor cell proliferation and angiogenesis is associated with clinical outcomes in breast cancer patients.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94553",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.963768,
            51.545865
          ],
          [
            -24.786621,
            51.6335
          ],
          [
            -16.721566,
            55.446504
          ],
          [
            -16.544376,
            55.526447
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "553",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Angiogenesis in the progression of breast ductal proliferations.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94554",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.969459,
            51.545857
          ],
          [
            -25.132623,
            51.633021
          ],
          [
            -32.561188,
            55.426449
          ],
          [
            -32.724393,
            55.506001
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "554",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94555",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.963291,
            51.54588
          ],
          [
            -24.771002,
            51.628671
          ],
          [
            -16.575186,
            55.018672
          ],
          [
            -16.383125,
            55.094903
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "555",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94556",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.970486,
            51.545863
          ],
          [
            -25.1806,
            51.627673
          ],
          [
            -34.136118,
            54.979174
          ],
          [
            -34.345985,
            55.054576
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "556",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94557",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.967863,
            51.545895
          ],
          [
            -25.020409,
            51.615258
          ],
          [
            -26.882785,
            54.005889
          ],
          [
            -26.934607,
            54.070539
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "557",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Which threshold for ER positivity? a retrospective study based on 9639 patients.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94558",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.966764,
            51.54588
          ],
          [
            -24.968516,
            51.621317
          ],
          [
            -25.036662,
            54.458627
          ],
          [
            -25.038423,
            54.529574
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "558",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Significance of syndecan-1 expression in ductal carcinoma in situ of the breast.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "39242",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.711164,
            27.230219
          ],
          [
            -12.507747,
            27.329538
          ],
          [
            -5.102164,
            30.883185
          ],
          [
            -4.897899,
            30.979441
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "242",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "39243",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.712508,
            27.23023
          ],
          [
            -12.550557,
            27.346237
          ],
          [
            -5.720511,
            32.124054
          ],
          [
            -5.558785,
            32.234381
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "243",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "39244",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.714176,
            27.230293
          ],
          [
            -12.641398,
            27.355114
          ],
          [
            -9.436763,
            32.706393
          ],
          [
            -9.364794,
            32.823193
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "244",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Progesterone receptor activates Msx2 expression by downregulating TNAP/Akp2 and activating the Bmp pathway in EpH4 mouse mammary epithelial cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "39245",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.716475,
            27.230213
          ],
          [
            -12.774045,
            27.345317
          ],
          [
            -15.201682,
            32.086291
          ],
          [
            -15.259759,
            32.196917
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "245",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Atbf1 regulates pubertal mammary gland development likely by inhibiting the pro-proliferative function of estrogen-ER signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "39246",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.716664,
            27.230263
          ],
          [
            -12.779329,
            27.338812
          ],
          [
            -15.216801,
            31.475986
          ],
          [
            -15.27868,
            31.578788
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "246",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Cellular localization of ATBF1 protein and its functional implication in breast epithelial cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "599137",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.774095,
            24.562521
          ],
          [
            -17.018513,
            24.46034
          ],
          [
            -25.998633,
            20.650828
          ],
          [
            -26.244138,
            20.54524
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "599",
        "dest": "137",
        "label": "Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures. -- Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "600129",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -20.102812,
            16.102856
          ],
          [
            -20.400266,
            15.989157
          ],
          [
            -31.748114,
            11.607121
          ],
          [
            -32.044504,
            11.491623
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "600",
        "dest": "129",
        "label": "Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters. -- Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "18100",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.606106,
            -31.889211
          ],
          [
            12.707174,
            -31.766639
          ],
          [
            17.257398,
            -26.085567
          ],
          [
            17.357368,
            -25.957335
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "18",
        "dest": "100",
        "label": "Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. -- Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1837",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.603972,
            -31.893369
          ],
          [
            12.574089,
            -32.03987
          ],
          [
            10.978174,
            -39.511155
          ],
          [
            10.948565,
            -39.643033
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "18",
        "dest": "37",
        "label": "Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. -- Progesterone induces adult mammary stem cell expansion.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "18102",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.604877,
            -31.893316
          ],
          [
            12.637722,
            -32.032383
          ],
          [
            14.346369,
            -38.966164
          ],
          [
            14.378905,
            -39.092296
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "18",
        "dest": "102",
        "label": "Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. -- A mouse model to dissect progesterone signaling in the female reproductive tract and mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "18103",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.604881,
            -31.8933
          ],
          [
            12.644128,
            -32.05689
          ],
          [
            15.060489,
            -41.541323
          ],
          [
            15.099422,
            -41.684352
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "18",
        "dest": "103",
        "label": "Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. -- Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "3754",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.948615,
            -39.646762
          ],
          [
            10.980592,
            -39.774886
          ],
          [
            12.644125,
            -46.108711
          ],
          [
            12.6758,
            -46.222971
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "54",
        "label": "Progesterone induces adult mammary stem cell expansion. -- Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "37229",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.949238,
            -39.646757
          ],
          [
            11.020181,
            -39.768241
          ],
          [
            14.529091,
            -45.507493
          ],
          [
            14.59933,
            -45.616957
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "229",
        "label": "Progesterone induces adult mammary stem cell expansion. -- Control of mammary stem cell function by steroid hormone signalling.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "37230",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.947324,
            -39.646717
          ],
          [
            10.893843,
            -39.765394
          ],
          [
            8.249219,
            -45.376997
          ],
          [
            8.19499,
            -45.486765
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "230",
        "label": "Progesterone induces adult mammary stem cell expansion. -- Molecular hierarchy of mammary differentiation yields refined markers of mammary stem cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "37231",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.947484,
            -39.646702
          ],
          [
            10.901963,
            -39.77068
          ],
          [
            8.534454,
            -45.908609
          ],
          [
            8.488219,
            -46.022387
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "231",
        "label": "Progesterone induces adult mammary stem cell expansion. -- The WNT-controlled transcriptional regulator LBH is required for mammary stem cell expansion and maintenance of the basal lineage.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "37232",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.947609,
            -39.646705
          ],
          [
            10.90858,
            -39.777764
          ],
          [
            8.768082,
            -46.580735
          ],
          [
            8.72837,
            -46.699764
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "232",
        "label": "Progesterone induces adult mammary stem cell expansion. -- Ovarian steroid hormones: what's hot in the stem cell pool?",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "102622",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.379296,
            -39.096015
          ],
          [
            14.374267,
            -39.216054
          ],
          [
            14.131444,
            -44.764549
          ],
          [
            14.126465,
            -44.873243
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "102",
        "dest": "622",
        "label": "A mouse model to dissect progesterone signaling in the female reproductive tract and mammary gland. -- Dual roles for Id4 in the regulation of estrogen signaling in the mammary gland and ovary.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "103623",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.102069,
            -41.687907
          ],
          [
            15.246972,
            -41.808583
          ],
          [
            22.594885,
            -47.629285
          ],
          [
            22.738385,
            -47.737122
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "623",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Pubertal bisphenol A exposure alters murine mammary stem cell function leading to early neoplasia in regenerated glands.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "103624",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.101353,
            -41.687888
          ],
          [
            15.185457,
            -41.791362
          ],
          [
            18.888853,
            -46.181675
          ],
          [
            18.972022,
            -46.276539
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "624",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "103625",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.100181,
            -41.687865
          ],
          [
            15.118574,
            -41.802705
          ],
          [
            16.028183,
            -47.224139
          ],
          [
            16.046836,
            -47.330025
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "625",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Cell proliferation and apoptosis in rat mammary glands following combinational exposure to bisphenol A and genistein.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "103626",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.10036,
            -41.687886
          ],
          [
            15.132023,
            -41.810188
          ],
          [
            16.779224,
            -47.84986
          ],
          [
            16.81059,
            -47.958716
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "626",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Bisphenol A alters the development of the rhesus monkey mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "103627",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.099903,
            -41.687856
          ],
          [
            15.100326,
            -41.79668
          ],
          [
            15.120174,
            -46.715238
          ],
          [
            15.120602,
            -46.81638
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "627",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Prenatal exposure to bisphenol A promotes angiogenesis and alters steroid-mediated responses in the mammary glands of cycling rats.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "103628",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.102265,
            -41.687851
          ],
          [
            15.25246,
            -41.798964
          ],
          [
            22.500984,
            -46.931886
          ],
          [
            22.653159,
            -47.034819
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "628",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Low-dose BPA exposure alters the mesenchymal and epithelial transcriptomes of the mouse fetal mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "103629",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.102506,
            -41.687849
          ],
          [
            15.258425,
            -41.79255
          ],
          [
            22.35713,
            -46.377831
          ],
          [
            22.513088,
            -46.474574
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "629",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Prenatal exposure to BPA alters the epigenome of the rat mammary gland and increases the propensity to neoplastic development.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "103630",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.102951,
            -41.687872
          ],
          [
            15.270072,
            -41.784977
          ],
          [
            22.244674,
            -45.706101
          ],
          [
            22.411522,
            -45.796755
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "630",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- The male mammary gland: a target for the xenoestrogen bisphenol A.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "54309",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.676616,
            -46.226307
          ],
          [
            12.701668,
            -46.344556
          ],
          [
            14.039541,
            -52.291424
          ],
          [
            14.064364,
            -52.395001
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "54",
        "dest": "309",
        "label": "Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. -- DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "54310",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.675582,
            -46.22626
          ],
          [
            12.629145,
            -46.338144
          ],
          [
            10.213979,
            -51.844271
          ],
          [
            10.166813,
            -51.945747
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "54",
        "dest": "310",
        "label": "Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. -- Effects of estrogen on the proportion of stem cells in the breast.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "54311",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.677945,
            -46.226301
          ],
          [
            12.780013,
            -46.327692
          ],
          [
            17.480786,
            -50.795069
          ],
          [
            17.581768,
            -50.886719
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "54",
        "dest": "311",
        "label": "Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. -- Progesterone stimulates progenitor cells in normal human breast and breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "22966",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.60107,
            -45.620281
          ],
          [
            14.639035,
            -45.7141
          ],
          [
            16.274442,
            -49.606557
          ],
          [
            16.312768,
            -49.694302
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "229",
        "dest": "66",
        "label": "Control of mammary stem cell function by steroid hormone signalling. -- Stem cells: Cues from steroid hormones.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "66390",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.320887,
            -49.697383
          ],
          [
            16.66403,
            -49.767304
          ],
          [
            28.770309,
            -52.17003
          ],
          [
            29.113096,
            -52.236259
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "66",
        "dest": "390",
        "label": "Stem cells: Cues from steroid hormones. -- A novel role of microRNA146b in promoting mammary alveolar progenitor cell maintenance.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34565",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            19.97534,
            -38.647215
          ],
          [
            20.020102,
            -38.774712
          ],
          [
            22.348799,
            -45.089874
          ],
          [
            22.39314,
            -45.204026
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "345",
        "dest": "65",
        "label": "Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation. -- Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "345116",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            19.975967,
            -38.647227
          ],
          [
            20.016682,
            -38.706757
          ],
          [
            21.013487,
            -40.148781
          ],
          [
            21.054353,
            -40.207266
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "345",
        "dest": "116",
        "label": "Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation. -- Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34664",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.039525,
            -36.031857
          ],
          [
            24.142077,
            -36.1445
          ],
          [
            28.657686,
            -40.941888
          ],
          [
            28.759099,
            -41.045931
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "346",
        "dest": "64",
        "label": "FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis. -- Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "346122",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.047629,
            -36.028018
          ],
          [
            24.270999,
            -35.985233
          ],
          [
            28.210523,
            -35.226845
          ],
          [
            28.434441,
            -35.183523
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "346",
        "dest": "122",
        "label": "FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis. -- The transcriptional co-factor RIP140 regulates mammary gland development by promoting the generation of key mitogenic signals.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "113660",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.681124,
            8.465469
          ],
          [
            3.063011,
            8.527586
          ],
          [
            11.023229,
            9.81994
          ],
          [
            11.405861,
            9.88194
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "113",
        "dest": "660",
        "label": "The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. -- ALU repeats in promoters are position-dependent co-response elements (coRE) that enhance or repress transcription by dimeric and monomeric progesterone receptors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "113661",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.691066,
            8.465469
          ],
          [
            3.121295,
            8.506596
          ],
          [
            9.162513,
            9.083634
          ],
          [
            9.593376,
            9.124753
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "113",
        "dest": "661",
        "label": "The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. -- Acetylation at lysine 183 of progesterone receptor by p300 accelerates DNA binding kinetics and transactivation of direct target genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108648",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.752665,
            29.611367
          ],
          [
            12.923079,
            29.668772
          ],
          [
            16.633454,
            30.910455
          ],
          [
            16.803665,
            30.967038
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "648",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Prolactin and epidermal growth factor stimulate adipophilin synthesis in HC11 mouse mammary epithelial cells via the PI3-kinase/Akt/mTOR pathway.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108649",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.740671,
            29.611386
          ],
          [
            12.49653,
            29.69602
          ],
          [
            4.804133,
            32.32556
          ],
          [
            4.560051,
            32.407798
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "649",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- The bovine mammary gland expresses multiple functional isoforms of serotonin receptors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "108650",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.747232,
            29.61138
          ],
          [
            12.775588,
            29.704793
          ],
          [
            13.762858,
            32.901898
          ],
          [
            13.791291,
            32.992361
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "650",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Short communication: retinoic acid plus prolactin to synergistically increase specific casein gene expression in MAC-T cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108651",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.746011,
            29.611367
          ],
          [
            12.713005,
            29.724219
          ],
          [
            11.321151,
            34.364274
          ],
          [
            11.287854,
            34.472353
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "651",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Increased STAT5 signaling in the ring dove brain in response to prolactin administration and spontaneous elevations in prolactin during the breeding cycle.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108652",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.741291,
            29.611389
          ],
          [
            12.464776,
            29.718586
          ],
          [
            1.496982,
            33.875859
          ],
          [
            1.221226,
            33.977942
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "652",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Serotonin regulates \u03b2-casein expression via 5-HT7 receptors in human mammary epithelial MCF-12A cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108653",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.743028,
            29.611383
          ],
          [
            12.540537,
            29.727647
          ],
          [
            3.817084,
            34.60468
          ],
          [
            3.614785,
            34.714637
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "653",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Inhibitory effect of fluvoxamine on \u03b2-casein expression via a serotonin-independent mechanism in human mammary epithelial cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "108654",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.74243,
            29.611391
          ],
          [
            12.492508,
            29.734884
          ],
          [
            1.114086,
            35.19085
          ],
          [
            0.864103,
            35.30695
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "654",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Serotonin suppresses \u03b2-casein expression via PTP1B activation in human mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108655",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.743094,
            29.611383
          ],
          [
            12.511551,
            29.746792
          ],
          [
            0.917793,
            36.28402
          ],
          [
            0.685715,
            36.409843
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "655",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- [Endogenous Serotonin and Milk Production Regulation in the Mammary Gland].",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "24131",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -32.294504,
            37.265403
          ],
          [
            -32.334582,
            37.389591
          ],
          [
            -34.366365,
            43.412352
          ],
          [
            -34.407036,
            43.527377
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "131",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "24132",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -32.291933,
            37.261635
          ],
          [
            -32.175501,
            37.148941
          ],
          [
            -26.933412,
            31.904262
          ],
          [
            -26.818243,
            31.785375
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "132",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "24134",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -32.298058,
            37.261682
          ],
          [
            -32.503639,
            37.169707
          ],
          [
            -40.271367,
            33.613416
          ],
          [
            -40.478039,
            33.51667
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "134",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "24139",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -32.296901,
            37.261645
          ],
          [
            -32.487115,
            37.141356
          ],
          [
            -41.668028,
            31.112694
          ],
          [
            -41.858528,
            30.983113
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "139",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "24143",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -32.294524,
            37.265437
          ],
          [
            -32.330443,
            37.375089
          ],
          [
            -33.911714,
            42.041571
          ],
          [
            -33.947997,
            42.144925
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "143",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "131750",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.40825,
            43.530821
          ],
          [
            -34.448982,
            43.646793
          ],
          [
            -36.567455,
            49.370475
          ],
          [
            -36.608829,
            49.47626
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "750",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "131751",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.408282,
            43.530823
          ],
          [
            -34.449012,
            43.641203
          ],
          [
            -36.463172,
            48.846866
          ],
          [
            -36.504473,
            48.948447
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "751",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "131752",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.404698,
            43.530834
          ],
          [
            -34.244565,
            43.623378
          ],
          [
            -27.630545,
            47.321357
          ],
          [
            -27.470708,
            47.407721
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "752",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kr\u00fcppel-like factor 4.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "131754",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.409079,
            43.530875
          ],
          [
            -34.495298,
            43.636732
          ],
          [
            -38.466258,
            48.310331
          ],
          [
            -38.551561,
            48.406404
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "754",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "131755",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.41214,
            43.530837
          ],
          [
            -34.572978,
            43.592233
          ],
          [
            -39.00666,
            45.260031
          ],
          [
            -39.166809,
            45.319383
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "755",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "131756",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.416274,
            43.530819
          ],
          [
            -34.595855,
            43.566095
          ],
          [
            -37.523253,
            44.138229
          ],
          [
            -37.703186,
            44.173215
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "756",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "132133",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -26.811344,
            31.781392
          ],
          [
            -26.584863,
            31.690686
          ],
          [
            -18.699711,
            28.478377
          ],
          [
            -18.472598,
            28.384326
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "132",
        "dest": "133",
        "label": "Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. -- A high-content assay to identify small-molecule modulators of a cancer stem cell population in luminal breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "132135",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -26.817341,
            31.781316
          ],
          [
            -26.882283,
            31.649917
          ],
          [
            -30.017177,
            25.094985
          ],
          [
            -30.08146,
            24.956442
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "132",
        "dest": "135",
        "label": "Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. -- Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "132757",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -26.818096,
            31.785438
          ],
          [
            -26.930946,
            31.915723
          ],
          [
            -32.378466,
            37.979049
          ],
          [
            -32.490172,
            38.098625
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "132",
        "dest": "757",
        "label": "Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. -- Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "132758",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -26.816312,
            31.785457
          ],
          [
            -26.815923,
            31.913719
          ],
          [
            -26.797572,
            37.751199
          ],
          [
            -26.797188,
            37.869254
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "132",
        "dest": "758",
        "label": "Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. -- Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "13443",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.4807,
            33.516662
          ],
          [
            -40.366386,
            33.662049
          ],
          [
            -33.920934,
            41.450246
          ],
          [
            -33.804497,
            41.583356
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "43",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Signaling inputs to progesterone receptor gene regulation and promoter selectivity.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134136",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.482329,
            33.516675
          ],
          [
            -40.488461,
            33.651599
          ],
          [
            -40.807349,
            40.369747
          ],
          [
            -40.813576,
            40.494965
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "136",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miR-221/222 control luminal breast cancer tumor progression by regulating different targets.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134142",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.493051,
            33.516649
          ],
          [
            -40.866032,
            33.583811
          ],
          [
            -50.766951,
            35.347359
          ],
          [
            -51.140277,
            35.413123
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "142",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134753",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.483502,
            33.516709
          ],
          [
            -40.553375,
            33.627689
          ],
          [
            -43.500503,
            38.176091
          ],
          [
            -43.569567,
            38.279517
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "753",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134764",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.486686,
            33.516659
          ],
          [
            -40.68731,
            33.60489
          ],
          [
            -47.611779,
            36.594186
          ],
          [
            -47.81291,
            36.679366
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "764",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134765",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.493206,
            33.516659
          ],
          [
            -40.92824,
            33.594269
          ],
          [
            -54.162893,
            35.92163
          ],
          [
            -54.59736,
            35.996914
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "765",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134766",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.521485,
            33.516649
          ],
          [
            -41.253962,
            33.553002
          ],
          [
            -52.002142,
            34.084681
          ],
          [
            -52.734063,
            34.120766
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "766",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134767",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.603488,
            33.514504
          ],
          [
            -42.224181,
            33.511874
          ],
          [
            -59.573012,
            33.483705
          ],
          [
            -61.176928,
            33.4811
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "767",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134768",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.50125,
            33.512751
          ],
          [
            -41.143824,
            33.446772
          ],
          [
            -57.864673,
            31.712413
          ],
          [
            -58.506368,
            31.645188
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "768",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "134769",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.482329,
            33.516732
          ],
          [
            -40.488642,
            33.659434
          ],
          [
            -40.825793,
            40.926763
          ],
          [
            -40.832049,
            41.054878
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "769",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134770",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.480323,
            33.516683
          ],
          [
            -40.349096,
            33.652124
          ],
          [
            -33.524028,
            40.394888
          ],
          [
            -33.39074,
            40.520539
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "770",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134771",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.480093,
            33.516696
          ],
          [
            -40.340449,
            33.646313
          ],
          [
            -33.433581,
            39.80789
          ],
          [
            -33.295322,
            39.926125
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "771",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "134772",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.479475,
            33.516651
          ],
          [
            -40.316115,
            33.631875
          ],
          [
            -32.962173,
            38.655989
          ],
          [
            -32.798813,
            38.763904
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "772",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "134773",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.51279,
            33.516651
          ],
          [
            -41.336772,
            33.569232
          ],
          [
            -58.559022,
            34.660878
          ],
          [
            -59.382664,
            34.712732
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "773",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134774",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.499116,
            33.512751
          ],
          [
            -41.250724,
            33.425771
          ],
          [
            -66.860026,
            30.410818
          ],
          [
            -67.611702,
            30.320844
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "774",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134775",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.499941,
            33.512748
          ],
          [
            -40.984073,
            33.459303
          ],
          [
            -51.239748,
            32.319428
          ],
          [
            -51.723968,
            32.265247
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "775",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134776",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.498889,
            33.512753
          ],
          [
            -41.15169,
            33.436274
          ],
          [
            -60.784892,
            31.104991
          ],
          [
            -61.437795,
            31.026444
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "776",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134777",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.490947,
            33.512748
          ],
          [
            -40.915741,
            33.417436
          ],
          [
            -56.742558,
            29.793039
          ],
          [
            -57.167518,
            29.693799
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "777",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139804",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.886026,
            30.979068
          ],
          [
            -42.340813,
            30.941914
          ],
          [
            -48.982219,
            30.397703
          ],
          [
            -49.437306,
            30.360301
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "804",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "139805",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.857133,
            30.983079
          ],
          [
            -41.610956,
            31.09558
          ],
          [
            -31.118336,
            35.763667
          ],
          [
            -30.872447,
            35.870013
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "805",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "139806",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.856192,
            30.983087
          ],
          [
            -41.578361,
            31.08809
          ],
          [
            -30.558356,
            35.157364
          ],
          [
            -30.281284,
            35.257218
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "806",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139807",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.858681,
            30.983097
          ],
          [
            -41.687958,
            31.104442
          ],
          [
            -33.91533,
            36.460115
          ],
          [
            -33.744564,
            36.573968
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "807",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139808",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.859092,
            30.983108
          ],
          [
            -41.732092,
            31.089176
          ],
          [
            -36.695294,
            35.198184
          ],
          [
            -36.567426,
            35.299963
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "808",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "139809",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.858894,
            30.983084
          ],
          [
            -41.709576,
            31.097061
          ],
          [
            -35.277626,
            35.873544
          ],
          [
            -35.126896,
            35.98228
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "809",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "139810",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.859421,
            30.983095
          ],
          [
            -41.757824,
            31.080486
          ],
          [
            -38.025031,
            34.588261
          ],
          [
            -37.922981,
            34.682194
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "810",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "139811",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.854679,
            30.983089
          ],
          [
            -41.55333,
            31.071902
          ],
          [
            -31.415981,
            34.01047
          ],
          [
            -31.114104,
            34.096488
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "811",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Oxidized LDL triggers pro-oncogenic signaling in human breast mammary epithelial cells partly via stimulation of MiR-21.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139812",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.863023,
            30.983129
          ],
          [
            -41.912835,
            31.052095
          ],
          [
            -43.196113,
            32.811484
          ],
          [
            -43.246222,
            32.879499
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "812",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-\u03baB signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139813",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.86895,
            30.979052
          ],
          [
            -42.194888,
            30.890382
          ],
          [
            -53.160123,
            27.860445
          ],
          [
            -53.485316,
            27.769227
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "813",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Generation of breast cancer stem cells by steroid hormones in irradiated human mammary cell lines.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "43248",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -33.805531,
            41.586926
          ],
          [
            -33.981142,
            41.703337
          ],
          [
            -42.88526,
            47.328836
          ],
          [
            -43.061323,
            47.434589
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "43",
        "dest": "248",
        "label": "Signaling inputs to progesterone receptor gene regulation and promoter selectivity. -- Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "25147",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.554829,
            21.645625
          ],
          [
            25.500319,
            21.524404
          ],
          [
            23.201715,
            16.326548
          ],
          [
            23.146727,
            16.200303
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "147",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "25148",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.554091,
            21.64559
          ],
          [
            25.466281,
            21.532165
          ],
          [
            22.050663,
            17.055236
          ],
          [
            21.963953,
            16.940042
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "148",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "25151",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.554832,
            21.645605
          ],
          [
            25.510054,
            21.544975
          ],
          [
            23.951061,
            17.999778
          ],
          [
            23.906158,
            17.896531
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "151",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- A comprehensive view of nuclear receptor cancer cistromes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "25152",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.571146,
            21.649985
          ],
          [
            26.176946,
            21.735638
          ],
          [
            44.53517,
            24.306435
          ],
          [
            45.142314,
            24.390607
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "152",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "25153",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.5579,
            21.650066
          ],
          [
            25.687099,
            21.789403
          ],
          [
            31.777379,
            28.192742
          ],
          [
            31.905235,
            28.32348
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "153",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "147842",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.213061,
            16.195759
          ],
          [
            24.464763,
            16.154103
          ],
          [
            42.761435,
            15.544194
          ],
          [
            44.013507,
            15.502388
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "842",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Growth regulation by estrogen in breast cancer 1 (GREB1) is a novel progesterone-responsive gene required for human endometrial stromal decidualization.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "147843",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.168822,
            16.200246
          ],
          [
            23.800513,
            16.261625
          ],
          [
            37.182082,
            17.557243
          ],
          [
            37.813892,
            17.618193
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "843",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Acceleration of the glycolytic flux by steroid receptor coactivator-2 is essential for endometrial decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147844",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.173167,
            16.20024
          ],
          [
            24.097636,
            16.27572
          ],
          [
            48.07407,
            18.222783
          ],
          [
            48.9986,
            18.297445
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "844",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- The Promyelocytic Leukemia Zinc Finger Transcription Factor Is Critical for Human Endometrial Stromal Cell Decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147845",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.303719,
            16.198179
          ],
          [
            24.993564,
            16.200106
          ],
          [
            39.699282,
            16.216867
          ],
          [
            41.207212,
            16.218584
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "845",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- The coregulator, repressor of estrogen receptor activity (REA), is a crucial regulator of the timing and magnitude of uterine decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147846",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.16185,
            16.200243
          ],
          [
            23.889619,
            16.301387
          ],
          [
            49.008976,
            19.758521
          ],
          [
            49.737076,
            19.857687
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "846",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Evaluation of human first trimester decidual and telomerase-transformed endometrial stromal cells as model systems of in vitro decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147847",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.150365,
            16.200243
          ],
          [
            23.367545,
            16.305125
          ],
          [
            31.132305,
            20.015642
          ],
          [
            31.350267,
            20.118628
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "847",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Evidence for a conserved function of heart and neural crest derivatives expressed transcript 2 in mouse and human decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147848",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.148249,
            16.200252
          ],
          [
            23.24149,
            16.28331
          ],
          [
            25.884794,
            18.622692
          ],
          [
            25.978983,
            18.705487
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "848",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- The p160/steroid receptor coactivator family: potent arbiters of uterine physiology and dysfunction.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147849",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.223144,
            16.200243
          ],
          [
            24.701334,
            16.243049
          ],
          [
            46.867273,
            16.883804
          ],
          [
            48.345027,
            16.926446
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "849",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Perturbing the cellular levels of steroid receptor coactivator-2 impairs murine endometrial function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147850",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.160266,
            16.200243
          ],
          [
            23.672523,
            16.279207
          ],
          [
            37.55005,
            18.405937
          ],
          [
            38.063166,
            18.484093
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "850",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Endometrial stromal beta-catenin is required for steroid-dependent mesenchymal-epithelial cross talk and decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147851",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.163334,
            16.200246
          ],
          [
            23.874427,
            16.290909
          ],
          [
            45.886817,
            19.075754
          ],
          [
            46.59736,
            19.164908
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "851",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Notch1 mediates uterine stromal differentiation and is critical for complete decidualization in the mouse.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "147852",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.155932,
            16.200261
          ],
          [
            23.711958,
            16.323339
          ],
          [
            46.796605,
            21.358994
          ],
          [
            47.35166,
            21.478142
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "852",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "147853",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.151197,
            16.200279
          ],
          [
            23.427414,
            16.315237
          ],
          [
            34.06665,
            20.68785
          ],
          [
            34.341936,
            20.799455
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "853",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Changes in global gene expression during in vitro decidualization of rat endometrial stromal cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147854",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.158546,
            16.200243
          ],
          [
            23.812012,
            16.314443
          ],
          [
            49.22551,
            20.70018
          ],
          [
            49.879974,
            20.811587
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "854",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147855",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.151156,
            16.200252
          ],
          [
            23.380048,
            16.295128
          ],
          [
            30.767676,
            19.33132
          ],
          [
            30.996679,
            19.424589
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "855",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- G-protein coupled receptor 64 is required for decidualization of endometrial stromal cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "148727",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.965889,
            16.935552
          ],
          [
            22.168143,
            16.809122
          ],
          [
            30.788642,
            11.349534
          ],
          [
            30.990657,
            11.220123
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "727",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "148241",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.962523,
            16.940117
          ],
          [
            21.974068,
            17.047024
          ],
          [
            22.383311,
            20.794372
          ],
          [
            22.394699,
            20.89741
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "241",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "148465",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.965775,
            16.935534
          ],
          [
            22.093202,
            16.852698
          ],
          [
            25.655411,
            14.522919
          ],
          [
            25.782345,
            14.439422
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "465",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "148856",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.963955,
            16.940051
          ],
          [
            22.073299,
            17.085749
          ],
          [
            27.480366,
            24.132277
          ],
          [
            27.591242,
            24.273196
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "856",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "148857",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.963998,
            16.940141
          ],
          [
            22.079153,
            17.095603
          ],
          [
            27.918641,
            24.788005
          ],
          [
            28.032683,
            24.934092
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "857",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with increased mitochondrial membrane potential.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "148858",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.963991,
            16.940096
          ],
          [
            22.067913,
            17.078419
          ],
          [
            26.854199,
            23.326643
          ],
          [
            26.957017,
            23.457994
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "858",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- LAT1 regulates growth of uterine leiomyoma smooth muscle cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "148859",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.963969,
            16.940084
          ],
          [
            22.090016,
            17.109039
          ],
          [
            29.198794,
            26.352857
          ],
          [
            29.323742,
            26.509706
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "859",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "148860",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.96403,
            16.940153
          ],
          [
            22.087568,
            17.104823
          ],
          [
            28.684951,
            25.658335
          ],
          [
            28.807351,
            25.812042
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "860",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- GSTM1 gene expression correlates to leiomyoma volume regression in response to mifepristone treatment.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "148861",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.962398,
            16.940102
          ],
          [
            21.970391,
            17.0856
          ],
          [
            22.356155,
            23.958993
          ],
          [
            22.364065,
            24.096553
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "861",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "148862",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.962228,
            16.940054
          ],
          [
            21.958919,
            17.102201
          ],
          [
            21.777402,
            25.749302
          ],
          [
            21.774034,
            25.90462
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "862",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Progesterone is essential for maintenance and growth of uterine leiomyoma.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "148863",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.964003,
            16.940126
          ],
          [
            22.096322,
            17.117182
          ],
          [
            29.773764,
            27.056353
          ],
          [
            29.90496,
            27.219743
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "863",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- The role of progesterone signaling in the pathogenesis of uterine leiomyoma.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "148864",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.961664,
            16.940147
          ],
          [
            21.920011,
            17.100057
          ],
          [
            19.753145,
            25.205063
          ],
          [
            19.711885,
            25.354856
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "864",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Mifepristone inhibits extracellular matrix formation in uterine\u00a0leiomyoma.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "151876",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.910912,
            17.896513
          ],
          [
            24.174808,
            18.000225
          ],
          [
            33.444683,
            21.602525
          ],
          [
            33.707156,
            21.703303
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "151",
        "dest": "876",
        "label": "A comprehensive view of nuclear receptor cancer cistromes. -- Genome-wide interplay of nuclear receptors with the epigenome.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "151877",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.908678,
            17.896501
          ],
          [
            24.085805,
            18.009771
          ],
          [
            30.908253,
            22.313663
          ],
          [
            31.08478,
            22.4234
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "151",
        "dest": "877",
        "label": "A comprehensive view of nuclear receptor cancer cistromes. -- Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "152878",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.160139,
            24.394897
          ],
          [
            45.256707,
            24.480646
          ],
          [
            48.205783,
            27.07053
          ],
          [
            48.302235,
            27.154268
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "878",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor \u03b1 in luminal breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "152879",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.156153,
            24.394905
          ],
          [
            45.063794,
            24.522636
          ],
          [
            40.906563,
            30.130547
          ],
          [
            40.813199,
            30.253155
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "879",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Binding of estrogen receptor alpha/beta heterodimers to chromatin in MCF-7 cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152880",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.161794,
            24.394914
          ],
          [
            45.30201,
            24.469559
          ],
          [
            49.012076,
            26.428304
          ],
          [
            49.151515,
            26.501293
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "880",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "152881",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.161478,
            24.394902
          ],
          [
            45.357091,
            24.507111
          ],
          [
            53.116039,
            28.87378
          ],
          [
            53.311118,
            28.981368
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "881",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Aryl hydrocarbon receptor modulation of estrogen receptor \u03b1-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152882",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.156496,
            24.394925
          ],
          [
            45.122218,
            24.456336
          ],
          [
            44.375849,
            25.785878
          ],
          [
            44.341609,
            25.846521
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "882",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Novel DNA motif binding activity observed in vivo with an estrogen receptor \u03b1 mutant mouse.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152883",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.166564,
            24.39488
          ],
          [
            45.346969,
            24.438433
          ],
          [
            48.227174,
            25.13174
          ],
          [
            48.407712,
            25.175069
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "883",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Nucleosome eviction and multiple co-factor binding predict estrogen-receptor-alpha-associated long-range interactions.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152884",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.155421,
            24.394931
          ],
          [
            45.013348,
            24.530521
          ],
          [
            38.316231,
            30.746342
          ],
          [
            38.175633,
            30.872951
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "884",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Integrative model of genomic factors for determining binding site selection by estrogen receptor-\u03b1.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "152885",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.160548,
            24.394874
          ],
          [
            45.349508,
            24.536959
          ],
          [
            54.930552,
            31.516877
          ],
          [
            55.120002,
            31.650198
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "885",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152886",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.161323,
            24.394882
          ],
          [
            45.322672,
            24.490546
          ],
          [
            50.843746,
            27.718858
          ],
          [
            51.005463,
            27.812053
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "886",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Research resource: Aorta- and liver-specific ER\u03b1-binding patterns and gene regulation by estrogen.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152887",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.155865,
            24.394925
          ],
          [
            45.053429,
            24.515707
          ],
          [
            40.732915,
            29.49952
          ],
          [
            40.631668,
            29.613603
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "887",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Genome-Wide Mapping of In Vivo ER\u03b1-Binding Sites in Male Mouse Efferent Ductules.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "153888",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            31.910269,
            28.32764
          ],
          [
            32.041752,
            28.418741
          ],
          [
            36.464813,
            31.436692
          ],
          [
            36.596526,
            31.525145
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "888",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Integrated microarray and ChIP analysis identifies multiple Foxa2 dependent target genes in the notochord.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "153889",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            31.910269,
            28.327634
          ],
          [
            32.068975,
            28.43725
          ],
          [
            38.491356,
            32.774968
          ],
          [
            38.649698,
            32.879421
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "889",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "153890",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            31.909142,
            28.327632
          ],
          [
            32.02747,
            28.458439
          ],
          [
            37.737994,
            34.571083
          ],
          [
            37.857879,
            34.695042
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "890",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Foxa2 is essential for mouse endometrial gland development and fertility.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "153891",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            31.910071,
            28.327648
          ],
          [
            32.068023,
            28.445259
          ],
          [
            38.872664,
            33.383688
          ],
          [
            39.030465,
            33.495138
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "891",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Cell-specific transcriptional profiling reveals candidate mechanisms regulating development and function of uterine epithelia in mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "153892",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            31.910317,
            28.32764
          ],
          [
            31.96755,
            28.366642
          ],
          [
            32.814746,
            28.9423
          ],
          [
            32.871766,
            28.980933
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "892",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Forkhead box a2 (FOXA2) is essential for uterine function and fertility.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "28163",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.59251,
            32.525313
          ],
          [
            25.241622,
            32.486914
          ],
          [
            19.883471,
            31.898537
          ],
          [
            19.532613,
            31.859875
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "28",
        "dest": "163",
        "label": "Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. -- Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "28164",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.616642,
            32.529266
          ],
          [
            25.871584,
            32.61197
          ],
          [
            34.033705,
            35.219011
          ],
          [
            34.288709,
            35.299168
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "28",
        "dest": "164",
        "label": "Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. -- Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "28165",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.607949,
            32.529273
          ],
          [
            25.449157,
            32.650936
          ],
          [
            18.051801,
            38.130663
          ],
          [
            17.892891,
            38.244245
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "28",
        "dest": "165",
        "label": "Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. -- Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "163108",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            19.50847,
            31.855883
          ],
          [
            19.2844,
            31.782281
          ],
          [
            12.975931,
            29.68637
          ],
          [
            12.752679,
            29.611367
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "108",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "16391",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            19.51439,
            31.859907
          ],
          [
            19.505398,
            31.953342
          ],
          [
            19.186725,
            35.201905
          ],
          [
            19.177703,
            35.292092
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "91",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "163162",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            19.509945,
            31.859915
          ],
          [
            19.225844,
            31.983897
          ],
          [
            5.98935,
            37.569501
          ],
          [
            5.708235,
            37.683974
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "162",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "163532",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            19.508502,
            31.859878
          ],
          [
            19.115336,
            31.988387
          ],
          [
            -0.209854,
            38.076543
          ],
          [
            -0.603772,
            38.195862
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "532",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "163685",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            19.516844,
            31.859918
          ],
          [
            19.611254,
            31.944658
          ],
          [
            22.633847,
            34.615797
          ],
          [
            22.728281,
            34.697922
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "685",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Scribble is required for pregnancy-induced alveologenesis in the adult mammary gland.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "163935",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            19.512588,
            31.859944
          ],
          [
            19.404382,
            31.971239
          ],
          [
            14.934621,
            36.448105
          ],
          [
            14.827695,
            36.552258
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "935",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary             carcinoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "163936",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            19.509836,
            31.859902
          ],
          [
            19.270185,
            31.961321
          ],
          [
            10.039402,
            35.780971
          ],
          [
            9.800561,
            35.877514
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "936",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Pten regulates development and lactation in the mammary glands of dairy cows.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "163937",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            19.508879,
            31.859878
          ],
          [
            19.17723,
            31.975469
          ],
          [
            4.49483,
            36.943294
          ],
          [
            4.1633,
            37.052015
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "937",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- miR-135a Targets and Regulates Prolactin Receptor Gene in Goat Mammary Epithelial Cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164124",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            34.297451,
            35.303027
          ],
          [
            34.485479,
            35.44136
          ],
          [
            44.661981,
            42.565881
          ],
          [
            44.848302,
            42.689568
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "124",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Estradiol, progesterone and prolactin modulate mammary gland morphogenesis in adult female plains vizcacha (Lagostomus maximus).",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164166",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            34.296888,
            35.303027
          ],
          [
            34.431821,
            35.429182
          ],
          [
            41.104153,
            41.416354
          ],
          [
            41.240975,
            41.533888
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "166",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Cloning and expression of a unique short form of the porcine prolactin receptor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164167",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            34.296856,
            35.303015
          ],
          [
            34.423396,
            35.42247
          ],
          [
            40.386877,
            40.847613
          ],
          [
            40.514986,
            40.959693
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "167",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Triennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164169",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            34.293152,
            35.303022
          ],
          [
            34.194974,
            35.417379
          ],
          [
            29.775873,
            40.393976
          ],
          [
            29.676627,
            40.501848
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "169",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Reproductive experience alters prolactin receptor expression in mammary and hepatic tissues in female rats.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164939",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            34.301162,
            35.302999
          ],
          [
            34.537218,
            35.374141
          ],
          [
            41.27813,
            37.379034
          ],
          [
            41.515042,
            37.448552
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "939",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Molecular characterization, mRNA expression of prolactin receptor (PRLR) gene during pregnancy, nonpregnancy in the yak (Bos grunniens).",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164940",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            34.29492,
            35.303088
          ],
          [
            34.299353,
            35.385443
          ],
          [
            34.439031,
            37.937439
          ],
          [
            34.443394,
            38.015799
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "940",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "164941",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            34.29244,
            35.303048
          ],
          [
            34.171504,
            35.403014
          ],
          [
            29.467392,
            39.193991
          ],
          [
            29.347971,
            39.287726
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "941",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Hormone interactions confer specific proliferative and histomorphogenic responses in the porcine mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164943",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            34.293015,
            35.303012
          ],
          [
            34.176074,
            35.428153
          ],
          [
            28.393383,
            41.369263
          ],
          [
            28.274806,
            41.485936
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "943",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Short form 1b human prolactin receptor down-regulates expression of the long form.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164944",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            34.290472,
            35.30301
          ],
          [
            34.01828,
            35.423484
          ],
          [
            21.036644,
            40.956418
          ],
          [
            20.76411,
            41.068031
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "944",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- A novel first exon directs hormone-sensitive transcription of the pig prolactin receptor.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "164945",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            34.301278,
            35.303017
          ],
          [
            34.587967,
            35.388656
          ],
          [
            44.315516,
            38.240023
          ],
          [
            44.600439,
            38.321931
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "945",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Metoclopramide-induced hyperprolactinemia effects on the pituitary and uterine prolactin receptor expression.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "164946",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            34.301217,
            35.303007
          ],
          [
            34.63087,
            35.401815
          ],
          [
            47.577891,
            39.185485
          ],
          [
            47.90657,
            39.279046
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "946",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- The progesterone and estrogen modify the uterine prolactin and prolactin receptor expression of hyperprolactinemic mice.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "164947",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            34.298733,
            35.303004
          ],
          [
            34.518028,
            35.410215
          ],
          [
            43.864844,
            39.845257
          ],
          [
            44.08388,
            39.945992
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "947",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Comparative genomics reveals tissue-specific regulation of prolactin receptor gene expression.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "165191",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.896113,
            38.24424
          ],
          [
            18.198742,
            38.147491
          ],
          [
            30.202303,
            34.20759
          ],
          [
            30.504105,
            34.105995
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "191",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165948",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.907537,
            38.244267
          ],
          [
            18.418974,
            38.189872
          ],
          [
            30.139116,
            36.932261
          ],
          [
            30.651055,
            36.876845
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "948",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165949",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.92367,
            38.247934
          ],
          [
            18.478723,
            38.27844
          ],
          [
            25.777418,
            38.678378
          ],
          [
            26.332568,
            38.708708
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "949",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165950",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.891648,
            38.248026
          ],
          [
            17.935764,
            38.31077
          ],
          [
            19.043954,
            39.868989
          ],
          [
            19.087225,
            39.929133
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "950",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Prolactin signaling through the short isoform of the mouse prolactin receptor regulates DNA binding of specific transcription factors, often with opposite effects in different reproductive issues.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "165951",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.891457,
            38.247995
          ],
          [
            17.951992,
            38.346398
          ],
          [
            20.353389,
            42.141424
          ],
          [
            20.413179,
            42.233188
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "951",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Differential roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signaling pathways for progesterone production in human ovarian cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "165952",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.890984,
            38.247978
          ],
          [
            17.933778,
            38.364291
          ],
          [
            19.951011,
            43.632862
          ],
          [
            19.993359,
            43.738933
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "952",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165953",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.890621,
            38.247985
          ],
          [
            17.913075,
            38.376983
          ],
          [
            19.081142,
            44.766817
          ],
          [
            19.103383,
            44.882323
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "953",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Prolactin (PRL) induction of cyclooxygenase 2 (COX2) expression and prostaglandin (PG) production in hamster Leydig cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165954",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.8908,
            38.248
          ],
          [
            17.923709,
            38.371513
          ],
          [
            19.55143,
            44.214649
          ],
          [
            19.584013,
            44.326243
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "954",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Prolactin activation of the long form of its cognate receptor causes increased visceral fat and obesity in males as shown in transgenic mice expressing only this receptor subtype.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "91535",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            19.182537,
            35.295977
          ],
          [
            19.283773,
            35.334836
          ],
          [
            20.880231,
            35.945183
          ],
          [
            20.981467,
            35.98373
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "91",
        "dest": "535",
        "label": "Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation. -- Expression mechanism of tryptophan hydroxylase 1 in mouse islets during pregnancy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "91536",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            19.176287,
            35.292138
          ],
          [
            19.136516,
            35.230037
          ],
          [
            18.137991,
            33.655289
          ],
          [
            18.098026,
            33.591647
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "91",
        "dest": "536",
        "label": "Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation. -- Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "29174",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -32.545389,
            -5.271878
          ],
          [
            -32.928319,
            -5.426163
          ],
          [
            -52.103426,
            -13.078739
          ],
          [
            -52.484925,
            -13.229067
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "174",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "29175",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -32.538867,
            -5.267166
          ],
          [
            -32.49393,
            -5.116814
          ],
          [
            -30.325273,
            2.161829
          ],
          [
            -30.279746,
            2.314675
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "175",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "29178",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -32.566371,
            -5.26721
          ],
          [
            -33.244892,
            -5.208315
          ],
          [
            -46.588051,
            -4.04908
          ],
          [
            -47.266824,
            -3.990059
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "178",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "29180",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -32.622521,
            -5.267213
          ],
          [
            -33.926288,
            -5.230678
          ],
          [
            -50.179933,
            -4.775055
          ],
          [
            -51.483854,
            -4.73849
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "180",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "29182",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -32.570407,
            -5.271862
          ],
          [
            -33.177312,
            -5.317646
          ],
          [
            -42.547094,
            -6.024048
          ],
          [
            -43.153799,
            -6.069757
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "182",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "29184",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -32.555956,
            -5.271865
          ],
          [
            -33.087955,
            -5.347486
          ],
          [
            -46.40353,
            -7.236872
          ],
          [
            -46.93646,
            -7.312343
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "184",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174176",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.494983,
            -13.233666
          ],
          [
            -52.642437,
            -13.313675
          ],
          [
            -56.544028,
            -15.420591
          ],
          [
            -56.690667,
            -15.499381
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "176",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174177",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.49054,
            -13.233678
          ],
          [
            -52.482745,
            -13.352892
          ],
          [
            -52.17956,
            -17.939686
          ],
          [
            -52.171865,
            -18.05473
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "177",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "174977",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.489383,
            -13.229036
          ],
          [
            -52.425171,
            -13.116088
          ],
          [
            -50.021702,
            -8.85487
          ],
          [
            -49.957167,
            -8.739662
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "977",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174978",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.487845,
            -13.229064
          ],
          [
            -52.360477,
            -13.127276
          ],
          [
            -48.002183,
            -9.620956
          ],
          [
            -47.874527,
            -9.517637
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "978",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174979",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.485763,
            -13.229051
          ],
          [
            -52.224156,
            -13.107668
          ],
          [
            -41.637638,
            -8.151139
          ],
          [
            -41.376632,
            -8.028001
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "979",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174980",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.489767,
            -13.229033
          ],
          [
            -52.452896,
            -13.137173
          ],
          [
            -51.327185,
            -10.317093
          ],
          [
            -51.289818,
            -10.223009
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "980",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174981",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.489586,
            -13.229033
          ],
          [
            -52.464308,
            -13.176385
          ],
          [
            -52.014455,
            -12.237601
          ],
          [
            -51.988994,
            -12.184367
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "981",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174982",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.465292,
            -13.233615
          ],
          [
            -51.990782,
            -13.276093
          ],
          [
            -45.021686,
            -13.899115
          ],
          [
            -44.546687,
            -13.94152
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "982",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- The role of tristetraprolin in cancer and inflammation.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "174983",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.491245,
            -13.233648
          ],
          [
            -52.514692,
            -13.331714
          ],
          [
            -53.277478,
            -16.498711
          ],
          [
            -53.30131,
            -16.596879
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "983",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Regulation of p21/CIP1/WAF-1 mediated cell-cycle arrest by RNase L and tristetraprolin, and involvement of AU-rich elements.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174984",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.491231,
            -13.233621
          ],
          [
            -52.525332,
            -13.378294
          ],
          [
            -54.171115,
            -20.241432
          ],
          [
            -54.205664,
            -20.382689
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "984",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Tristetraprolin down-regulates IL-23 expression in colon cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174985",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.490865,
            -13.233621
          ],
          [
            -52.500978,
            -13.368549
          ],
          [
            -52.956167,
            -19.353293
          ],
          [
            -52.966391,
            -19.485472
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "985",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Tristetraprolin is involved in the glucocorticoid-mediated interleukin 8 repression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174986",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.488465,
            -13.233639
          ],
          [
            -52.327433,
            -13.399795
          ],
          [
            -43.494201,
            -22.30399
          ],
          [
            -43.332473,
            -22.462552
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "986",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Dysregulation of TTP and HuR plays an important role in cancers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174987",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.486527,
            -13.233624
          ],
          [
            -52.228412,
            -13.375149
          ],
          [
            -40.062805,
            -19.93769
          ],
          [
            -39.804433,
            -20.074478
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "987",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Control of pro-angiogenic cytokine mRNA half-life in cancer: the role of AU-rich elements and associated proteins.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174988",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.491088,
            -13.233706
          ],
          [
            -52.51814,
            -13.395716
          ],
          [
            -53.925361,
            -21.646247
          ],
          [
            -53.952156,
            -21.79945
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "988",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "17580",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.275928,
            2.319505
          ],
          [
            -30.061518,
            2.485371
          ],
          [
            -18.761219,
            11.164337
          ],
          [
            -18.548805,
            11.325646
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "80",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "17536",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.278366,
            2.314665
          ],
          [
            -30.233632,
            2.147001
          ],
          [
            -27.906487,
            -6.567068
          ],
          [
            -27.862176,
            -6.732161
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "36",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "175183",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.273065,
            2.314762
          ],
          [
            -30.09429,
            2.244184
          ],
          [
            -25.948665,
            0.6068
          ],
          [
            -25.770616,
            0.536456
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "183",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "175989",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.299792,
            2.314777
          ],
          [
            -30.95309,
            2.241281
          ],
          [
            -46.80212,
            0.457427
          ],
          [
            -47.454802,
            0.383947
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "989",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175990",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.3115,
            2.31478
          ],
          [
            -30.923829,
            2.270792
          ],
          [
            -39.995359,
            1.618974
          ],
          [
            -40.607588,
            1.574976
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "990",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175991",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.276798,
            2.314681
          ],
          [
            -30.148406,
            2.174051
          ],
          [
            -24.494937,
            -4.019321
          ],
          [
            -24.367972,
            -4.158143
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "991",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "175992",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.287677,
            2.314771
          ],
          [
            -30.616937,
            2.225637
          ],
          [
            -40.228346,
            -0.377766
          ],
          [
            -40.556766,
            -0.466738
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "992",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175993",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.289918,
            2.314783
          ],
          [
            -30.758863,
            2.214443
          ],
          [
            -46.207714,
            -1.093101
          ],
          [
            -46.677182,
            -1.193612
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "993",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- The gene desert mammary carcinoma susceptibility locus Mcs1a regulates Nr2f1 modifying mammary epithelial cell differentiation and proliferation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175994",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.282734,
            2.314755
          ],
          [
            -30.46661,
            2.197987
          ],
          [
            -37.415031,
            -2.216852
          ],
          [
            -37.598209,
            -2.333175
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "994",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Regulated expression of PTPRJ/CD148 and an antisense long noncoding RNA in macrophages by proinflammatory stimuli.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175995",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.277021,
            2.314706
          ],
          [
            -30.168795,
            2.18421
          ],
          [
            -25.698173,
            -3.208281
          ],
          [
            -25.591224,
            -3.337124
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "995",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175996",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.279996,
            2.314715
          ],
          [
            -30.315492,
            2.227499
          ],
          [
            -31.307611,
            -0.211429
          ],
          [
            -31.343447,
            -0.299544
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "996",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- FoxM1 regulates mammary luminal cell fate.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "175997",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.27661,
            2.314734
          ],
          [
            -30.102519,
            2.142798
          ],
          [
            -20.551813,
            -7.27672
          ],
          [
            -20.379282,
            -7.44584
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "997",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "36222",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -27.8648,
            -6.736872
          ],
          [
            -28.032855,
            -6.856471
          ],
          [
            -34.632422,
            -11.524291
          ],
          [
            -34.801572,
            -11.643051
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "36",
        "dest": "222",
        "label": "Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. -- Role of epithelial stem/progenitor cells in mammary cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "36224",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -27.867741,
            -6.736891
          ],
          [
            -28.160736,
            -6.847478
          ],
          [
            -38.732222,
            -10.817177
          ],
          [
            -39.023811,
            -10.926021
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "36",
        "dest": "224",
        "label": "Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. -- Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "36225",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -27.864457,
            -6.736884
          ],
          [
            -28.029678,
            -6.868862
          ],
          [
            -35.147556,
            -12.510829
          ],
          [
            -35.31262,
            -12.640433
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "36",
        "dest": "225",
        "label": "Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. -- Mammary stem cells and the differentiation hierarchy: current status and perspectives.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "36227",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -27.867818,
            -6.736869
          ],
          [
            -28.072579,
            -6.81243
          ],
          [
            -33.213582,
            -8.705351
          ],
          [
            -33.41934,
            -8.780928
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "36",
        "dest": "227",
        "label": "Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. -- The mammary cellular hierarchy and breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "222160",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.806204,
            -11.647719
          ],
          [
            -34.866393,
            -11.754446
          ],
          [
            -36.961939,
            -15.442059
          ],
          [
            -37.022297,
            -15.547383
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "222",
        "dest": "160",
        "label": "Role of epithelial stem/progenitor cells in mammary cancer. -- From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "30185",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.121233,
            32.947888
          ],
          [
            -16.066981,
            32.858461
          ],
          [
            -14.178119,
            29.689613
          ],
          [
            -14.123715,
            29.59678
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "185",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30186",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.119231,
            32.951819
          ],
          [
            -15.940532,
            33.061881
          ],
          [
            -8.323987,
            37.62242
          ],
          [
            -8.145499,
            37.726175
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "186",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30187",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.116277,
            32.951809
          ],
          [
            -15.850527,
            33.036416
          ],
          [
            -7.059343,
            35.788895
          ],
          [
            -6.793264,
            35.870782
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "187",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30188",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.121219,
            32.951851
          ],
          [
            -16.05975,
            33.053717
          ],
          [
            -13.669364,
            36.922083
          ],
          [
            -13.607515,
            37.019729
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "188",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30190",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.118402,
            32.951811
          ],
          [
            -15.913371,
            33.051603
          ],
          [
            -7.940139,
            36.84314
          ],
          [
            -7.733835,
            36.938898
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "190",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Prolactin activates ER\u03b1 in the absence of ligand in female mammary development and carcinogenesis in vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30192",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.12066,
            32.951817
          ],
          [
            -16.037364,
            33.0445
          ],
          [
            -13.032294,
            36.322098
          ],
          [
            -12.948674,
            36.411433
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "192",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30193",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.122999,
            32.951874
          ],
          [
            -16.15855,
            33.077055
          ],
          [
            -17.834392,
            38.770931
          ],
          [
            -17.869572,
            38.886021
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "193",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30194",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.121206,
            32.951858
          ],
          [
            -16.041854,
            33.08237
          ],
          [
            -12.11704,
            39.289572
          ],
          [
            -12.038475,
            39.408741
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "194",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "30195",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.122215,
            32.951832
          ],
          [
            -16.107734,
            33.08733
          ],
          [
            -15.354686,
            39.838593
          ],
          [
            -15.339981,
            39.964512
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "195",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Hormone signaling requirements for the conversion of non-mammary mouse cells to mammary cell fate(s) in vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "19568",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -15.352705,
            39.968172
          ],
          [
            -15.647518,
            40.008988
          ],
          [
            -20.883035,
            40.729745
          ],
          [
            -21.178064,
            40.77013
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "195",
        "dest": "68",
        "label": "Hormone signaling requirements for the conversion of non-mammary mouse cells to mammary cell fate(s) in vivo. -- <i>In vivo</i> reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "68393",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.192547,
            40.773751
          ],
          [
            -21.289006,
            40.890887
          ],
          [
            -25.945372,
            46.297655
          ],
          [
            -26.040854,
            46.40343
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "68",
        "dest": "393",
        "label": "<i>In vivo</i> reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling. -- Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "68394",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.194051,
            40.773704
          ],
          [
            -21.379268,
            40.883773
          ],
          [
            -30.007614,
            45.807682
          ],
          [
            -30.192968,
            45.909068
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "68",
        "dest": "394",
        "label": "<i>In vivo</i> reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling. -- Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "32138",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.096188,
            30.343618
          ],
          [
            -33.717805,
            30.306356
          ],
          [
            -28.223383,
            29.763723
          ],
          [
            -27.844884,
            29.726234
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "32",
        "dest": "138",
        "label": "Role of KLF5 in hormonal signaling and breast cancer development. -- The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "32200",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.120008,
            30.343585
          ],
          [
            -34.256516,
            30.259265
          ],
          [
            -38.55762,
            27.56603
          ],
          [
            -38.694096,
            27.479442
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "32",
        "dest": "200",
        "label": "Role of KLF5 in hormonal signaling and breast cancer development. -- Alpha-actinin 4 and tumorigenesis of breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "32201",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.120892,
            30.343604
          ],
          [
            -34.314059,
            30.250245
          ],
          [
            -41.098604,
            26.916128
          ],
          [
            -41.292361,
            26.819379
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "32",
        "dest": "201",
        "label": "Role of KLF5 in hormonal signaling and breast cancer development. -- Impact of obesity on mammary gland inflammation and local estrogen production.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "138135",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -27.825374,
            29.722133
          ],
          [
            -27.878497,
            29.612322
          ],
          [
            -30.027928,
            25.071851
          ],
          [
            -30.081446,
            24.956473
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "135",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "138198",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -27.83388,
            29.722166
          ],
          [
            -28.272599,
            29.628185
          ],
          [
            -43.750834,
            26.257614
          ],
          [
            -44.189095,
            26.160668
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "198",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "138799",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -27.83693,
            29.726231
          ],
          [
            -28.259939,
            29.794586
          ],
          [
            -39.230839,
            31.550916
          ],
          [
            -39.653875,
            31.617997
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "799",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Kr\u00fcppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "138800",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -27.852858,
            29.722174
          ],
          [
            -28.360491,
            29.686032
          ],
          [
            -35.489047,
            29.177133
          ],
          [
            -35.99659,
            29.140802
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "800",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Kr\u00fcppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "138801",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -27.83878,
            29.722168
          ],
          [
            -28.236116,
            29.666067
          ],
          [
            -36.7219,
            28.460485
          ],
          [
            -37.119454,
            28.403659
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "801",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "138802",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -27.833883,
            29.722171
          ],
          [
            -28.341013,
            29.613828
          ],
          [
            -48.966348,
            25.111858
          ],
          [
            -49.474853,
            24.998598
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "802",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "138803",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -27.828311,
            29.722136
          ],
          [
            -28.058432,
            29.601365
          ],
          [
            -38.302701,
            24.084165
          ],
          [
            -38.532768,
            23.957247
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "803",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Kruppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34213",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.335954,
            30.392568
          ],
          [
            -20.870286,
            30.422479
          ],
          [
            -15.373875,
            30.774846
          ],
          [
            -14.908403,
            30.804629
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "213",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34206",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.366326,
            30.392648
          ],
          [
            -21.296392,
            30.536141
          ],
          [
            -17.658256,
            37.697213
          ],
          [
            -17.588983,
            37.827579
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "206",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34207",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.368126,
            30.392578
          ],
          [
            -21.420044,
            30.527813
          ],
          [
            -24.052206,
            37.128284
          ],
          [
            -24.104896,
            37.255121
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "207",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- A role for the TGFbeta-Par6 polarity pathway in breast cancer progression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34209",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.367878,
            30.392645
          ],
          [
            -21.400787,
            30.522433
          ],
          [
            -22.952067,
            36.437295
          ],
          [
            -22.984635,
            36.557076
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "209",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- Inhibiting breast cancer progression by exploiting TGFbeta signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34210",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.365535,
            30.392608
          ],
          [
            -21.265267,
            30.506345
          ],
          [
            -17.037168,
            35.17826
          ],
          [
            -16.936021,
            35.286973
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "210",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34212",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.367506,
            30.392576
          ],
          [
            -21.376916,
            30.512249
          ],
          [
            -21.800418,
            35.741868
          ],
          [
            -21.809928,
            35.855688
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "212",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- A role of TGF\u00df1 dependent 14-3-3\u03c3 phosphorylation at Ser69 and Ser74 in the regulation of gene transcription, stemness and radioresistance.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34214",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.365508,
            30.392576
          ],
          [
            -21.269915,
            30.497803
          ],
          [
            -17.478702,
            34.577197
          ],
          [
            -17.382457,
            34.678319
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "214",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGF\u03b2 in claudin-low breast tumor cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34215",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.367706,
            30.392597
          ],
          [
            -21.383395,
            30.48255
          ],
          [
            -21.911107,
            33.458594
          ],
          [
            -21.927081,
            33.547151
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "215",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "38234",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            40.68367,
            -20.037218
          ],
          [
            40.670157,
            -20.079331
          ],
          [
            40.467208,
            -20.710444
          ],
          [
            40.45335,
            -20.753444
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "234",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- Small molecule antagonists of the Wnt/\u03b2-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "38233",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            40.691381,
            -20.037226
          ],
          [
            40.986544,
            -20.130309
          ],
          [
            50.513093,
            -23.103718
          ],
          [
            50.808399,
            -23.194893
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "233",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "38238",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            40.683999,
            -20.037311
          ],
          [
            40.672296,
            -20.108367
          ],
          [
            40.392604,
            -21.796864
          ],
          [
            40.381137,
            -21.865678
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "238",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- Key signaling nodes in mammary gland development and cancer: \u03b2-catenin.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "38239",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            40.691137,
            -20.037232
          ],
          [
            40.942523,
            -20.119604
          ],
          [
            48.122134,
            -22.453309
          ],
          [
            48.372713,
            -22.53408
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "239",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "38240",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            40.696596,
            -20.037218
          ],
          [
            41.054706,
            -20.101686
          ],
          [
            49.166627,
            -21.554809
          ],
          [
            49.524914,
            -21.618663
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "240",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- Wnt signaling in stem and cancer stem cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "65380",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            22.39434,
            -45.207348
          ],
          [
            22.433695,
            -45.324731
          ],
          [
            24.534936,
            -51.241054
          ],
          [
            24.574948,
            -51.347081
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "380",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Lineage enforcement by inductive mesenchyme on adult epithelial stem cells across developmental germ layers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "65381",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            22.397964,
            -45.207337
          ],
          [
            22.704415,
            -45.328963
          ],
          [
            39.746739,
            -51.684569
          ],
          [
            40.054606,
            -51.792079
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "381",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Embryonic stem cells are redirected to non-tumorigenic epithelial cell fate by interaction with the mammary microenvironment.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "65382",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            22.397858,
            -45.207339
          ],
          [
            22.673314,
            -45.31956
          ],
          [
            36.81848,
            -50.785264
          ],
          [
            37.094727,
            -50.886246
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "382",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Peroxisomal membrane channel Pxmp2 in the mammary fat pad is essential for stromal lipid homeostasis and for development of mammary gland epithelium in mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "65383",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            22.394501,
            -45.207394
          ],
          [
            22.440186,
            -45.316341
          ],
          [
            24.645546,
            -50.327552
          ],
          [
            24.690769,
            -50.425261
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "383",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "65384",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            22.399401,
            -45.207333
          ],
          [
            22.73179,
            -45.305227
          ],
          [
            37.694805,
            -49.537749
          ],
          [
            38.027195,
            -49.627915
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "384",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Amniotic fluid stem cell-based models to study the effects of gene mutations and toxicants on male germ cell formation.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "65385",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            22.394053,
            -45.207331
          ],
          [
            22.409116,
            -45.298856
          ],
          [
            23.044257,
            -49.024223
          ],
          [
            23.059451,
            -49.110147
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "385",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Bovine mammary epithelial cells retain stem-like phenotype in long-term cultures.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "65386",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            22.395067,
            -45.207329
          ],
          [
            22.459352,
            -45.289818
          ],
          [
            24.911496,
            -48.347083
          ],
          [
            24.97614,
            -48.425331
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "386",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- The potential of amniotic fluid stem cells for cellular therapy and tissue engineering.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "65387",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            22.402746,
            -45.207322
          ],
          [
            22.875974,
            -45.294182
          ],
          [
            41.928777,
            -48.681051
          ],
          [
            42.403162,
            -48.762643
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "387",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Reconstitution of mammary epithelial morphogenesis by murine embryonic stem cells undergoing hematopoietic stem cell differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "65388",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            22.419572,
            -45.207322
          ],
          [
            23.123926,
            -45.252225
          ],
          [
            38.024609,
            -46.193855
          ],
          [
            38.72905,
            -46.237979
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "388",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- The mouse mammary microenvironment redirects mesoderm-derived bone marrow cells to a mammary epithelial progenitor cell fate.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "116674",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.056001,
            -40.210906
          ],
          [
            21.072417,
            -40.293885
          ],
          [
            21.654193,
            -43.168321
          ],
          [
            21.670666,
            -43.247833
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "116",
        "dest": "674",
        "label": "Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. -- The miR-17/92 cluster is targeted by STAT5 but dispensable for mammary development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "116676",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.060216,
            -40.210901
          ],
          [
            21.256046,
            -40.287405
          ],
          [
            27.68079,
            -42.749191
          ],
          [
            27.876811,
            -42.822826
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "116",
        "dest": "676",
        "label": "Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. -- Basal cell signaling by p63 controls luminal progenitor function and lactation via NRG1.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "64368",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            28.760981,
            -41.049515
          ],
          [
            28.767562,
            -41.130366
          ],
          [
            28.99283,
            -43.836744
          ],
          [
            28.999427,
            -43.914248
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "368",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Extracellular matrix composition reveals complex and dynamic stromal-epithelial interactions in the mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "64369",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            28.762099,
            -41.049527
          ],
          [
            28.835299,
            -41.154598
          ],
          [
            32.058505,
            -45.613656
          ],
          [
            32.130892,
            -45.710025
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "369",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- P190A RhoGAP is required for mammary gland development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64370",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            28.774757,
            -41.049473
          ],
          [
            29.33363,
            -41.120248
          ],
          [
            46.533395,
            -43.261021
          ],
          [
            47.091736,
            -43.3293
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "370",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90\u03b2.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "64371",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            28.764142,
            -41.049499
          ],
          [
            28.982133,
            -41.167404
          ],
          [
            39.897364,
            -46.798805
          ],
          [
            40.115861,
            -46.906068
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "371",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Mast cells contribute to the stromal microenvironment in mammary gland branching morphogenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "64372",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            28.760049,
            -41.049478
          ],
          [
            28.720894,
            -41.137828
          ],
          [
            27.227283,
            -44.418907
          ],
          [
            27.187907,
            -44.50305
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "372",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- The role of the microenvironment in mammary gland development and cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "64373",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            28.764403,
            -41.049489
          ],
          [
            29.022306,
            -41.178051
          ],
          [
            43.169291,
            -47.842148
          ],
          [
            43.428307,
            -47.957048
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "373",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "64374",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            28.769137,
            -41.049468
          ],
          [
            29.296158,
            -41.161161
          ],
          [
            54.733536,
            -46.324966
          ],
          [
            55.261355,
            -46.427388
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "374",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64375",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            28.846182,
            -41.046013
          ],
          [
            30.425292,
            -41.014645
          ],
          [
            53.405989,
            -40.556479
          ],
          [
            55.014271,
            -40.524297
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "375",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Transplantation of a mammary stromal cell line into a mammary fat pad: development of the site-specific in vivo analysis system for mammary stromal cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "64376",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            28.767337,
            -41.049468
          ],
          [
            29.11073,
            -41.14234
          ],
          [
            42.936108,
            -44.771961
          ],
          [
            43.280339,
            -44.859598
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "376",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64377",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            28.764787,
            -41.049471
          ],
          [
            29.039166,
            -41.17158
          ],
          [
            43.49836,
            -47.283204
          ],
          [
            43.773682,
            -47.39341
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "377",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64378",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            28.76733,
            -41.049468
          ],
          [
            29.138839,
            -41.149979
          ],
          [
            45.316679,
            -45.376978
          ],
          [
            45.689874,
            -45.471017
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "378",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Mammary ductal elongation and myoepithelial migration are regulated by the composition of the extracellular matrix.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64379",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            28.776188,
            -41.049471
          ],
          [
            29.172776,
            -41.095016
          ],
          [
            37.121895,
            -42.001247
          ],
          [
            37.518522,
            -42.046131
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "379",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- SHARPIN regulates collagen architecture and ductal outgrowth in the developing mouse mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "38167",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            40.047302,
            -51.795003
          ],
          [
            39.597076,
            -51.851599
          ],
          [
            26.107071,
            -53.51455
          ],
          [
            25.65764,
            -53.568866
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "381",
        "dest": "67",
        "label": "Embryonic stem cells are redirected to non-tumorigenic epithelial cell fate by interaction with the mammary microenvironment. -- Reprogramming human cancer cells in the mouse mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "67391",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.661249,
            -53.568864
          ],
          [
            25.943273,
            -53.542893
          ],
          [
            30.08556,
            -53.159613
          ],
          [
            30.367383,
            -53.13341
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "67",
        "dest": "391",
        "label": "Reprogramming human cancer cells in the mouse mammary gland. -- The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "67392",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.671259,
            -53.568864
          ],
          [
            26.349308,
            -53.531331
          ],
          [
            40.540274,
            -52.738131
          ],
          [
            41.218081,
            -52.699876
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "67",
        "dest": "392",
        "label": "Reprogramming human cancer cells in the mouse mammary gland. -- Human breast cancer cells are redirected to mammary epithelial cells upon interaction with the regenerating mammary gland microenvironment in-vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81211",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.691323,
            -43.053035
          ],
          [
            -1.851701,
            -43.167291
          ],
          [
            -9.983503,
            -48.68058
          ],
          [
            -10.144297,
            -48.784075
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "211",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "81479",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.688389,
            -43.053058
          ],
          [
            -1.662967,
            -43.136531
          ],
          [
            -0.728924,
            -46.124388
          ],
          [
            -0.703388,
            -46.203913
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "479",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81480",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.688848,
            -43.053042
          ],
          [
            -1.684615,
            -43.157074
          ],
          [
            -1.489671,
            -47.755471
          ],
          [
            -1.485388,
            -47.852288
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "480",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "81481",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.689089,
            -43.053029
          ],
          [
            -1.701402,
            -43.17623
          ],
          [
            -2.37675,
            -49.553372
          ],
          [
            -2.389278,
            -49.664659
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "481",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "81482",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.691346,
            -43.053049
          ],
          [
            -1.859769,
            -43.172761
          ],
          [
            -10.735303,
            -49.149727
          ],
          [
            -10.904306,
            -49.25724
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "482",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- Cell fate takes a slug in BRCA1-associated breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81484",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.69133,
            -43.053047
          ],
          [
            -1.865607,
            -43.177677
          ],
          [
            -11.425316,
            -49.625003
          ],
          [
            -11.600345,
            -49.735952
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "484",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "81485",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.689719,
            -43.053038
          ],
          [
            -1.743082,
            -43.167418
          ],
          [
            -4.448434,
            -48.685848
          ],
          [
            -4.502588,
            -48.790711
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "485",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81486",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.689135,
            -43.053056
          ],
          [
            -1.705292,
            -43.181894
          ],
          [
            -2.616494,
            -50.008805
          ],
          [
            -2.63251,
            -50.121117
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "486",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81487",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.691375,
            -43.05307
          ],
          [
            -1.876567,
            -43.184711
          ],
          [
            -12.469387,
            -50.24299
          ],
          [
            -12.652988,
            -50.3572
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "487",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- BRCA1 mutations and luminal-basal transformation.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "83495",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.345312,
            -45.660141
          ],
          [
            -0.400559,
            -45.774396
          ],
          [
            -3.202144,
            -51.263478
          ],
          [
            -3.256857,
            -51.364772
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "495",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "83496",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.345303,
            -45.66013
          ],
          [
            -0.402823,
            -45.779716
          ],
          [
            -3.474568,
            -51.796465
          ],
          [
            -3.531558,
            -51.901304
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "496",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "83497",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.345305,
            -45.660098
          ],
          [
            -0.406281,
            -45.784094
          ],
          [
            -3.845143,
            -52.334793
          ],
          [
            -3.905587,
            -52.442245
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "497",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "83498",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.343087,
            -45.660091
          ],
          [
            -0.247385,
            -45.773912
          ],
          [
            4.731254,
            -51.377065
          ],
          [
            4.826054,
            -51.477751
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "498",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "83499",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.34253,
            -45.660069
          ],
          [
            -0.218451,
            -45.764191
          ],
          [
            5.769614,
            -50.559426
          ],
          [
            5.895325,
            -50.655304
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "499",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- Correlations between BRCA1 defect and environmental factors in the risk of breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "83500",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.345298,
            -45.660128
          ],
          [
            -0.396916,
            -45.768036
          ],
          [
            -2.888591,
            -50.73017
          ],
          [
            -2.939686,
            -50.826897
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "500",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "83501",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.342455,
            -45.660109
          ],
          [
            -0.222512,
            -45.759421
          ],
          [
            5.177592,
            -50.048441
          ],
          [
            5.296233,
            -50.138689
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "501",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "92189",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.947231,
            -42.81457
          ],
          [
            6.817425,
            -42.910891
          ],
          [
            1.343812,
            -46.835531
          ],
          [
            1.212872,
            -46.926138
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "189",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "92443",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.935166,
            -42.814543
          ],
          [
            6.609276,
            -42.853349
          ],
          [
            0.861248,
            -43.533778
          ],
          [
            0.535235,
            -43.572142
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "443",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "92524",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.948842,
            -42.814545
          ],
          [
            6.897261,
            -42.935239
          ],
          [
            4.143324,
            -49.036012
          ],
          [
            4.090886,
            -49.145658
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "524",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "92525",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.950004,
            -42.814566
          ],
          [
            6.976524,
            -42.922222
          ],
          [
            8.226346,
            -47.782411
          ],
          [
            8.253194,
            -47.882238
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "525",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- FOXA1 represses the molecular phenotype of basal breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "92538",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.948397,
            -42.814561
          ],
          [
            6.871661,
            -42.927224
          ],
          [
            3.077137,
            -48.241341
          ],
          [
            2.999329,
            -48.345047
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "538",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "92539",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.950349,
            -42.814605
          ],
          [
            6.995034,
            -42.917313
          ],
          [
            8.962668,
            -47.270094
          ],
          [
            9.006858,
            -47.364038
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "539",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- Loss of ER\u03b1 and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "75349",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.678936,
            -48.690876
          ],
          [
            9.62742,
            -48.591372
          ],
          [
            7.199103,
            -43.677189
          ],
          [
            7.148124,
            -43.569314
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "75",
        "dest": "349",
        "label": "Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis. -- Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "75445",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.679972,
            -48.694034
          ],
          [
            9.692078,
            -48.78586
          ],
          [
            10.236991,
            -52.74676
          ],
          [
            10.249228,
            -52.831881
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "75",
        "dest": "445",
        "label": "Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis. -- Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34992",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.14686,
            -43.565879
          ],
          [
            7.136757,
            -43.527539
          ],
          [
            6.960198,
            -42.853606
          ],
          [
            6.950033,
            -42.814582
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "349",
        "dest": "92",
        "label": "Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. -- Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "9092",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.486454,
            -49.581322
          ],
          [
            8.459427,
            -49.469493
          ],
          [
            6.976729,
            -42.939662
          ],
          [
            6.949945,
            -42.814545
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "92",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "90526",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.483924,
            -49.584404
          ],
          [
            8.285157,
            -49.689489
          ],
          [
            -2.054005,
            -54.846966
          ],
          [
            -2.253398,
            -54.940574
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "526",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "90527",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.486731,
            -49.584446
          ],
          [
            8.479898,
            -49.695361
          ],
          [
            8.114947,
            -55.256864
          ],
          [
            8.108178,
            -55.353457
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "527",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "90528",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.483986,
            -49.58439
          ],
          [
            8.299123,
            -49.683294
          ],
          [
            -0.843307,
            -54.326895
          ],
          [
            -1.028546,
            -54.416033
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "528",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Foxa1 is essential for mammary duct formation.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "90529",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.483947,
            -49.584396
          ],
          [
            8.309627,
            -49.676794
          ],
          [
            0.282036,
            -53.743803
          ],
          [
            0.10763,
            -53.828126
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "529",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Runx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasion.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "90530",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.487604,
            -49.584388
          ],
          [
            8.535681,
            -49.678449
          ],
          [
            10.801349,
            -53.907382
          ],
          [
            10.85002,
            -53.9939
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "530",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Distinct luminal-type mammary carcinomas arise from orthotopic Trp53-null mammary transplantation of juvenile versus adult mice.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "90531",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.487635,
            -49.584412
          ],
          [
            8.541462,
            -49.687414
          ],
          [
            11.271035,
            -54.628487
          ],
          [
            11.324342,
            -54.719558
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "531",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- RUNX1 prevents oestrogen-mediated AXIN1 suppression and \u03b2-catenin activation in ER-positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97312",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.649437,
            6.399675
          ],
          [
            -62.564561,
            6.50271
          ],
          [
            -59.709324,
            9.954508
          ],
          [
            -59.6243,
            10.056806
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "312",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "97584",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.66384,
            6.399653
          ],
          [
            -62.893153,
            6.442396
          ],
          [
            -66.21023,
            7.060236
          ],
          [
            -66.439945,
            7.102991
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "584",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "97585",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.645958,
            6.399647
          ],
          [
            -62.3618,
            6.521424
          ],
          [
            -50.979265,
            11.369376
          ],
          [
            -50.69308,
            11.490357
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "585",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "97586",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.640715,
            6.399663
          ],
          [
            -62.354171,
            6.462426
          ],
          [
            -56.380648,
            7.768929
          ],
          [
            -56.09497,
            7.831318
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "586",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97587",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.646719,
            6.394995
          ],
          [
            -62.540531,
            6.341705
          ],
          [
            -60.650373,
            5.392236
          ],
          [
            -60.544319,
            5.338915
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "587",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- The diverse distribution of risk factors between breast cancer subtypes of ER, PR and HER2: a 10-year retrospective multi-center study in China.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97588",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.62333,
            6.39501
          ],
          [
            -61.772618,
            6.324589
          ],
          [
            -41.841564,
            4.672202
          ],
          [
            -40.990407,
            4.60154
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "588",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "97589",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.634681,
            6.395007
          ],
          [
            -62.015384,
            6.308851
          ],
          [
            -44.361088,
            3.847524
          ],
          [
            -43.741698,
            3.761015
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "589",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "97590",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.646553,
            6.395004
          ],
          [
            -62.443635,
            6.296929
          ],
          [
            -55.894396,
            3.123213
          ],
          [
            -55.691378,
            3.024628
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "590",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patients.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "97591",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.642246,
            6.394995
          ],
          [
            -62.219377,
            6.286756
          ],
          [
            -47.233982,
            2.439387
          ],
          [
            -46.811503,
            2.330676
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "591",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Expression of AIB1 protein as a prognostic factor in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97592",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.648091,
            6.394988
          ],
          [
            -62.487481,
            6.280142
          ],
          [
            -56.475105,
            1.966755
          ],
          [
            -56.315136,
            1.851729
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "592",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Estrogen and progesterone receptors in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97593",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.653954,
            6.394976
          ],
          [
            -62.734997,
            6.321169
          ],
          [
            -64.694885,
            4.533342
          ],
          [
            -64.776193,
            4.459062
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "593",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97594",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.648671,
            6.394988
          ],
          [
            -62.485432,
            6.253221
          ],
          [
            -54.968168,
            -0.302761
          ],
          [
            -54.804849,
            -0.445461
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "594",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97595",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.651732,
            6.394995
          ],
          [
            -62.670989,
            6.271057
          ],
          [
            -63.450233,
            1.237974
          ],
          [
            -63.469633,
            1.112372
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "595",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Histological and immunohistochemical study of estrogen and progesterone receptors in normal human breast tissue in adult age groups vulnerable to malignancy.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "97596",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.654604,
            6.394976
          ],
          [
            -62.837569,
            6.261892
          ],
          [
            -70.719844,
            0.505919
          ],
          [
            -70.902636,
            0.372151
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "596",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Progesterone receptor targeting with radiolabelled steroids: an approach in predicting breast cancer response to therapy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "585141",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -50.674271,
            11.49497
          ],
          [
            -50.059637,
            11.600762
          ],
          [
            -28.374982,
            15.305064
          ],
          [
            -27.76099,
            15.409078
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "585",
        "dest": "141",
        "label": "Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers. -- Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "112645",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            59.749014,
            19.08916
          ],
          [
            60.142327,
            19.048311
          ],
          [
            65.853886,
            18.45398
          ],
          [
            66.246647,
            18.413032
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "112",
        "dest": "645",
        "label": "Multimodal regulation of E2F1 gene expression by progestins. -- Deep sequencing reveals new aspects of progesterone receptor signaling in breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "112657",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            59.725968,
            19.089084
          ],
          [
            59.67813,
            19.026153
          ],
          [
            58.659145,
            17.680165
          ],
          [
            58.611406,
            17.616853
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "112",
        "dest": "657",
        "label": "Multimodal regulation of E2F1 gene expression by progestins. -- Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1).",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "112659",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            59.730227,
            19.089157
          ],
          [
            59.830511,
            19.000878
          ],
          [
            62.893121,
            16.283242
          ],
          [
            62.993287,
            16.193683
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "112",
        "dest": "659",
        "label": "Multimodal regulation of E2F1 gene expression by progestins. -- The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "657127",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            58.606916,
            17.612278
          ],
          [
            58.427555,
            17.464129
          ],
          [
            49.556152,
            10.00501
          ],
          [
            49.378569,
            9.853483
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "657",
        "dest": "127",
        "label": "Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1). -- Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "115181",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.934203,
            55.998028
          ],
          [
            30.702043,
            56.087947
          ],
          [
            18.778768,
            60.430871
          ],
          [
            18.548823,
            60.509456
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "181",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115520",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.924202,
            55.998
          ],
          [
            30.230894,
            56.065313
          ],
          [
            2.935873,
            58.62327
          ],
          [
            2.241281,
            58.686055
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "520",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Coregulation of genetic programs by the transcription factors NFIB and STAT5.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115537",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.928829,
            55.998
          ],
          [
            30.41087,
            56.074673
          ],
          [
            7.224255,
            59.35365
          ],
          [
            6.706358,
            59.423528
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "537",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Loss of EZH2 results in precocious mammary gland development and activation of STAT5-dependent genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115666",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.931394,
            55.998008
          ],
          [
            30.64958,
            56.057211
          ],
          [
            20.922879,
            58.045507
          ],
          [
            20.640351,
            58.101677
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "666",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Genome-wide chromatin occupancy analysis reveals a role for ASH2 in transcriptional pausing.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115667",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.934474,
            55.998015
          ],
          [
            30.749425,
            56.075186
          ],
          [
            22.511667,
            59.356851
          ],
          [
            22.326662,
            59.427166
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "667",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Chromatin signature of embryonic pluripotency is established during genome activation.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "115668",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.93339,
            55.998007
          ],
          [
            30.670205,
            56.079217
          ],
          [
            18.265586,
            59.716724
          ],
          [
            18.00214,
            59.790023
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "668",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Three distinct patterns of histone H3Y41 phosphorylation mark active genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115669",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.93836,
            55.995369
          ],
          [
            30.973066,
            55.931563
          ],
          [
            32.248158,
            53.513509
          ],
          [
            32.283016,
            53.445366
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "669",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "115670",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.932153,
            55.998014
          ],
          [
            30.630241,
            56.070492
          ],
          [
            17.965055,
            58.990209
          ],
          [
            17.662072,
            59.057215
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "670",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Epigenetic modifications unlock the milk protein gene loci during mouse mammary gland development and differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115671",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.93021,
            55.998001
          ],
          [
            30.562576,
            56.062614
          ],
          [
            16.670914,
            58.425824
          ],
          [
            16.302998,
            58.486367
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "671",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115673",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.931688,
            55.998008
          ],
          [
            30.544549,
            56.083377
          ],
          [
            11.398548,
            60.074668
          ],
          [
            11.010621,
            60.150975
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "673",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Differential cytokine sensitivities of STAT5-dependent enhancers rely on Stat5 autoregulation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "669118",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            32.278183,
            53.442537
          ],
          [
            31.923093,
            53.352721
          ],
          [
            14.679463,
            48.75993
          ],
          [
            14.325871,
            48.660953
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "669",
        "dest": "118",
        "label": "Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration. -- PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "118179",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.322835,
            48.660976
          ],
          [
            14.472764,
            48.755709
          ],
          [
            21.376253,
            52.926188
          ],
          [
            21.527923,
            53.013648
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "179",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Forced activation of Stat5 subjects mammary epithelial cells to DNA damage and preferential induction of the cellular response mechanism during proliferation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118665",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.315777,
            48.657861
          ],
          [
            14.140263,
            48.598513
          ],
          [
            8.979503,
            46.822221
          ],
          [
            8.803163,
            46.760454
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "665",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "118672",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.330405,
            48.660953
          ],
          [
            14.914473,
            48.750697
          ],
          [
            40.771696,
            52.564535
          ],
          [
            41.355555,
            52.647092
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "672",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118679",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.325532,
            48.660962
          ],
          [
            14.608865,
            48.745955
          ],
          [
            26.433411,
            52.165844
          ],
          [
            26.716283,
            52.244638
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "679",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Prolactin promotes mammary pathogenesis independently from cyclin D1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118680",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.330368,
            48.660958
          ],
          [
            14.798711,
            48.733391
          ],
          [
            31.54436,
            51.255058
          ],
          [
            32.012378,
            51.32364
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "680",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "118681",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.326971,
            48.660964
          ],
          [
            14.662365,
            48.739768
          ],
          [
            27.643528,
            51.695543
          ],
          [
            27.977824,
            51.76925
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "681",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Dystroglycan controls signaling of multiple hormones through modulation of STAT5 activity.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118682",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.328141,
            48.660953
          ],
          [
            14.590381,
            48.712962
          ],
          [
            21.391651,
            50.043085
          ],
          [
            21.653909,
            50.093656
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "682",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Fyn regulates adipogenesis by promoting PIKE-A/STAT5a interaction.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118683",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.321808,
            48.660974
          ],
          [
            14.418592,
            48.765284
          ],
          [
            19.325353,
            53.773154
          ],
          [
            19.423573,
            53.867862
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "683",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Function of phosphoenolpyruvate carboxykinase in mammary gland epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118684",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.317988,
            48.661011
          ],
          [
            14.183962,
            48.751501
          ],
          [
            8.40935,
            52.497
          ],
          [
            8.276846,
            52.579456
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "684",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "665120",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.797757,
            46.760445
          ],
          [
            8.745752,
            46.867808
          ],
          [
            6.109293,
            52.03189
          ],
          [
            6.056517,
            52.129732
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "665",
        "dest": "120",
        "label": "Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. -- Signal transducer and activator of transcription 5a inhibited by pimozide may regulate survival of goat mammary gland epithelial cells by regulating parathyroid hormone-related protein.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "665168",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.792916,
            46.757232
          ],
          [
            8.552073,
            46.688513
          ],
          [
            0.650495,
            44.385419
          ],
          [
            0.409413,
            44.313666
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "665",
        "dest": "168",
        "label": "Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. -- Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "119140",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -64.935262,
            19.919146
          ],
          [
            -63.92625,
            19.960343
          ],
          [
            -49.049381,
            20.566488
          ],
          [
            -48.040832,
            20.607494
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "119",
        "dest": "140",
        "label": "Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a. -- Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.",
        "weight": "",
        "level": 2
      }
    }
  ]
}